WO2016030822A1 - Leadless neurostimulator - Google Patents

Leadless neurostimulator Download PDF

Info

Publication number
WO2016030822A1
WO2016030822A1 PCT/IB2015/056437 IB2015056437W WO2016030822A1 WO 2016030822 A1 WO2016030822 A1 WO 2016030822A1 IB 2015056437 W IB2015056437 W IB 2015056437W WO 2016030822 A1 WO2016030822 A1 WO 2016030822A1
Authority
WO
WIPO (PCT)
Prior art keywords
antenna
mems film
implementations
stimulation
ribbon cable
Prior art date
Application number
PCT/IB2015/056437
Other languages
French (fr)
Inventor
Andre Mercanzini
Original Assignee
Aleva Neurotherapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aleva Neurotherapeutics Sa filed Critical Aleva Neurotherapeutics Sa
Priority to EP15760290.5A priority Critical patent/EP3185948B1/en
Priority to CA2959281A priority patent/CA2959281A1/en
Priority to EP21184317.2A priority patent/EP3912676A1/en
Priority to JP2017530449A priority patent/JP2017525545A/en
Publication of WO2016030822A1 publication Critical patent/WO2016030822A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526Head electrodes
    • A61N1/0529Electrodes for brain stimulation
    • A61N1/0534Electrodes for deep brain stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36125Details of circuitry or electric components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36135Control systems using physiological parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37205Microstimulators, e.g. implantable through a cannula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • A61N1/37223Circuits for electromagnetic coupling
    • A61N1/37229Shape or location of the implanted or external antenna
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3756Casings with electrodes thereon, e.g. leadless stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source

Definitions

  • Deep brain stimulation is a neurostimulation therapy which involves electrical stimulation systems that stimulate the human brain and body.
  • DBS can be used to treat a number of neurological disorders.
  • DBS involves electrically stimulating a target area of the brain.
  • a neurostimulation device includes a stimulation capsule with a proximal and distal end.
  • the stimulation capsule includes a MEMS film with a plurality of electrodes.
  • the MEMS film defines a lumen.
  • the stimulation capsule also includes a stimulation source disposed within the lumen and electrically coupled to at least one of the plurality of electrodes.
  • the stimulation capsule can also include a power supply disposed within the lumen and electrically coupled with the stimulation source.
  • the stimulation capsule can include a tether coupled with the proximal end of the stimulation capsule.
  • a diameter of the stimulation capsule is less than a diameter of the tether.
  • the tether can include an antenna or the MEMS film can include a strip or a serpentine antenna.
  • the antenna can be configured to operate at a center frequency of one of 6.790 MHz, 13.560 MHz, 27.120 MHz, 40.680 MHz, 433.920 MHz, 915.000 MHz, 2.450 GHz, 5.800 GHz, and 24.125 GHz.
  • the antenna is forms a loop.
  • the antenna can be used to program the stimulation capsule, and the antenna can include one or more wires in electrical communication with the stimulation capsule.
  • the one or more wires can each couple with a wire tether contact disposed on a ribbon cable.
  • the ribbon cable can extend from a distal end of the MEMS film into the lumen.
  • the stimulation source and the power supply are disposed on the ribbon cable.
  • the power supply can be battery or super-capacitor.
  • a recording circuit can also be coupled with the ribbon cable.
  • the MEMS film includes a first polymeric layer, a first barrier layer, a metal layer, a second barrier layer, and a second polymeric layer.
  • a method of manufacturing a stimulation device includes forming a MEMS film.
  • the MEMS film can include a plurality of electrodes and a ribbon cable extending from a distal end of the MEMS film.
  • the method can also include coupling a stimulation source with a first plurality of contacts.
  • the first plurality of contacts can be disposed on a first face of the ribbon cable and can be in electrical communication with at least one of the plurality of electrodes.
  • a power supply can be coupled with a second plurality of contacts.
  • the second plurality of contacts can be disposed on a second face of the ribbon cable.
  • the method also includes folding the ribbon cable toward a face of the MEMS film, and forming, with the MEMS film, a lumen.
  • the ribbon cable can be disposed within the lumen.
  • the method also includes coupling a recording circuit on a third plurality of contacts disposed on the first face of the ribbon cable.
  • the first face of the ribbon cable can be different than the second face of the ribbon cable.
  • the method can also include filling the lumen with an encapsulating epoxy.
  • a lead wire can be coupled with a tether contact.
  • the tether contact can be disposed toward a distal tip of the ribbon cable.
  • the method includes heat molding the MEMS film to form the lumen.
  • the power source can include a rechargeable battery of a super capacitor.
  • FIGS. 1A and IB illustrates an example leadless stimulator system.
  • FIGS. 2 and 3 illustrate an example leadless stimulator from the leadless stimulator system of FIG. 1A.
  • FIG. 4 illustrates an enlarged view of the leadless stimulator from FIGS. 2 and 3.
  • FIGS. 5 and 6 illustrate an example MEMS film for use in the example leadless stimulator of FIG. 1A.
  • FIG. 7 illustrates an enlarged view of example contact pads for the MEMS film of FIGS. 5 and 6.
  • FIGS. 8-13 illustrate an example, assembled contact pad for the MEMS film of FIGS. 5 and 6.
  • FIG. 14 illustrates an example leadless stimulator with a micro -antenna.
  • FIGS. 15-17 illustrate an example MEMS film for the example leadless stimulator of FIG. 14.
  • FIGS. 18 and 19 illustrate a cutaway view of an example leadless stimulator with micro-antenna.
  • FIGS. 20A and 20B illustrate the internal arrangement of an example leadless stimulator.
  • FIGS. 21 and 22 illustrate another example MEMS film with a micro-antenna.
  • FIGS. 23A-23M illustrate an example thin-film micro-fabrication method for fabricating a MEMS film.
  • FIG. 23N illustrates an example method for forming the thin-film of FIGS. 23 A- 23M into a leadless stimulator.
  • FIG. 24 illustrates an example deployment system of the leadless stimulator system of FIG. 1.
  • FIGS. 25A and 25B illustrate a cut away and perspective view, respectively, of the distal end of the guide tube for the deployment system of FIG. 24.
  • FIGS 26A-26C illustrate an example leg support stent for the deployment system of FIG. 24.
  • FIG. 27 illustrates an example MEMS film for the deployment system of FIG. 24.
  • FIGS. 28A and 28B illustrate the MEMS film coupled with the leg support stent.
  • FIGS. 29A and 29B illustrate an example outer tube of the guide tube.
  • FIGS. 30A and 30B illustrate two views of the guide tube with the distal legs deployed.
  • FIGS. 31 A and 3 IB illustrate an example deployment mechanism for the deployment system of FIG. 24.
  • FIGS. 32A and 32B illustrate the distal end of the example deployment system of FIG. 24.
  • FIGS. 33A and 33B illustrate the distal end of the example deployment system of FIG. 24, with the distal legs deployed.
  • FIGS. 34A and 34B illustrate the distal end of the example deployment system of FIG. 24, with the guide tube separated from the leadless stimulator.
  • FIGS. 35A-38B illustrate an example method of implanting the leadless stimulator.
  • FIG. 39 illustrates a patient with a burr hole cover frame.
  • FIG. 40 illustrates a top view of the example burr hole cover frame after implantation into the craniotomy.
  • FIG. 41 illustrates a side view of the example burr hole cover frame after implantation into the craniotomy.
  • FIGS. 42A-42C illustrate the example lower part of the burr hole cover frame from FIG. 39.
  • FIGS. 43A, 43B, and 43C illustrate side, top, and perspective views of the burr hole cover cap.
  • FIGS. 44A and 44B illustrate different views of the bottom-side of the burr hole cover cap from FIGS. 43A-43C.
  • FIGS. 45-47 illustrate the wrapping of the antenna around the lower part of the bun- hole cover frame from FIG. 39.
  • FIGS. 48A-48E illustrates an example of the leadless stimulator implanted near a patient's spinal cord.
  • FIG. 49 illustrates an example distributed stimulator.
  • FIG. 50 illustrates the example distributed stimulator of FIG. 49 implanted into a patient.
  • FIG. 1A illustrates an example leadless stimulator system 50.
  • the leadless stimulator system 50 can include a leadless stimulator 100, a deployment system 305, a bun- hole cover frame 400, and an external programmer 500.
  • the leadless stimulator 100 can include an antenna 200 and a stimulation capsule 120.
  • the stimulation capsule 120 is coupled with the antenna 200 by a tether 190.
  • the deployment system 305 can be used to implant the leadless stimulator 100 into a patient - for example, into a patient's brain through a craniotomy.
  • the burr hole cover frame 400 can be used to secure the antenna 200 and the correctly position the antenna 200 for communication with the external programmer 500.
  • the external programmer 500 can read and write data to the leadless stimulator 100 through wireless communication with the leadless stimulator 100 using the antenna 200 of the leadless stimulator 100.
  • the leadless stimulator system 50 can include an external programmer 500.
  • the external programmer 500 can include a main unit 510, which holds the power source and electronics for the operation of the external programmer 500.
  • the main unit 510 can include a screen 520 to provide visual information to the user.
  • the screen 520 is a touch screen.
  • the external programmer 500 can also include an antenna tether 530 that tethers the external programmer 500 to the external antenna 540.
  • the external antenna 540 can have a diameter that provides efficient communication with the leadless stimulator 100 via the antenna 200 of the leadless stimulator 100.
  • the external antenna 540 could have a diameter between about 25 mm and about 75 mm or between about 45 mm and about 55 mm while the implanted antenna 200 can have a diameter between about 15 mm and about 35 mm or between about 20 mm and about 30 mm.
  • the external programmer 500 can communicate with the leadless stimulator 100 wirelessly after the implantation of the leadless stimulator 100.
  • the external programmer 500 can send data to the leadless stimulator 100 in order to set the stimulation parameters of the leadless stimulator 100.
  • the external programmer 500 can set signal attributes such as frequency, pulse width, amplitude, polarity, and signal shape, along with additional stimulation parameters, or a combination thereof.
  • the final delivered pulses can be charge balanced, such that the pulse can have a cathodal and anodal phase. In some implementations, it is advantageous for the electrode if the amount of charge delivered during the cathodal phase is substantially equal to the amount of charge delivered during the anodal phase. Generally the pulses have a pulse width between 20 us and 1 ms, and the pulse frequency is between 20 Hz and 10 kHz depending on the clinical application.
  • the external programmer 500 can also be used to turn the leadless stimulator 100 on or off.
  • the external programmer 500 can also be used to control the post-operative neural recording features of the leadless stimulator 100.
  • the external programmer 500 can be used to download data (e.g., usage data and recorded physiological data) from the leadless stimulator 100.
  • the external programmer 500 can receive the data from the leadless stimulator 100 in substantially real time and in other implementations the leadless stimulator 100 may store the data for later retrieval with the external programmer 500.
  • the external programmer 500 may be used to recharge the internal batteries of the leadless stimulator 100.
  • the external antenna 540 can be used to inductively couple power from an external power source to the leadless stimulator 100.
  • the leadless stimulator 100 can have no internal power source. In this case the inductively coupled power from external programmer 500 can be used to power the leadless stimulator 100.
  • the leadless stimulator 100 can consume between about 5 mW and about 15 mW in clinical operation, and therefore the external programmer 500 is configured to supply sufficient power to charge the leadless stimulator 100 based on these demands.
  • FIG. IB illustrates the leadless stimulator 100 implanted into a patient's brain system 50 with the burr hole cover frame 400 and the external programmer 500 external to the patient's brain.
  • the leadless stimulator 100 can be implanted responsive to the patient having a surgical planning procedure that involves MRI and/or CT scans to localize brain targets, thereafter the leadless neurostimulator 100 can be implanted in the deep brain using components of the leadless neurostimulator system 50.
  • the deployment system 305 can push the leadless neurostimulator 100 to the brain target, and subsequently removed leaving the leadless stimulator 100 towards the brain target.
  • the implantable antenna 200 remains remain extra-cranial.
  • the burr hole cover frame 400 is used to fill the burr hole and stabilize the leadless stimulator 100.
  • implantable antenna 200 is wrapped around the burr hole cover frame 400 to provide the correct diameter for efficient extra-corporeal communication.
  • the external programmer 500 is used to program the leadless stimulator 100.
  • the external programmer 500 can also provide power, or in some implementations recharge, the leadless stimulator 100.
  • FIGS. 2 and 3 illustrate the leadless stimulator 100.
  • the antenna 200 is in a wrapped configuration, and in FIG. 3 the antenna 200 is in an outstretched configuration.
  • the leadless stimulator 100 can include a stimulation capsule 120, a tether 190, and an antenna 200.
  • the stimulation capsule 120 can include a plurality of electrodes and can record and/or stimulate the neurological tissue into which it is implanted.
  • the leadless stimulator 100 also includes an antenna 200 that can be coupled to the stimulation capsule 120 with the tether 190.
  • the tether 190 can provide a mechanical and electrical coupling between the antenna 200 and the stimulation capsule 120.
  • the antenna 200 is reversibly coupled with the tether 190 and in other implementations the antenna 200 is permanently coupled with the tether 190.
  • the tether 190 and the antenna 200 refer to the same part of the leadless stimulator 100.
  • the part of the antenna outside of the patient may be referred to as the antenna 200 while the portion of the antenna inside the patient may be referred to as the tether 190. As illustrated in FIGS.
  • the tether 190 and antenna 200 can be flexible.
  • the antenna 200 can be configured to be flexible enough to enable the antenna 200 to be coiled within a burr cover that is implanted in the patient's skull or to form a loop as illustrated in FIG. 2.
  • the tether 190 and the antenna 200 have a diameter of about 0.5 mm, but could range from as small as 0.2 mm to as large as 2 mm.
  • the wires that form the antenna 200 can form a bifurcated tail body.
  • the bifurcated tail body forms an antenna loop.
  • the antenna 200 can include a wire coil that is embedded in a flexible, elastomeric body.
  • the antenna loop may be flexible enough be stretched over a burr hole cover, which can position the antenna 200 in a predetermined shape (e.g., a loop of a predetermined diameter).
  • a predetermined shape e.g., a loop of a predetermined diameter
  • the antenna 200 may be wound into a circular loop of the predetermined diameter.
  • the below discussed bun- hole cover frame may be used to ensure the antenna 200 maintains the predetermined diameter.
  • the predetermined diameter of the antenna can enable the efficient coupling of antenna 200 and the external antenna 540 of the external programmer 500.
  • the leadless stimulator 100 communicates wirelessly with the external programmer 500 over the 27 MHz frequency.
  • the antenna diameter can be inversely proportional to the wavelength of the signal the antenna 200 transmits over. For example, with a 27 MHz frequency the loop diameter of the antenna 200 can be about 25 mm in diameter. In general, the loop diameter of the antenna is about half the wavelength of the frequency used to communicate with the antenna.
  • FIG. 4 illustrates an enlarged view of the distal end of the leadless stimulator 100 from FIGS. 1-3.
  • the stimulation capsule 120 is coupled with the tether 190 at the proximal end 127 of the capsule body 125.
  • the capsule body 125 can be conical or cylindrical in shape.
  • the proximal end 127 can mate with the distal end of a cannula (not illustrated) during the implantation procedure.
  • the capsule body 125 includes a polymeric material and houses the active electronic components of the leadless stimulator 100.
  • electronic components may also be housed in the tether 190 and antenna 200.
  • the stimulation capsule 120 can include a hemispherical distal tip 126.
  • the distal tip 126 can include electronic components. These electronic components are generally integrated circuits, resistors, capacitors, or a combination thereof.
  • the stimulation capsule 120 can be cylindrical and have a larger diameter than the tether 190.
  • the diameter of the stimulation capsule 120 is between about 0.3 mm and about 3 mm, between about .75 mm and about 2.5 mm, between about 1 mm and about 2 mm, or between about 1.2 mm and about 1.6 mm.
  • the stimulation capsule 120 can also include a MEMS film 150.
  • the MEMS film 150 can manufactured as a substantially planar film, which is coupled around the capsule body 125. In some implementations, the MEMS film 150 is wrapped to form a cylindrical shape and then glued or co-molded into place.
  • the MEMS film 150 can include one or more electrodes 160. As illustrated in FIG. 4, the MEMS film 150 includes twelve electrodes (only eight of the electrodes 160 are visible in FIG. 4).
  • the electrodes 160 can be implemented in a noble metal, such as platinum.
  • the electrodes 160 can be implemented in gold, titanium, iridium oxide, platinum grey, platinum black, and oxides of titanium. As illustrated the electrodes 160 substantially square with rounded corners. In some implementations, the electrodes 160 can be circular, rectangular, or any other shape. In some implementations, the electrodes 160 can be used for physiological recordings and simulations.
  • FIGS. 5 and 6 illustrate the MEMS film 150 in its substantially planar configuration.
  • the MEMS film 150 includes twelve electrodes 160 disposed across the exterior portion 157 of the MEMS film 150.
  • the MEMS film 150 has about 4, 6, 8, 12, 16, 24, 36, 48, 64, or more electrodes 160.
  • the electrodes 160 can be arranged in specific patterns.
  • FIGS. 5 and 6 illustrate an electrode arrangement that includes three columns and four rows of electrodes 160.
  • the electrodes 160 can be rectangular electrodes that span the width of the exterior portion 157 and form ring electrodes when the MEMS film 150 is rolled into its cylindrical shape.
  • the MEMS film 150 also includes a ribbon cable 165.
  • the lower portion of the ribbon cable 165 includes the contact pad 175.
  • the contact pad 175 includes a plurality of contacts 170.
  • Each of the contacts 170 can be coupled with one or more of the electrodes 160 through traces embedded within the MEMS film 150.
  • the MEMS film 150 may include twelve electrodes 160 and twelve contacts 170.
  • each of the contacts 170 may be coupled with a different one of the twelve electrodes 160.
  • the contact pad 175 may include fewer contacts 170 than electrodes 160.
  • one or more electrodes 160 may be coupled with the same contact 170, such that they may be stimulated (or recorded from) as a single unit.
  • the contact pad 175 includes contacts 170 configured for different purposes.
  • the contact pad 175 illustrated in FIGS. 5 and 6 includes a second type of contacts - the wire tether contacts 172.
  • the different types of contacts are generally referred to as contacts 170.
  • the wire tether contacts 172 are used to couple the MEMS film 150 to the wires of the tether 190 and antenna 200.
  • the contacts 170 may be coupled to an application-specific integrated circuit (ASIC) or other electronic component that is housed within the stimulation capsule 120.
  • ASIC application-specific integrated circuit
  • FIG. 7 illustrates an enlarged view of the contact pad 175 from FIGS. 5 and 6.
  • a metal layer 174 is deposited on the contacts 170.
  • the metal layer 174 can include gold or other metal such as platinum, titanium, or copper.
  • the addition of a metal layer 174 increases the ease of welding or attaching electronic components (e.g., antenna wires) to the contacts 170.
  • the metal layer 174 improves the contacts' 170 ability to go undergo flip-chip bonding. The improvement in creating a contact with the contacts 170 may be caused by the metal layer 174 rising above the polyimide surface of the contact pad 175, making it easier for electronic components to be coupled to the contacts 170.
  • FIGS. 8-13 illustrate the assembly of an example contact pad 175.
  • FIG. 8 illustrates an ASIC 180 prior to its coupling with the contact pad 175.
  • the internal electronics of the stimulation capsule 120 are coupled to the contact pad 175.
  • a single ASIC 180 is coupled with the contact pad 175; however, the electronic components of the leadless stimulator 100 can be divided among a plurality of ASICs 180, batteries, passive electronic components (e.g., resistors and capacitors), or other electronic components.
  • the ASIC 180 includes a plurality of contacts 170, which are bound to the contacts 170 of the contact pad 175.
  • the contacts 170 of the ASIC 180 can have the same pitch (e.g., spacing) as the pitch of the contact pad 175, such that the contacts 170 align and can be coupled together.
  • the ASIC 180 is coupled with the contact pad 175 when the MEMS film 150 is a planar configuration - prior to the MEMS film 150 being formed into a cylindrical (or other) shape.
  • the ASIC 180 may be coupled with the contact pad 175 prior to the contact pad 175 being removed from the substrate on which it was fabricated.
  • the ASIC 180 can be thinned to a thickness of about 50 ⁇ , and generally has a thickness between about 20 and about 550 ⁇ , prior to the ASIC 180 being coupled with the contact pad 175.
  • the ASIC 180 includes the stimulation source that is used to stimulate tissue via the electrodes 160.
  • the ASIC 180 can also include a recording circuit.
  • the stimulation capsule includes a plurality of ASIC 180.
  • FIG. 10 illustrates the lead wires 192 coupled with the contact pad 175.
  • One or more lead wires 192 can be coupled to the one or more wire tether contacts 172.
  • the lead wires 192 can be electrically coupled with the antenna 200 through the tether 190.
  • the lead wires 192 can include platinum-iridium wire, and have a thin electrically isolating coating.
  • Incoming signals from the antenna 200 can be transmitted to the ASIC 180.
  • the ASIC 180 can process these signals and record and stimulate through the electrodes 160 as instructed by the signals.
  • the ASIC 180 can also transmit captured neural signals to a computer or other external device through by a transmission the signals over the antenna 200.
  • the MEMS film 150 can be molded into a cylindrical shape.
  • FIG. 11 illustrates the MEMS film 150 molded into a cylindrical shape.
  • the shaping of the MEMS film 150 into a non-planar shape can be performed by heat molding the MEMS film 150 while protecting the mounted ASIC 180 or by molding the ASIC 180 in place.
  • the contact pad 175, with its coupled ASIC 180 is toward the MEMS film 150.
  • the exterior portion 157 can then be rolled around the contact pad 175, such that the contact pad 175 with its coupled ASIC 180 (e.g., the stimulation source, the power supply, and the recording circuit) is within a lumen created by the rolled exterior portion 157.
  • ASIC 180 e.g., the stimulation source, the power supply, and the recording circuit
  • FIG. 12 illustrates a cutaway view of the MEMS film 150 molded into a cylindrical shape.
  • FIG. 12 illustrates the folding of the MEMS film 150 into a cylindrical and the internal electronics of the MEMS film 150.
  • the ribbon cable 165 can be folded back such that the contact pad 175 at least partially overlaps the exterior portion 157.
  • the edges of the exterior portion 157 are then rolled to create a cylinder around the ASIC 180. Once the exterior portion 157 is rolled into a cylindrical form, the created cylinder can be co-molded to create the leadless stimulator 100.
  • FIG. 13 illustrates an enlarged view of an example stimulation capsule 120.
  • the rolled MEMS film 150 can be over-molded to create a mechanically stable device.
  • the MEMS film 150 is rolled to create the cylindrical shape.
  • the capsule body 125 of the leadless stimulator 100 is then manufactured by co-molding the MEMS film 150 to encapsulate the interior of the MEMS film 150 and the electronics therein.
  • the co- molding of the MEMS film 150 can involve securing the MEMS film 150 in place and having it back-filled with a polymer precursor, such as an epoxy, to backfill the cavities within the molded MEMS film 150.
  • the over-molding material may include epoxy materials, such as EPO-Tek 353, that provide sealing of the electronics and wire traces therein, protecting the electronics from body fluids that may disrupt electrical function.
  • the stimulation capsule 120 can also include a distal tip 126.
  • the distal tip 126 can be coupled with the capsule body 125 or the distal tip 126 can be created as part of the capsule body 125 during the over-molding process. As illustrated the distal tip 126 is hemispherical, although other shapes may be used. For example, the distal tip 126 can be beveled or blunt. The distal tip 126 enables atraumatic insertion of the leadless stimulator 100 into tissue during the implantation procedure.
  • FIG. 13 also illustrates the tether 190.
  • the tether 190 can include a jacket, such as a polymeric tubing, around the lead wires 192.
  • the tether 190 can be hollow and have a lumen through which the lead wires 192 run.
  • the tether 190 can be filled, encapsulating the lead wires 192 or other electronic components in the lumen of the tether 190.
  • the tether 190 is of a diameter of 0.5 mm, is flexible and easily wraps around a finger of a surgeon for example.
  • the leadless stimulator 100 may not include an antenna 200 at the surface of the skull.
  • the leadless stimulator 100 may include an integrated antenna (also referred to as a micro-antenna) on the stimulation capsule 120.
  • An integrated antenna can reduce the risk of malfunction due to broken lead wires.
  • FIG. 14 illustrates an example leadless stimulator 100 with a micro-antenna.
  • the leadless stimulator 100 with a micro-antenna can include a stimulation capsule 120 and a tether 190.
  • the tether 190 may not include lead wires to form an antenna; however, the leadless stimulator 100 may still include the tether 190 to facilitate the removal of the leadless stimulator 100 from a patient's tissue after implantation.
  • FIGS. 15 and 16 illustrate an example MEMS film 150 with a micro-antenna.
  • the MEMS film 150 can include an exterior portion 157, a ribbon cable 165, and contacts 170.
  • the exterior portion 157 includes nine electrodes 160 and a micro-antenna 661. In some implementations, the exterior portion 157 includes more than or fewer than nine electrodes 160.
  • the contact pad 175 includes a battery pad 684, on which a battery may be coupled. The battery may be coupled with the battery pad 684 in a means (e.g., flip chip bonding) similar to the means that an ASIC 180 is coupled to the contact pad 175.
  • the battery pad 684 can be folded over on the contacts 170 of the contact pad 175.
  • the ribbon cable 165 is divided into two separate ribbon cables.
  • the metal layer of the MEMS film 150 that includes the traces from the electrodes 160 to the contacts 170 and the micro-antenna 661 is covered by a top insulating layer to electrically insulate the components.
  • FIG. 16 illustrates an enlarged view of the example MEMS film 150 from FIG. 15.
  • the top insulating layer of the MEMS film 150 is removed to illustrate the electrical elements embedded within the MEMS film 150.
  • removal of the top insulating layer exposes the micro-antenna 661 and the electrical traces 658.
  • the electrical traces couple the electrodes 160 with the contacts 170 (or other electrodes 160).
  • the micro- antenna 661 is embedded in the metal layer of the MEMS film 150.
  • the micro-antenna 661 is serpentine in shape and is designed in order to be highly efficient at the chosen transmission frequencies.
  • FIG. 17 illustrates a perspective view of an example leadless stimulator 100 with a micro-antenna 661.
  • the MEMS film 150 can be rolled into a cylindrical shape.
  • the MEMS film 150 can then be over-molded to create a capsule body 125.
  • the tether 190 does not include antenna wires, and the tether 190 is used for the extraction of the leadless stimulator 100 from a patient after implantation.
  • the tether 190 is embedded within the distal tip 126. Having the tether 190 run through the length of the body can reduce the chance of the tether 190 breaking free of the stimulation capsule 120.
  • FIGS. 18 and 19 illustrate a cutaway view of an example leadless stimulator 100 with micro-antenna 661.
  • the tether 190 can be coupled to the distal tip 126.
  • FIG. 18 illustrates that the tether 190 passes through the body of the stimulation capsule 120 and is coupled with the distal tip 126.
  • the ribbon cable 165 is divided into two parts (ribbon cable 165 A and ribbon cable 165B) to facilitate the passage of the tether 190 through the capsule body 125.
  • the tether 190 can pass between the two parts of the ribbon cable 165.
  • FIGS. 18 and 19 also illustrate the placement of the power supply 181.
  • the power supply 181 is a battery.
  • the power supply 181 may be recharged by the external programmer 500.
  • the power supply 181 can have enough charge to provide stimulation for at least one day, or about 200 mAh, and in some implementations up to several weeks, or around 2300 mAh.
  • FIGS. 20A and 20B illustrate the internal arrangement of an example leadless stimulator 100 with a micro-antenna.
  • the contacts 170 of the ASIC 180 can be aligned with and bonded to the respective contacts 170 of the contact pad 175.
  • the contacts 170 of the power supply 181 can be aligned with and bonded to the respective contacts 170 of the battery pad 684.
  • the ASIC 180 (or other components) can be wire bonded to the MEMS film 150 through wire bonds.
  • the power supply 181 and the ASIC 180 are placed on opposite sides of the tether 190 as the tether 190 passes through the body of the stimulation capsule 120.
  • FIGS. 21 and 22 illustrate an example MEMS film 150 with a micro-antenna 661.
  • the MEMS film 150 includes a micro-antenna 661 on the distal portion of the contact pad 175.
  • the micro-antenna 661 is disposed on a projection 176 from the contact pad 175.
  • the micro-antenna 661 can be rolled to form a loop, which is housed within the rolled MEMS film 150.
  • FIG. 22 illustrates a cutaway view of the stimulation capsule 120 with the rolled micro-antenna 661 located in the internal portion created by the rolled MEMS film 150.
  • FIGS. 23A-23M illustrate a cross-sectional view of an example thin-film micro- fabrication method for fabricating the MEMS film 150.
  • the MEMS film 150 can be fabricated using a plurality of techniques and the below describe method illustrates one possible method for fabricating the MEMS film 150.
  • the fabrication procedure can include a series of procedural steps in which various layers are deposited or removed (e.g., etched) to achieve a final form.
  • the cross sections in FIG. 23 A through FIG. 23M demonstrate the process steps to build a MEMS film 150.
  • a carrier substrate 2301 is provided, such as a wafer composed of a crystalline material, such as silicon, or an amorphous material, such as a thermal shock resistant borosilicate glass or other suitable smooth supportive material.
  • a first layer 2302 which can include one or more sub-layers, is applied to a surface of the wafer 2301.
  • One of the sub-layers can be a sacrificial layer deposited on the wafer 2301, which is removed in a subsequent electrochemical etching step.
  • the sacrificial sub-layer is preceded by another sub-layer, referred to as an underlayer, which can serve to form the electrochemical cell required to etch the sacrificial layer.
  • the sacrificial sub-layer can be aluminum, or an alloy of aluminum such as AISi, which has a smaller granularity, whereas the underlayer can be a TiW alloy such as Chrome or similar metal.
  • the next step in the fabrication process can include depositing a first polymeric layer 2305.
  • the first polymeric layer 2305 can be deposited upon the sacrificial layer 2302 by MEMS processes such as, but not limited to, (i) spin coating a liquid polymer precursor such as Polyimide or Silicone precursor; (ii) depositing a polymer through chemical vapor deposition as is done with parylene-C; or (iii) laminating a polymer sheet onto the wafer.
  • the polymer layer 2305 is heated, or baked, to polymerize.
  • the first polymeric layer 2305 includes polyamic-acid dissolved in NMP and spun onto the sacrificial layer 2302 in liquid form.
  • the polymeric layer 2305 is heated into a imidized polyimide.
  • the polymer in its cured form is between about 5 ⁇ and about 15 ⁇ thick.
  • the deposition of a barrier layer can serve both as a layer to aid the adhesion and durability of subsequent layers.
  • the barrier layer can also serve as an ionic barrier, and limit ions from reaching the metal layers, which could compromise electrical performance.
  • the barrier layer can also block humidity from reaching the interlayers and the metal layer, which could create short circuits and compromise electrical isolation.
  • the barrier layer is deposited onto the first polymeric layer 2305 by vapor deposition techniques such as chemical vapor deposition (CV) and plasma enhanced chemical vapor deposition (PECVD), or by sputtering techniques such as direct current (DC) or RF (Radio Frequency) sputtering.
  • CV chemical vapor deposition
  • PECVD plasma enhanced chemical vapor deposition
  • sputtering techniques such as direct current (DC) or RF (Radio Frequency) sputtering.
  • the barrier layer can include Silicon Nitride, Silicon Oxide, Silicon Carbide, Poly-Silicon, or Amorphous-Silicon. In some implementations, the barrier layer can also include other non-conductive materials, such as Titanium Dioxide or Titanium (III) Oxide.
  • the final thickness of the barrier layer can range from about 100 nm to about 2 ⁇ . In some implementations, the barrier layer is about 400 nm to about 600 nm, which can permit the barrier layer to be flexible enough to bend during subsequent assembly techniques.
  • a metal layer 2315 can be deposited over the entire wafer on the surface of the barrier layer 2310. Subsequently, a photoresist layer 2317 can be deposited.
  • the photoresist layer 2317 can be defined by exposing areas of the photoresist layer 2317 to ultra-violet light and developing those areas in a solvent. Thus, the exposed areas of the photoresist layer 2317 will be selectively removed and areas of the metal layer 2315 will be exposed.
  • the areas of the metal layer 2315 covered by the photoresist layer 2317 can form the electrodes, traces, and other components of the final product that are within the metal layer.
  • the metal layer 2315 can include a variety of metals such as titanium, platinum, gold, and others metals used in neuromodulation. To improve adhesion of a metal layer 2315, the metal layer 2315 can be applied in layers. For example, the metal layer 2315 can be applied as a first layer, such as titanium, then a middle layer, such as platinum, and finally an upper layer, such as titanium. This tri-layer metal structure can improve adhesion below and above the platinum layer by using the titanium as an adhesion layer to the barrier layer.
  • the typical thicknesses for the adhesion layer of titanium can be between about 20 nm and about 100 nm or between about 25 nm and about 75 nm.
  • Typical thicknesses for the platinum layer can be between about 200 nm and about 400 nm or between about 250 nm and about 350 nm.
  • FIG. 23E illustrates the process after the etching of the metal layer 2315.
  • the metal layer 2315 can be locally removed in the areas that were not covered by the photoresist 2317.
  • etching of the metal layer is performed in a plasma etcher such as a Reactive Ion Etcher.
  • titanium and platinum can be etched with chlorine gas.
  • the photoresist layer 2317 can be removed using a solvent.
  • Another method to deposit and define the metal layer is using the so-called "lift off technique.
  • the photoresist layer can be deposited onto the barrier layer 2310 first.
  • the photoresist layer can be defined using photolithography.
  • the metal layer 2315 can then be deposited through this "lift off mask, and the remaining photoresist removed in a solvent.
  • the metal layer is transferred onto the barrier layer without the need of plasma etching and may have some process costs and speed advantages.
  • a deposition of a second barrier layer 2320 is performed.
  • the second barrier layer can be deposited using the same techniques as the first barrier layer 2310.
  • the second barrier layer 2320 can be the same thickness, or a different thickness as the first barrier layer.
  • the second barrier layer is optional.
  • the second barrier layer 2320 and the first barrier layer 2310 can substantially surround the metal layer 2315, rendering it electrically isolated.
  • a second photoresist layer 2327 is deposited and photolithographically defined with clean room techniques.
  • the two barrier layers are etched, as illustrated in FIG. 23G.
  • the barrier layers can be etched using a plasma etch.
  • An example of an etching process would be a reactive ion etching using a tetrafluoromethane gas, (CF4).
  • the second photoresist layer 2327 can be removed using a solvent dissolution.
  • FIG. 23G illustrates that the edges of the barrier layers 2310 and 2320 are defined, but the etch does not reach the metal layer 2315. This is optional, and in some
  • the photolithography can include an opening above the metal layer 2315, which would result in exposing the metal layer 2315.
  • FIG. 23H illustrates the application of a second polymer layer 2330.
  • the second polymer layer 2330 can be the same or a different polymer from the first polymer layer 2305, and it can be the same or a different thickness.
  • FIG. 231 illustrates the deposition of a third photoresist 2337, which can form the etching perimeter of the first and second polyimide layers 2305 and 2330, respectively.
  • a sacrificial layer such as Silicon Dioxide or Silicon Nitride, is deposited in order to serve as an etch mask for the polyimide etch.
  • a silicon dioxide layer of thickness of about 500 nm can be deposited, which will serve as the etch mask for the process.
  • FIG. 23J illustrates the result of an oxygen plasma etching of the first and second polyimide layers 2305 and 2330, respectively. If applied, the silicon dioxide layer can be removed through an additional etch.
  • FIG. 23K illustrates the deposition of a fourth photoresist layer 2347.
  • the fourth photoresist layer 2347 does not cover part of the metal layer 2315.
  • the opening 2332 maintained is designed to create a region for a gold layer to grow.
  • FIG. 23L illustrates the galvanic growth of a thick gold layer 2350 into the opening 2332.
  • the gold layer 2350 is achieved by connecting the metal traces in the wafer to a perimetric metal band that allows an electrical connection between the edge of the wafer and the metal opening 2332. When immersed in a galvanic bath and a current applied, the gold will grow on the metal layer 2315 using the metal layer 2315 as the seed layer for galvanic growth.
  • the gold layer 2350 is about 2 ⁇ to about 20 ⁇ thick.
  • the fourth photoresist layer 2347 can be removed using a solvent.
  • FIG. 23M illustrates the removal of the MEMS film from the wafer 2301.
  • the removal of the fourth photoresist layer 2347 exposes the electrode opening 2333.
  • the MEMS film can be removed from the wafer 2301 by the removal of the sacrificial layer 2302 using electrochemically etching. Removal of the sacrificial layer 2301 frees the underside of the MEMS film from the wafer 2301.
  • the sacrificial layer 2301 is removed by placing the wafer in a saline bath with a high NaCl concentration. A platinum electrode also placed in the bath can be used as a reference, and a voltage can be applied to the aluminum layer with respect to the platinum electrode.
  • the electrochemical cell created by the aluminum and TiW etches the aluminum - separating the MEMS film from the wafer 2301.
  • FIG. 23N illustrates a method 2360 for manufacturing a leadless stimulator.
  • a MEMS film is formed.
  • the method for forming the MEMS film is described above in relation to FIGS. 23A-23M.
  • the MEMS film is formed as a planar film.
  • the MEMS film can include a plurality of electrodes and a ribbon cable that extends from the distal end of the MEMS film.
  • a stimulation source is coupled with the MEMS film.
  • the stimulation source may be a component of an ASIC 180.
  • the stimulation source (or ASIC 180) can include a plurality of contacts 170.
  • the ribbon cable can also include a plurality of contacts 170. As illustrated in FIG. 8, the contacts 170 of the ASIC 180 can be coupled with the contacts 170 of the ribbon cable. Coupling the contacts 170 of the ASIC 180 with the contacts 170 of the ribbon cable can enable an electrical connection between the ASIC 180 and one or more electrodes.
  • a power supply is coupled with the MEMS film.
  • a power supply 181 can be coupled with the MEMS film.
  • the power supply can include a plurality of contacts, through which an electrical connection is established with the MEMS film.
  • the power supply is coupled to the same face of the ribbon cable as the stimulation source, and in other implementations the power supply is coupled with a face opposite to the face the stimulation source is coupled.
  • other circuitry such as recording circuitry, control circuitry, or other ASICs can be coupled with the ribbon cable.
  • the ribbon cable is folded toward a face of the MEMS film.
  • the ribbon cable 165, with the coupled stimulation source and power supply are folded toward a face of the MEMS film.
  • the MEMS film can include two primary faces. The first face includes the plurality of electrodes and the second face is the opposite face of the MEMS film. As illustrated in FIG. 12, the ribbon cable 165 is folded toward the second face of the MEMS film.
  • the MEMS film is formed into a lumen. Also as illustrated in FIG. 12, the sides of the MEMS film are formed around the portion of the ribbon cable to which the stimulation source and power supply are coupled. The formed MEMS film defines a lumen, in which the stimulation source and power supply are disposed.
  • the MEMS film can be heat formed such that the MEMS film maintains it shape after the forming process.
  • the lumen defined by the formed MEMS film is filled with an encapsulating epoxy.
  • the encapsulating epoxy can provide structural stability to the stimulation capsule and can also electrically isolate the electrical components disposed within the lumen.
  • FIG. 24 illustrates an example deployment system 305.
  • the deployment system 305 is used to implant the leadless stimulator 100.
  • the deployment system 305 includes a guide tube 300.
  • deployment system 305 can include a connection plug 310.
  • the connection plug 310 enables electrical connections between the deployment system 305 and a controller or recording device used during the implantation of the leadless stimulator 100.
  • the connection plug 310 is coupled with the other components of the deployment system 305 via the connection cable 315.
  • the connection cable 315 can include electrical conductors, in the form of wires or traces, which electrically couple the distal electrodes 355 to the connection plug 310.
  • the deployment system 305 also includes a depth stop 320 to enable the surgeon to couple the deployment system 305 with stereotactic equipment.
  • the depth stop 320 may also house pre-amplifier circuitry to improve the signals coming from the distal electrodes 355.
  • the depth stop 320 also includes a deployment handle 325.
  • the deployment handle 325 may be pushed up or down by the surgeon to deploy or retract, respectively, the distal legs 360. In FIG. 24, the distal legs 360 are illustrated in the deployed state.
  • the body of the deployment system 305 includes guide tube 300.
  • the guide tube 300 can include a leg support stent that is disposed around an inner cylinder.
  • a MEMS film can be disposed around the leg support stent to form the distal legs 360.
  • FIGS. 25A and 25B illustrate a cut away and perspective view, respectively, of the distal end of the guide tube 300.
  • the inner cylinder 330 includes a central lumen 337.
  • the distal most end of the inner cylinder 330 includes a guide 339.
  • the guide 339 can mate with the proximal end of the stimulation capsule 120.
  • the external diameter of the inner cylinder 330 is between about 0.5 mm and about 3 mm, between about 1 mm and about 2 mm, or about 1 mm and 1.5 mm.
  • the internal diameter of the central lumen 337 is between about 0.25 mm and about 1.5 mm or between about 0.5 mm and about 1 mm.
  • the internal diameter of the central lumen 337 can enable the insertion of the tether 190 and the antenna 200.
  • the guide 339 can have a slightly larger external diameter when compared to the inner cylinder 330.
  • the diameter of the guide 339 may be about 1.5 mm when the outer diameter of the inner cylinder 330 is about 1 mm.
  • the guide 339 can either be a separate piece, which is later coupled with the inner cylinder 330, or the guide 339 can be machined from the same stock material as the inner cylinder 330.
  • the inner wall 340 of the guide 339 can surround the leadless stimulator 100, and the outer wall 341 of the guide 339 can be used to guide the below described distal legs 360 during deployment.
  • the inner cylinder 330 includes a metal, such as surgical stainless steel, and in other implementations, the inner cylinder 330 can include a polymer or other MRI compatible material such as a ceramic or titanium oxide.
  • FIGS 26A-26C illustrate an example leg support stent 344.
  • the external diameter of the leg support stent 344 is between about 0.5 mm and about 3 mm, between about 1 mm and about 2 mm, or about 1 mm and 1.85 mm.
  • the internal diameter of the leg support stent 344 can be at least the external diameter of the inner cylinder 330, such that the leg support stent 344 can be disposed around the inner cylinder 330.
  • the leg support stent 344 can include leg supports 342 at distal end of the leg support stent 344. As illustrated, the leg support stent 344 includes four leg supports 342.
  • the leg supports 342 can be flexible enough to expand with the typical forces that can be applied by hand.
  • Fig. 26B and 26C illustrate the expanded leg supports 342.
  • the leg supports 342 of the leg support stent 344 slide distally along the inner cylinder 330.
  • the outer wall 341 can cause the leg supports 342 to expand.
  • FIG. 27 illustrates an example MEMS film 350 that can be coupled around the leg support stent 344.
  • the MEMS film 350 can include legs 352.
  • the MEMS film 150 includes four legs 352.
  • the legs 352 are between about 5 mm and about 15 mm or between about 7 and about 12 mm in length.
  • the legs 352 can be about 0.25 mm to about 1 mm in width.
  • the legs 352 are about the same length and width as the leg supports 342.
  • One or more surfaces of the legs 352 can include a plurality of microelectrode elements 355. As illustrated, each leg 352 includes five microelectrode elements 355. In some implementations, different legs 352 can include a different number of microelectrode elements 355.
  • Each microelectrode elements 355 can include between 1 and about 10 microelectrode elements 355.
  • the legs 352 include more than 10 microelectrode elements 355.
  • the microelectrode elements 355 can be circular or rectangular in shape and have a diameter between about 100 ⁇ and about 1000 ⁇ , or between about 200 ⁇ and about 700 ⁇ , or between about 300 ⁇ and about 500 ⁇ .
  • the MEMS film 350 can also include a shoulder 357 that can be coupled around the leg support stent 344.
  • the MEMS film 350 can further include a tether 359, which carries traces from the microelectrode elements 355 to the proximal end of the guide tube 300. In some implementations, there is one trace for each microelectrode elements 355 and in other implementations one or more microelectrode elements 355 may be coupled with the same trace.
  • FIG. 28A illustrates the MEMS film 350 coupled with the leg support stent 344.
  • the MEMS film 350 can be coupled to the leg support stent 344 with glue or pressure bonding.
  • the legs 352 are aligned and coupled with the leg supports 342.
  • FIG. 28B illustrates the MEMS film 150 coupled with the leg support stent 344, with the leg supports 342 in the retracted state.
  • FIG. 29A illustrates an example outer tube 370 of the guide tube 300.
  • the distal end of the outer tube 370 can include leg gaps 372.
  • the outer tube 370 can enable the leg supports 342 to fit within the leg gaps 372.
  • the outer tube 370 can have an outer diameter between about 0.5 and about 2.5 mm.
  • the wall thickness of the outer tube 370 is about 0.2 mm.
  • the outer tube 370 is generally implemented in a medical grade Stainless Steel such as 316, or could be implemented in a polymer such as polyimide to promote improved MRI Compatibility.
  • FIG. 29B illustrates an example guide tube 300 with an outer tube 370 in place.
  • the outer tube 370 can be placed concentrically over the MEMS film 350 and the leg support stent 344.
  • the assembly guide tube 300 exposes the microelectrode elements 355 through the leg gaps 372 of the outer tube 370.
  • exposure of the microelectrode elements 355 through the leg gaps 372 enables the microelectrode elements 355 to record neural activity as the guide tube 300 descends into brain tissue.
  • the guide tube 300 can perform neural recording to enable a surgeon to identify the guide tube's location with a patient's tissue.
  • FIGS. 30A and 30B illustrate two views of the guide tube 300 with the distal legs 360 deployed.
  • the distal legs 360 can be deployed by a surgeon to perform neural recording.
  • Each of the distal legs 360 can include a plurality of microelectrode elements 355.
  • each of the four distal legs 360 include five microelectrode elements 355, for a total of twenty recording and stimulation sites.
  • the guide tube 300 can include more or fewer distal legs 360, each with more or fewer microelectrode elements 355.
  • FIGS. 31A and 3 IB illustrate an example deployment mechanism 319.
  • the deployment mechanism 319 can include a handle 325 that can be used to deploy the distal legs 360, as illustrated in FIGS. 30A and 30B.
  • the leg support stent 344 can be attached to the deployment handle 325. Accordingly, movement of the deployment handle 325 can be translated into movement of the leg support stent 344, which results in the deployment or retraction of the distal legs 360.
  • FIG. 31A illustrates the position of the deployment handle 325 when the distal legs 360 are in the deployed state
  • FIG. 3 IB illustrates the position of the deployment handle 325 when the distal legs 360 are in the retracted state.
  • the central lumen 337 is visible on the proximal end of the deployment mechanism 319.
  • the deployment mechanism 319 can include depth stops 320 that can limit the movement of the deployment handle 325 in the proximal and distal directions.
  • FIGS. 32A and 32B illustrate the distal end of the example deployment system 305 coupled with the leadless stimulator 100.
  • the deployment system 305 includes the guide tube 300 coupled with the leadless stimulator 100.
  • the stimulation capsule 120 is exposed at the distal end of the guide tube 300.
  • the proximal end 127 of the leadless stimulator 100 (hidden in FIGS. 32A and 32B) can couple with the guide 339 (hidden in FIGS. 32A and 32B) of the guide tube 300.
  • the guide tube 300 can be used to push the leadless stimulator 100 toward the target location in the tissue.
  • FIGS. 33A and 33B illustrate the distal end of the example deployment system 305, with the distal legs 360 deployed.
  • the distal legs 360 when deployed, can enable the recording and stimulation of the region surrounding the stimulation capsule 120.
  • the intra-operative recording and stimulation procedure can be used to further determine the final position of the leadless stimulator 100.
  • the recording and stimulation procedure can be used to determine an improved stimulation and recording configuration for the leadless stimulator 100. For example, the procedure may be used to determine if a subset of the electrodes 160 of the leadless stimulator 100 should be used for recording and stimulating.
  • FIGS. 34A and 34B illustrate the distal end of the example deployment system 305, with the guide tube 300 and stimulation capsule 120 separated - for example, after the surgeon has begun to retract the deployment system 305 from the patient's tissue.
  • the distal legs 360 are retracted and then the deployment system 305 can be retracted from the tissue, leaving, as illustrated in FIGS. 34A and 34B, the leadless stimulator 100 at the target location.
  • FIGS. 35-38 illustrate an example method of implanting the leadless stimulator 100.
  • FIG. 35A and 35B illustrate the leadless stimulator 100 in the preimplantation position.
  • the leadless stimulator 100 is positioned above a craniotomy 1055 in a patient's skull 1050.
  • the craniotomy exposes a portion of the brain 1060.
  • the leadless stimulator 100 and deployment system 305 are lowered into place from the exterior of the patient using stereotactic implantation tools (not illustrated).
  • FIGS. 36A and 36B illustrate the positioning of the leadless stimulator 100 into the patient's brain 1060.
  • the surgeon drives the deployment system 305 into the patient's brain 1060, which in turn pushes the leadless stimulator 100 into the position.
  • the surgeon can record neural activity as with the deployment system 305 and leadless stimulator 100 as they are lowered toward the target location.
  • FIGS. 37A and 37B illustrate the deployment of the distal legs 360 of the leadless stimulator 100.
  • the distal legs 360 are deployed to record neural activity when the leadless stimulator 100 is believed to be at the proper implantation location.
  • the microelectrode elements 355 of the guide tube 300, and optionally the electrodes 160 of the leadless stimulator 100 can be used to record the neural activity of the implanted location. This procedure may be referred to as "targeting."
  • Targeting procedure may include recording the electrical activity of the target anatomy using the microelectrode elements 355 and the electrodes 160.
  • a signal processing software can record and display the neural activity to the neurosurgical team. Responsive to the recorded neural activity, the team may determine if the leadless stimulator 100 is placed in the proper anatomical location.
  • the microelectrode elements 355 and the electrodes 160 can be used to stimulate the anatomical target in order to evoke a physiological response in the patient - for example, eye twitching or parasthesia. This procedure of neurophysiological recording and evoked patient responses can lead the neurosurgical team to determine the best placement of the leadless stimulator 100.
  • FIGS. 38A and 38B illustrate the placement of the leadless stimulator 100 after the retraction of the deployment system 305.
  • the distal legs 360 can be retracted.
  • the leadless stimulator 100 can be left in place and the deployment system 305 is retracted from the patient.
  • the stimulation capsule 120 remains in place and is tethered with the antenna 200 by the tether 190.
  • the antenna 200 may exit the patient through the craniotomy 1055.
  • the surgeon may fill the craniotomy 1055 with surgical cement or bone paste, which can secure the antenna 200 in place.
  • the antenna 200 is wound into a burr hole cover frame to secure and position the antenna 200.
  • FIG. 39 illustrates a patient 1000 with a burr hole cover frame 400 in place.
  • FIG. 40 illustrates a closer view of the example burr hole cover frame 400.
  • the burr hole cover frame 400 can include a burr hole cover cap 450 that protects the antenna 200 and area of the skull where the craniotomy was performed.
  • the burr hole cover frame 400 can also include a lower part 410.
  • the burr hole cover cap 450 can be secured to the lower part 410 by the burr hole cover cap 450 clipping into the lower part 410.
  • the burr hole cover cap 450 can be secured to the lower part 410 by screws 462 through screw holes 456.
  • FIG. 41 illustrates a side view of the example burr hole cover frame 400 after implantation into the craniotomy 1055.
  • the burr hole cover frame 400 can include the burr hole cover cap 450 coupled with the lower part 410.
  • the lower part 410 can include a bun- hole insert 412, through which the leadless stimulator 100 exits the patient.
  • the burr hole insert 412 can fill the hole in the skull left by the craniotomy.
  • the antenna 200 can wrap around the circumference of the lower part 410 to ensure the antenna 200 maintains a predetermined loop diameter.
  • the lower part 410 is secured to the patient by one or more screws 462 or glue.
  • FIGS. 42A-42C illustrate the example lower part 410 of the burr hole cover frame 400.
  • FIGS. 42A, 42B, and 42C illustrate side, top, and perspective views of the lower part 410, respectively.
  • the lower part 410 can include a cartwheel frame 415.
  • the cartwheel frame 415 can include an antenna notch 417 around the perimeter of the cartwheel frame 415.
  • the antenna 200 is wound around the perimeter of the cartwheel frame 415 and lies within the antenna notch 417.
  • the antenna notch 417 of the cartwheel frame 415 can include a hole 418 from which the antenna 200 can exit the central lumen 411 of the lower part 410 to be wrapped around the perimeter of the cartwheel frame 415.
  • the lower part 410 can also include a burr hole insert 412 that is inserted into the craniotomy 1055 of the patient.
  • the burr hole insert 412 is about 8 mm in diameter in some
  • the burr hole insert 412 is about 4 mm deep, but can range from 1 mm to 8 mm deep in some implementations.
  • FIG. 42B illustrates that the lower part 410 can include securing screw holes 425 on the inner perimeter of the cartwheel frame 415 and on the spokes 416 of the lower part 410.
  • the securing screw holes 425 can be used to secure the burr hole cover frame 400 to the patient's skull by screwing screws through the securing screw holes 425 and into the patient's skull.
  • the lower part 410 can also include screw holes 426 to secure the lower part 410 to the burr hole cover cap 450.
  • the lower part 410 has a diameter 420 of about 25 mm. Generally, the diameter is equivalent to the most efficient antenna diameter for the chosen transmission frequency as described above.
  • FIGS. 43A, 43B, and 43C illustrate side, top, and perspective views of the burr hole cover cap 450, respectively.
  • the burr hole cover cap 450 can protect the antenna 200 and the patient's brain after its exposure by the craniotomy.
  • the bun- hole cover cap 450 can include a smoothed edge 452.
  • the smoothed edge 452 can reduce tissue erosion once implanted.
  • the burr hole cover cap 450 can also include three securing screw holes 456 that can align with screw holes 426.
  • FIGS. 44A and 44B illustrate different views of the bottom-side of the burr hole cover cap 450.
  • the burr hole cover cap 450 can include a plurality of alignment guides 458 that are used to align the burr hole cover cap 450 with the lower part 410 before the two components are secured together.
  • the burr hole cover cap 450 can also include a central boss 460 that can be used in the alignment of the two components and to plug the central lumen 411.
  • FIGS. 45-47 illustrate the wrapping of the antenna 200 around the lower part 410.
  • FIG. 45 illustrates the lower part 410 and the leadless stimulator 100 after implantation.
  • the leadless stimulator 100 is implanted into the patient's brain and the lower part 410 has been inserted into the craniotomy.
  • the tether 190 is coupled with the stimulation capsule 120 and extends through the central lumen 41 1 and transitions into the antenna 200.
  • FIG. 46 illustrates the insertion of antenna 200 into the hole 418.
  • the hole 418 begins in the central lumen 411 and traverses through one of the spokes of the lower part 410 to the antenna notch 417.
  • the antenna 200 can then be wrapped around the lower part 410 in the antenna notch 417. Wrapping the antenna 200 around lower part 410 can ensure that the antenna 200 forms a loop of proper diameter to increase the effectiveness of the antenna 200.
  • the antenna 200 can be secured to the lower part 410 with a clip or with a bonding agent.
  • the proximal end of the antenna 200 includes a loop, which can be stretched over the perimeter of the cartwheel frame 415 and into the antenna notch 417.
  • the systems and methods described herein can provide efficient stimulation of the sub-thalamic nucleus, the Globus Pallidus interna, the Globus Pallidus externus, the Zone Incerta, or the Ventral Intermediate Nucleus to relieve symptoms such as rigidity and tremor.
  • the systems and devices described herein can be implanted in the Cingulate Gyrus 25, the Medial Forebrain Bundle, the Nucleus Accumbens, the Ventral Striatum to deliver electrical stimulation and relieve the symptoms of Depression, Anxiety, Phobias, Obsessive
  • the leadless stimulator 100 can be implanted into anatomy of the patient other than the brain.
  • the leadless stimulator 100 may be used for pain management, spasticity, movement disorders, and spinal cord injury.
  • the leadless stimulator 100 can be implanted near the patient's spinal cord.
  • Fig. 48A demonstrates a representative human anatomy of the spinal column 4800. There are a series of vertebrae 4820 separated by intervertebral discs 4830. The spinal cord 4840 is also represented in the spinal canal 4845.
  • Fig. 48B illustrates a magnified section of the anatomy 4800 demonstrating the same anatomical sections with greater detail.
  • FIG. 48C illustrates a perspective view of the anatomy 4800 with four implanted stimulation capsules 120.
  • the implantable antennas 200 remain outside of the epidural space, while the distal ends have been implanted on the surface of the spinal cord.
  • Fig. 48D demonstrates the same surgical position from a different viewpoint angle.
  • FIG. 48E illustrates a side, cut-away view of the patient's spinal cord.
  • the stimulation capsule 120 is implanted dorsal to the spinal cord 1140, vertebrae 1120, and the intervertebral discs 1130.
  • FIG. 49 illustrates an example distributed stimulator 900.
  • a plurality of leadless stimulators 100 can be implanted into a patient, and in other implementations a distributed stimulator 900 can be implanted into the patient.
  • the distributed stimulator 900 includes a plurality of stimulation capsules 120 (four as illustrated in FIG. 49) that can act in unison or similar to a plurality of independently implanted stimulation capsules 120.
  • the stimulation capsules 120 are coupled to a central control device 995, which can include central antenna for the plurality of stimulation capsules 120.
  • Each of the stimulation capsules 120 are coupled to the central control device 995 by a tether 190.
  • the stimulation capsule 120 includes a plurality of ring electrodes around the circumference of each stimulation capsule 120.
  • Fig. 50 illustrates the example distributed stimulator 900 implanted into a patient.
  • the distributed stimulator 900 is implanted into the lumbar region 1210 of the patient.
  • the distributed stimulator 900 has been implanted in a region that permits the distributed distal capsules to cover a region which would be advantageous to the surgical procedure, for example, the placement of the stimulation capsules 120 near the patient's spinal column as illustrated in FIG. 48E.
  • microelectrode device Various implementations of the microelectrode device have been described herein. These embodiments are giving by way of example and not to limit the scope of the present disclosure. The various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the disclosure.
  • Devices described herein as either acute or chronic may be used acutely or chronically. They may be implanted for such periods, such as during a surgery, and then removed. They may be implanted for extended periods, or indefinitely. Any devices described herein as being chronic may also be used acutely.
  • any ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. Language such as “up to,” “at least,” “greater than,” “less than,” and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, a range includes each individual member.
  • One or more or any part thereof of the techniques described herein can be implemented in computer hardware or software, or a combination of both.
  • the methods can be implemented in computer programs using standard programming techniques following the method and figures described herein.
  • Program code is applied to input data to perform the functions described herein and generate output information.
  • the output information is applied to one or more output devices such as a display monitor.
  • Each program may be implemented in a high level procedural or object oriented programming language to communicate with a computer system.
  • the programs can be implemented in assembly or machine language, if desired. In any case, the language can be a compiled or interpreted language.
  • the program can run on dedicated integrated circuits preprogrammed for that purpose.
  • Each such computer program can be stored on a storage medium or device (e.g., ROM or magnetic diskette) readable by a general or special purpose programmable computer, for configuring and operating the computer when the storage media or device is read by the computer to perform the procedures described herein.
  • the computer program can also reside in cache or main memory during program execution.
  • the analysis, preprocessing, and other methods described herein can also be implemented as a computer-readable storage medium, configured with a computer program, where the storage medium so configured causes a computer to operate in a specific and predefined manner to perform the functions described herein.
  • the computer readable media is tangible and substantially non-transitory in nature, e.g., such that the recorded information is recorded in a form other than solely as a propagating signal.
  • a program product may include a signal bearing medium.
  • the signal bearing medium may include one or more instructions that, when executed by, for example, a processor, may provide the functionality described above.
  • signal bearing medium may encompass a computer-readable medium, such as, but not limited to, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, memory, etc.
  • the signal bearing medium may encompass a recordable medium , such as, but not limited to, memory, read/write (R/W) CDs, R/W DVDs, etc.
  • signal bearing medium may encompass a communications medium such as, but not limited to, a digital or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.).
  • the program product may be conveyed by an RF signal bearing medium, where the signal bearing medium is conveyed by a wireless communications medium (e.g., a wireless communications medium conforming with the IEEE 802.11 standard).

Abstract

The present disclosure describes a medical device to provide neurostimulation therapy to a patient's brain. The device can be surgically implanted and can remain in the patient until end of life. The present disclosure also describes accessories which guide the implantation of the device, and the components that form a leadless stimulator implantation kit.

Description

LEADLESS NEUROSTIMULATOR
BACKGROUND
[0001] Deep brain stimulation (DBS) is a neurostimulation therapy which involves electrical stimulation systems that stimulate the human brain and body. DBS can be used to treat a number of neurological disorders. Typically DBS involves electrically stimulating a target area of the brain.
SUMMARY
[0002] According to one aspect of the disclosure a neurostimulation device includes a stimulation capsule with a proximal and distal end. The stimulation capsule includes a MEMS film with a plurality of electrodes. The MEMS film defines a lumen. The stimulation capsule also includes a stimulation source disposed within the lumen and electrically coupled to at least one of the plurality of electrodes. The stimulation capsule can also include a power supply disposed within the lumen and electrically coupled with the stimulation source. The stimulation capsule can include a tether coupled with the proximal end of the stimulation capsule.
[0003] In some implementations, a diameter of the stimulation capsule is less than a diameter of the tether. The tether can include an antenna or the MEMS film can include a strip or a serpentine antenna. The antenna can be configured to operate at a center frequency of one of 6.790 MHz, 13.560 MHz, 27.120 MHz, 40.680 MHz, 433.920 MHz, 915.000 MHz, 2.450 GHz, 5.800 GHz, and 24.125 GHz. In some implementations, the antenna is forms a loop. The antenna can be used to program the stimulation capsule, and the antenna can include one or more wires in electrical communication with the stimulation capsule. The one or more wires can each couple with a wire tether contact disposed on a ribbon cable. The ribbon cable can extend from a distal end of the MEMS film into the lumen.
[0004] In some implementations, the stimulation source and the power supply are disposed on the ribbon cable. The power supply can be battery or super-capacitor. A recording circuit can also be coupled with the ribbon cable. In some implementations, the MEMS film includes a first polymeric layer, a first barrier layer, a metal layer, a second barrier layer, and a second polymeric layer.
[0005] According to another aspect of the disclosure, a method of manufacturing a stimulation device includes forming a MEMS film. The MEMS film can include a plurality of electrodes and a ribbon cable extending from a distal end of the MEMS film. The method can also include coupling a stimulation source with a first plurality of contacts. The first plurality of contacts can be disposed on a first face of the ribbon cable and can be in electrical communication with at least one of the plurality of electrodes. A power supply can be coupled with a second plurality of contacts. The second plurality of contacts can be disposed on a second face of the ribbon cable. The method also includes folding the ribbon cable toward a face of the MEMS film, and forming, with the MEMS film, a lumen. The ribbon cable can be disposed within the lumen.
[0006] In some implementations, the method also includes coupling a recording circuit on a third plurality of contacts disposed on the first face of the ribbon cable. The first face of the ribbon cable can be different than the second face of the ribbon cable.
[0007] The method can also include filling the lumen with an encapsulating epoxy. A lead wire can be coupled with a tether contact. The tether contact can be disposed toward a distal tip of the ribbon cable. In some implementations, the method includes heat molding the MEMS film to form the lumen. The power source can include a rechargeable battery of a super capacitor.
BRIEF DESCRIPTION OF THE DRAWINGS
[0008] The figures, described herein, are for illustration purposes only. Various aspects of the described implementations may be shown exaggerated or enlarged to facilitate an understanding of the described implementations. In the drawings, like reference characters generally refer to like features, functionally similar and/or structurally similar elements throughout the various drawings. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the teachings. The drawings are not intended to limit the scope of the present teachings. The systems and methods may be better understood from the following illustrative description with reference to the following drawings in which:
[0009] FIGS. 1A and IB illustrates an example leadless stimulator system.
[0010] FIGS. 2 and 3 illustrate an example leadless stimulator from the leadless stimulator system of FIG. 1A.
[0011] FIG. 4 illustrates an enlarged view of the leadless stimulator from FIGS. 2 and 3.
[0012] FIGS. 5 and 6 illustrate an example MEMS film for use in the example leadless stimulator of FIG. 1A.
[0013] FIG. 7 illustrates an enlarged view of example contact pads for the MEMS film of FIGS. 5 and 6.
[0014] FIGS. 8-13 illustrate an example, assembled contact pad for the MEMS film of FIGS. 5 and 6.
[0015] FIG. 14 illustrates an example leadless stimulator with a micro -antenna.
[0016] FIGS. 15-17 illustrate an example MEMS film for the example leadless stimulator of FIG. 14.
[0017] FIGS. 18 and 19 illustrate a cutaway view of an example leadless stimulator with micro-antenna.
[0018] FIGS. 20A and 20B illustrate the internal arrangement of an example leadless stimulator.
[0019] FIGS. 21 and 22 illustrate another example MEMS film with a micro-antenna.
[0020] FIGS. 23A-23M illustrate an example thin-film micro-fabrication method for fabricating a MEMS film.
[0021] FIG. 23N illustrates an example method for forming the thin-film of FIGS. 23 A- 23M into a leadless stimulator. [0022] FIG. 24 illustrates an example deployment system of the leadless stimulator system of FIG. 1.
[0023] FIGS. 25A and 25B illustrate a cut away and perspective view, respectively, of the distal end of the guide tube for the deployment system of FIG. 24.
[0024] FIGS 26A-26C illustrate an example leg support stent for the deployment system of FIG. 24.
[0025] FIG. 27 illustrates an example MEMS film for the deployment system of FIG. 24.
[0026] FIGS. 28A and 28B illustrate the MEMS film coupled with the leg support stent.
[0027] FIGS. 29A and 29B illustrate an example outer tube of the guide tube.
[0028] FIGS. 30A and 30B illustrate two views of the guide tube with the distal legs deployed.
[0029] FIGS. 31 A and 3 IB illustrate an example deployment mechanism for the deployment system of FIG. 24.
[0030] FIGS. 32A and 32B illustrate the distal end of the example deployment system of FIG. 24.
[0031] FIGS. 33A and 33B illustrate the distal end of the example deployment system of FIG. 24, with the distal legs deployed.
[0032] FIGS. 34A and 34B illustrate the distal end of the example deployment system of FIG. 24, with the guide tube separated from the leadless stimulator.
[0033] FIGS. 35A-38B illustrate an example method of implanting the leadless stimulator.
[0034] FIG. 39 illustrates a patient with a burr hole cover frame.
[0035] FIG. 40 illustrates a top view of the example burr hole cover frame after implantation into the craniotomy. [0036] FIG. 41 illustrates a side view of the example burr hole cover frame after implantation into the craniotomy.
[0037] FIGS. 42A-42C illustrate the example lower part of the burr hole cover frame from FIG. 39.
[0038] FIGS. 43A, 43B, and 43C illustrate side, top, and perspective views of the burr hole cover cap.
[0039] FIGS. 44A and 44B illustrate different views of the bottom-side of the burr hole cover cap from FIGS. 43A-43C.
[0040] FIGS. 45-47 illustrate the wrapping of the antenna around the lower part of the bun- hole cover frame from FIG. 39.
[0041] FIGS. 48A-48E illustrates an example of the leadless stimulator implanted near a patient's spinal cord.
[0042] FIG. 49 illustrates an example distributed stimulator.
[0043] FIG. 50 illustrates the example distributed stimulator of FIG. 49 implanted into a patient.
DETAILED DESCRIPTION
[0044] The various concepts introduced above and discussed in greater detail below may be implemented in any of numerous ways, as the described concepts are not limited to any particular manner of implementation. Examples of specific implementations and applications are provided primarily for illustrative purposes.
[0045] The present disclosure describes a medical device to provide neuro stimulation therapy to a patient's brain. The device can be surgically implanted and generally can remain in the patient until end of life. The present disclosure also describes accessories which guide the implantation of the device, and the components that form a leadless stimulator implantation kit. [0046] FIG. 1A illustrates an example leadless stimulator system 50. The leadless stimulator system 50 can include a leadless stimulator 100, a deployment system 305, a bun- hole cover frame 400, and an external programmer 500. The leadless stimulator 100 can include an antenna 200 and a stimulation capsule 120. The stimulation capsule 120 is coupled with the antenna 200 by a tether 190. The deployment system 305 can be used to implant the leadless stimulator 100 into a patient - for example, into a patient's brain through a craniotomy. The burr hole cover frame 400 can be used to secure the antenna 200 and the correctly position the antenna 200 for communication with the external programmer 500. The external programmer 500 can read and write data to the leadless stimulator 100 through wireless communication with the leadless stimulator 100 using the antenna 200 of the leadless stimulator 100.
[0047] As illustrated in FIG. 1, the leadless stimulator system 50 can include an external programmer 500. The external programmer 500 can include a main unit 510, which holds the power source and electronics for the operation of the external programmer 500. The main unit 510 can include a screen 520 to provide visual information to the user. In some implementations, the screen 520 is a touch screen. The external programmer 500 can also include an antenna tether 530 that tethers the external programmer 500 to the external antenna 540. In some implementations, the external antenna 540 can have a diameter that provides efficient communication with the leadless stimulator 100 via the antenna 200 of the leadless stimulator 100. For example, the external antenna 540 could have a diameter between about 25 mm and about 75 mm or between about 45 mm and about 55 mm while the implanted antenna 200 can have a diameter between about 15 mm and about 35 mm or between about 20 mm and about 30 mm. The external programmer 500 can communicate with the leadless stimulator 100 wirelessly after the implantation of the leadless stimulator 100. The external programmer 500 can send data to the leadless stimulator 100 in order to set the stimulation parameters of the leadless stimulator 100. For example, the external programmer 500 can set signal attributes such as frequency, pulse width, amplitude, polarity, and signal shape, along with additional stimulation parameters, or a combination thereof. The final delivered pulses can be charge balanced, such that the pulse can have a cathodal and anodal phase. In some implementations, it is advantageous for the electrode if the amount of charge delivered during the cathodal phase is substantially equal to the amount of charge delivered during the anodal phase. Generally the pulses have a pulse width between 20 us and 1 ms, and the pulse frequency is between 20 Hz and 10 kHz depending on the clinical application. The external programmer 500 can also be used to turn the leadless stimulator 100 on or off. The external programmer 500 can also be used to control the post-operative neural recording features of the leadless stimulator 100. The external programmer 500 can be used to download data (e.g., usage data and recorded physiological data) from the leadless stimulator 100. In some implementations, the external programmer 500 can receive the data from the leadless stimulator 100 in substantially real time and in other implementations the leadless stimulator 100 may store the data for later retrieval with the external programmer 500.
[0048] In some implementations, the external programmer 500 may be used to recharge the internal batteries of the leadless stimulator 100. The external antenna 540 can be used to inductively couple power from an external power source to the leadless stimulator 100. In other implementations, the leadless stimulator 100 can have no internal power source. In this case the inductively coupled power from external programmer 500 can be used to power the leadless stimulator 100. In general, the leadless stimulator 100 can consume between about 5 mW and about 15 mW in clinical operation, and therefore the external programmer 500 is configured to supply sufficient power to charge the leadless stimulator 100 based on these demands.
[0049] FIG. IB illustrates the leadless stimulator 100 implanted into a patient's brain system 50 with the burr hole cover frame 400 and the external programmer 500 external to the patient's brain. The leadless stimulator 100 can be implanted responsive to the patient having a surgical planning procedure that involves MRI and/or CT scans to localize brain targets, thereafter the leadless neurostimulator 100 can be implanted in the deep brain using components of the leadless neurostimulator system 50. The deployment system 305 can push the leadless neurostimulator 100 to the brain target, and subsequently removed leaving the leadless stimulator 100 towards the brain target. The implantable antenna 200 remains remain extra-cranial. The burr hole cover frame 400 is used to fill the burr hole and stabilize the leadless stimulator 100. As described below, in some implementations, implantable antenna 200 is wrapped around the burr hole cover frame 400 to provide the correct diameter for efficient extra-corporeal communication. After implantation and surgical recovery, the external programmer 500 is used to program the leadless stimulator 100. The external programmer 500 can also provide power, or in some implementations recharge, the leadless stimulator 100.
[0050] FIGS. 2 and 3 illustrate the leadless stimulator 100. In FIG. 2 the antenna 200 is in a wrapped configuration, and in FIG. 3 the antenna 200 is in an outstretched configuration. The leadless stimulator 100 can include a stimulation capsule 120, a tether 190, and an antenna 200. The stimulation capsule 120 can include a plurality of electrodes and can record and/or stimulate the neurological tissue into which it is implanted.
[0051] The leadless stimulator 100 also includes an antenna 200 that can be coupled to the stimulation capsule 120 with the tether 190. The tether 190 can provide a mechanical and electrical coupling between the antenna 200 and the stimulation capsule 120. In some implementations, the antenna 200 is reversibly coupled with the tether 190 and in other implementations the antenna 200 is permanently coupled with the tether 190. In some implementations, the tether 190 and the antenna 200 refer to the same part of the leadless stimulator 100. For example, the part of the antenna outside of the patient may be referred to as the antenna 200 while the portion of the antenna inside the patient may be referred to as the tether 190. As illustrated in FIGS. 2 and 3, part, or all, of the tether 190 and antenna 200 can be flexible. For example, the antenna 200 can be configured to be flexible enough to enable the antenna 200 to be coiled within a burr cover that is implanted in the patient's skull or to form a loop as illustrated in FIG. 2. The tether 190 and the antenna 200 have a diameter of about 0.5 mm, but could range from as small as 0.2 mm to as large as 2 mm. The wires that form the antenna 200 can form a bifurcated tail body. The bifurcated tail body forms an antenna loop. The antenna 200 can include a wire coil that is embedded in a flexible, elastomeric body. The antenna loop may be flexible enough be stretched over a burr hole cover, which can position the antenna 200 in a predetermined shape (e.g., a loop of a predetermined diameter). In other implementations, as illustrated if FIG. 2, the antenna 200 may be wound into a circular loop of the predetermined diameter. The below discussed bun- hole cover frame may be used to ensure the antenna 200 maintains the predetermined diameter. [0052] The predetermined diameter of the antenna can enable the efficient coupling of antenna 200 and the external antenna 540 of the external programmer 500. In some implementations, the leadless stimulator 100 communicates wirelessly with the external programmer 500 over the 27 MHz frequency. Other frequencies which could be used are any of those determined by the International Telecommunication Union Radiocommunication Sector (ITU-R) in their reserved Industrial, Scientific, and Medical (ISM) Bands such as for example, but not limited to, 6.780 Mhz, 13.560 MHz, 40.680 MHz, 2.450 GHz, 5.80 GHz. The antenna diameter can be inversely proportional to the wavelength of the signal the antenna 200 transmits over. For example, with a 27 MHz frequency the loop diameter of the antenna 200 can be about 25 mm in diameter. In general, the loop diameter of the antenna is about half the wavelength of the frequency used to communicate with the antenna.
[0053] FIG. 4 illustrates an enlarged view of the distal end of the leadless stimulator 100 from FIGS. 1-3. The stimulation capsule 120 is coupled with the tether 190 at the proximal end 127 of the capsule body 125. The capsule body 125 can be conical or cylindrical in shape. The proximal end 127 can mate with the distal end of a cannula (not illustrated) during the implantation procedure. In general, the capsule body 125 includes a polymeric material and houses the active electronic components of the leadless stimulator 100. In some implementations, electronic components may also be housed in the tether 190 and antenna 200. The stimulation capsule 120 can include a hemispherical distal tip 126. The distal tip 126 can include electronic components. These electronic components are generally integrated circuits, resistors, capacitors, or a combination thereof.
[0054] The stimulation capsule 120 can be cylindrical and have a larger diameter than the tether 190. In some implementations, the diameter of the stimulation capsule 120 is between about 0.3 mm and about 3 mm, between about .75 mm and about 2.5 mm, between about 1 mm and about 2 mm, or between about 1.2 mm and about 1.6 mm.
[0055] The stimulation capsule 120 can also include a MEMS film 150. The MEMS film 150 can manufactured as a substantially planar film, which is coupled around the capsule body 125. In some implementations, the MEMS film 150 is wrapped to form a cylindrical shape and then glued or co-molded into place. The MEMS film 150 can include one or more electrodes 160. As illustrated in FIG. 4, the MEMS film 150 includes twelve electrodes (only eight of the electrodes 160 are visible in FIG. 4). In some implementations, the electrodes 160 can be implemented in a noble metal, such as platinum. In other implementations, the electrodes 160 can be implemented in gold, titanium, iridium oxide, platinum grey, platinum black, and oxides of titanium. As illustrated the electrodes 160 substantially square with rounded corners. In some implementations, the electrodes 160 can be circular, rectangular, or any other shape. In some implementations, the electrodes 160 can be used for physiological recordings and simulations.
[0056] FIGS. 5 and 6 illustrate the MEMS film 150 in its substantially planar configuration. The MEMS film 150 includes twelve electrodes 160 disposed across the exterior portion 157 of the MEMS film 150. In some implementations, the MEMS film 150 has about 4, 6, 8, 12, 16, 24, 36, 48, 64, or more electrodes 160. The electrodes 160 can be arranged in specific patterns. For example, FIGS. 5 and 6 illustrate an electrode arrangement that includes three columns and four rows of electrodes 160. In other implementations, the electrodes 160 can be rectangular electrodes that span the width of the exterior portion 157 and form ring electrodes when the MEMS film 150 is rolled into its cylindrical shape.
[0057] The MEMS film 150 also includes a ribbon cable 165. The lower portion of the ribbon cable 165 includes the contact pad 175. The contact pad 175 includes a plurality of contacts 170. Each of the contacts 170 can be coupled with one or more of the electrodes 160 through traces embedded within the MEMS film 150. For example, the MEMS film 150 may include twelve electrodes 160 and twelve contacts 170. In this example, each of the contacts 170 may be coupled with a different one of the twelve electrodes 160. In some
implementations, the contact pad 175 may include fewer contacts 170 than electrodes 160. In this example, one or more electrodes 160 may be coupled with the same contact 170, such that they may be stimulated (or recorded from) as a single unit. In some implementations, the contact pad 175 includes contacts 170 configured for different purposes. For example, the contact pad 175 illustrated in FIGS. 5 and 6 includes a second type of contacts - the wire tether contacts 172. The different types of contacts are generally referred to as contacts 170. The wire tether contacts 172 are used to couple the MEMS film 150 to the wires of the tether 190 and antenna 200. The contacts 170 may be coupled to an application-specific integrated circuit (ASIC) or other electronic component that is housed within the stimulation capsule 120.
[0058] FIG. 7 illustrates an enlarged view of the contact pad 175 from FIGS. 5 and 6. In some implementations, a metal layer 174 is deposited on the contacts 170. The metal layer 174 can include gold or other metal such as platinum, titanium, or copper. In some implementations, the addition of a metal layer 174 increases the ease of welding or attaching electronic components (e.g., antenna wires) to the contacts 170. In some implementations, the metal layer 174 improves the contacts' 170 ability to go undergo flip-chip bonding. The improvement in creating a contact with the contacts 170 may be caused by the metal layer 174 rising above the polyimide surface of the contact pad 175, making it easier for electronic components to be coupled to the contacts 170.
[0059] FIGS. 8-13 illustrate the assembly of an example contact pad 175. FIG. 8 illustrates an ASIC 180 prior to its coupling with the contact pad 175. In some implementations, the internal electronics of the stimulation capsule 120 are coupled to the contact pad 175. As illustrated, a single ASIC 180 is coupled with the contact pad 175; however, the electronic components of the leadless stimulator 100 can be divided among a plurality of ASICs 180, batteries, passive electronic components (e.g., resistors and capacitors), or other electronic components. The ASIC 180 includes a plurality of contacts 170, which are bound to the contacts 170 of the contact pad 175. The contacts 170 of the ASIC 180 can have the same pitch (e.g., spacing) as the pitch of the contact pad 175, such that the contacts 170 align and can be coupled together. In some implementations, the ASIC 180 is coupled with the contact pad 175 when the MEMS film 150 is a planar configuration - prior to the MEMS film 150 being formed into a cylindrical (or other) shape. For example, the ASIC 180 may be coupled with the contact pad 175 prior to the contact pad 175 being removed from the substrate on which it was fabricated. The ASIC 180 can be thinned to a thickness of about 50 μπι, and generally has a thickness between about 20 and about 550 μπι, prior to the ASIC 180 being coupled with the contact pad 175. FIG. 9 illustrates the contact pad 175 after the ASIC 180 is bound to the contact pad 175. As illustrated, the contacts 170 of the ASIC 180 are aligned and coupled with the contacts 170 of the contact pad 175. In some implementations, the ASIC 180 includes the stimulation source that is used to stimulate tissue via the electrodes 160. The ASIC 180 can also include a recording circuit. In some implementations, the stimulation capsule includes a plurality of ASIC 180.
[0060] FIG. 10 illustrates the lead wires 192 coupled with the contact pad 175. One or more lead wires 192 can be coupled to the one or more wire tether contacts 172. The lead wires 192 can be electrically coupled with the antenna 200 through the tether 190. The lead wires 192 can include platinum-iridium wire, and have a thin electrically isolating coating.
Incoming signals from the antenna 200 can be transmitted to the ASIC 180. The ASIC 180 can process these signals and record and stimulate through the electrodes 160 as instructed by the signals. The ASIC 180 can also transmit captured neural signals to a computer or other external device through by a transmission the signals over the antenna 200.
[0061] In some implementations, after the components of the leadless stimulator 100 are coupled together (while the MEMS film 150 is in a planar configuration) the MEMS film 150 can be molded into a cylindrical shape. FIG. 11 illustrates the MEMS film 150 molded into a cylindrical shape. The shaping of the MEMS film 150 into a non-planar shape (e.g., a cylinder) can be performed by heat molding the MEMS film 150 while protecting the mounted ASIC 180 or by molding the ASIC 180 in place. As illustrated the contact pad 175, with its coupled ASIC 180, is toward the MEMS film 150. The exterior portion 157 can then be rolled around the contact pad 175, such that the contact pad 175 with its coupled ASIC 180 (e.g., the stimulation source, the power supply, and the recording circuit) is within a lumen created by the rolled exterior portion 157.
[0062] FIG. 12 illustrates a cutaway view of the MEMS film 150 molded into a cylindrical shape. FIG. 12 illustrates the folding of the MEMS film 150 into a cylindrical and the internal electronics of the MEMS film 150. As illustrated the ribbon cable 165 can be folded back such that the contact pad 175 at least partially overlaps the exterior portion 157. The edges of the exterior portion 157 are then rolled to create a cylinder around the ASIC 180. Once the exterior portion 157 is rolled into a cylindrical form, the created cylinder can be co-molded to create the leadless stimulator 100.
[0063] FIG. 13 illustrates an enlarged view of an example stimulation capsule 120. The rolled MEMS film 150 can be over-molded to create a mechanically stable device. In some implementations, the MEMS film 150 is rolled to create the cylindrical shape. The capsule body 125 of the leadless stimulator 100 is then manufactured by co-molding the MEMS film 150 to encapsulate the interior of the MEMS film 150 and the electronics therein. The co- molding of the MEMS film 150 can involve securing the MEMS film 150 in place and having it back-filled with a polymer precursor, such as an epoxy, to backfill the cavities within the molded MEMS film 150. The over-molding material may include epoxy materials, such as EPO-Tek 353, that provide sealing of the electronics and wire traces therein, protecting the electronics from body fluids that may disrupt electrical function. The stimulation capsule 120 can also include a distal tip 126. The distal tip 126 can be coupled with the capsule body 125 or the distal tip 126 can be created as part of the capsule body 125 during the over-molding process. As illustrated the distal tip 126 is hemispherical, although other shapes may be used. For example, the distal tip 126 can be beveled or blunt. The distal tip 126 enables atraumatic insertion of the leadless stimulator 100 into tissue during the implantation procedure.
[0064] FIG. 13 also illustrates the tether 190. The tether 190 can include a jacket, such as a polymeric tubing, around the lead wires 192. In some implementations, the tether 190 can be hollow and have a lumen through which the lead wires 192 run. In other implementations, the tether 190 can be filled, encapsulating the lead wires 192 or other electronic components in the lumen of the tether 190. In some implementations, the tether 190 is of a diameter of 0.5 mm, is flexible and easily wraps around a finger of a surgeon for example.
[0065] In some implementations, the leadless stimulator 100 may not include an antenna 200 at the surface of the skull. For example, the leadless stimulator 100 may include an integrated antenna (also referred to as a micro-antenna) on the stimulation capsule 120. An integrated antenna can reduce the risk of malfunction due to broken lead wires.
[0066] FIG. 14 illustrates an example leadless stimulator 100 with a micro-antenna. The leadless stimulator 100 with a micro-antenna can include a stimulation capsule 120 and a tether 190. In some implementations, for example with a micro-antenna, the tether 190 may not include lead wires to form an antenna; however, the leadless stimulator 100 may still include the tether 190 to facilitate the removal of the leadless stimulator 100 from a patient's tissue after implantation. [0067] FIGS. 15 and 16 illustrate an example MEMS film 150 with a micro-antenna. The MEMS film 150 can include an exterior portion 157, a ribbon cable 165, and contacts 170. The exterior portion 157 includes nine electrodes 160 and a micro-antenna 661. In some implementations, the exterior portion 157 includes more than or fewer than nine electrodes 160. As illustrated in FIG. 15, the contact pad 175 includes a battery pad 684, on which a battery may be coupled. The battery may be coupled with the battery pad 684 in a means (e.g., flip chip bonding) similar to the means that an ASIC 180 is coupled to the contact pad 175. After the electronic components are coupled with the MEMS film 150, the battery pad 684 can be folded over on the contacts 170 of the contact pad 175. In the example illustrated in FIG. 15, the ribbon cable 165 is divided into two separate ribbon cables. In some implementations, the metal layer of the MEMS film 150 that includes the traces from the electrodes 160 to the contacts 170 and the micro-antenna 661 is covered by a top insulating layer to electrically insulate the components.
[0068] FIG. 16 illustrates an enlarged view of the example MEMS film 150 from FIG. 15. In FIG. 16 the top insulating layer of the MEMS film 150 is removed to illustrate the electrical elements embedded within the MEMS film 150. For example, removal of the top insulating layer exposes the micro-antenna 661 and the electrical traces 658. The electrical traces couple the electrodes 160 with the contacts 170 (or other electrodes 160). The micro- antenna 661 is embedded in the metal layer of the MEMS film 150. The micro-antenna 661 is serpentine in shape and is designed in order to be highly efficient at the chosen transmission frequencies.
[0069] FIG. 17 illustrates a perspective view of an example leadless stimulator 100 with a micro-antenna 661. The MEMS film 150 can be rolled into a cylindrical shape. The MEMS film 150 can then be over-molded to create a capsule body 125. In some implementations with a micro-antenna 661, the tether 190 does not include antenna wires, and the tether 190 is used for the extraction of the leadless stimulator 100 from a patient after implantation. In some implementations, the tether 190 is embedded within the distal tip 126. Having the tether 190 run through the length of the body can reduce the chance of the tether 190 breaking free of the stimulation capsule 120. [0070] FIGS. 18 and 19 illustrate a cutaway view of an example leadless stimulator 100 with micro-antenna 661. As discussed above in relation to FIG. 17, the tether 190 can be coupled to the distal tip 126. FIG. 18 illustrates that the tether 190 passes through the body of the stimulation capsule 120 and is coupled with the distal tip 126. The ribbon cable 165 is divided into two parts (ribbon cable 165 A and ribbon cable 165B) to facilitate the passage of the tether 190 through the capsule body 125. As illustrated in FIG. 19, the tether 190 can pass between the two parts of the ribbon cable 165. FIGS. 18 and 19 also illustrate the placement of the power supply 181. In some implementations, the power supply 181 is a battery. The power supply 181 may be recharged by the external programmer 500. Generally, the power supply 181 can have enough charge to provide stimulation for at least one day, or about 200 mAh, and in some implementations up to several weeks, or around 2300 mAh.
[0071] FIGS. 20A and 20B illustrate the internal arrangement of an example leadless stimulator 100 with a micro-antenna. The contacts 170 of the ASIC 180 can be aligned with and bonded to the respective contacts 170 of the contact pad 175. The contacts 170 of the power supply 181 can be aligned with and bonded to the respective contacts 170 of the battery pad 684. In some implementations, the ASIC 180 (or other components) can be wire bonded to the MEMS film 150 through wire bonds. Referring to FIGS. 20A-20B, among others, the power supply 181 and the ASIC 180 are placed on opposite sides of the tether 190 as the tether 190 passes through the body of the stimulation capsule 120.
[0072] FIGS. 21 and 22 illustrate an example MEMS film 150 with a micro-antenna 661. As illustrated in FIG. 21, the MEMS film 150 includes a micro-antenna 661 on the distal portion of the contact pad 175. The micro-antenna 661 is disposed on a projection 176 from the contact pad 175. When forming the stimulation capsule 120, the micro-antenna 661 can be rolled to form a loop, which is housed within the rolled MEMS film 150. FIG. 22 illustrates a cutaway view of the stimulation capsule 120 with the rolled micro-antenna 661 located in the internal portion created by the rolled MEMS film 150.
[0073] FIGS. 23A-23M illustrate a cross-sectional view of an example thin-film micro- fabrication method for fabricating the MEMS film 150. The MEMS film 150 can be fabricated using a plurality of techniques and the below describe method illustrates one possible method for fabricating the MEMS film 150. The fabrication procedure can include a series of procedural steps in which various layers are deposited or removed (e.g., etched) to achieve a final form. The cross sections in FIG. 23 A through FIG. 23M demonstrate the process steps to build a MEMS film 150.
[0074] In a first step illustrated in FIG. 23 A, a carrier substrate 2301 is provided, such as a wafer composed of a crystalline material, such as silicon, or an amorphous material, such as a thermal shock resistant borosilicate glass or other suitable smooth supportive material. A first layer 2302, which can include one or more sub-layers, is applied to a surface of the wafer 2301. One of the sub-layers can be a sacrificial layer deposited on the wafer 2301, which is removed in a subsequent electrochemical etching step. In some implementations, the sacrificial sub-layer is preceded by another sub-layer, referred to as an underlayer, which can serve to form the electrochemical cell required to etch the sacrificial layer. The sacrificial sub-layer can be aluminum, or an alloy of aluminum such as AISi, which has a smaller granularity, whereas the underlayer can be a TiW alloy such as Chrome or similar metal.
[0075] Referring to FIG. 23B, the next step in the fabrication process can include depositing a first polymeric layer 2305. The first polymeric layer 2305 can be deposited upon the sacrificial layer 2302 by MEMS processes such as, but not limited to, (i) spin coating a liquid polymer precursor such as Polyimide or Silicone precursor; (ii) depositing a polymer through chemical vapor deposition as is done with parylene-C; or (iii) laminating a polymer sheet onto the wafer. In some embodiments, the polymer layer 2305 is heated, or baked, to polymerize. In some implementations, the first polymeric layer 2305 includes polyamic-acid dissolved in NMP and spun onto the sacrificial layer 2302 in liquid form. The polymeric layer 2305 is heated into a imidized polyimide. The polymer in its cured form is between about 5 μπι and about 15 μπι thick.
[0076] Referring next to FIG. 23C, the deposition of a barrier layer. The barrier layer can serve both as a layer to aid the adhesion and durability of subsequent layers. The barrier layer can also serve as an ionic barrier, and limit ions from reaching the metal layers, which could compromise electrical performance. The barrier layer can also block humidity from reaching the interlayers and the metal layer, which could create short circuits and compromise electrical isolation. [0077] In some implementations, the barrier layer is deposited onto the first polymeric layer 2305 by vapor deposition techniques such as chemical vapor deposition (CV) and plasma enhanced chemical vapor deposition (PECVD), or by sputtering techniques such as direct current (DC) or RF (Radio Frequency) sputtering. The barrier layer can include Silicon Nitride, Silicon Oxide, Silicon Carbide, Poly-Silicon, or Amorphous-Silicon. In some implementations, the barrier layer can also include other non-conductive materials, such as Titanium Dioxide or Titanium (III) Oxide. The final thickness of the barrier layer can range from about 100 nm to about 2 μιη. In some implementations, the barrier layer is about 400 nm to about 600 nm, which can permit the barrier layer to be flexible enough to bend during subsequent assembly techniques.
[0078] Now referring to FIG. 23D, a metal layer 2315 can be deposited over the entire wafer on the surface of the barrier layer 2310. Subsequently, a photoresist layer 2317 can be deposited. The photoresist layer 2317 can be defined by exposing areas of the photoresist layer 2317 to ultra-violet light and developing those areas in a solvent. Thus, the exposed areas of the photoresist layer 2317 will be selectively removed and areas of the metal layer 2315 will be exposed. The areas of the metal layer 2315 covered by the photoresist layer 2317 can form the electrodes, traces, and other components of the final product that are within the metal layer.
[0079] The metal layer 2315 can include a variety of metals such as titanium, platinum, gold, and others metals used in neuromodulation. To improve adhesion of a metal layer 2315, the metal layer 2315 can be applied in layers. For example, the metal layer 2315 can be applied as a first layer, such as titanium, then a middle layer, such as platinum, and finally an upper layer, such as titanium. This tri-layer metal structure can improve adhesion below and above the platinum layer by using the titanium as an adhesion layer to the barrier layer. The typical thicknesses for the adhesion layer of titanium can be between about 20 nm and about 100 nm or between about 25 nm and about 75 nm. Typical thicknesses for the platinum layer can be between about 200 nm and about 400 nm or between about 250 nm and about 350 nm.
[0080] FIG. 23E illustrates the process after the etching of the metal layer 2315. As illustrated, the metal layer 2315 can be locally removed in the areas that were not covered by the photoresist 2317. In some implementations, etching of the metal layer is performed in a plasma etcher such as a Reactive Ion Etcher. In some implementations, titanium and platinum can be etched with chlorine gas. After the etching process is finished, the photoresist layer 2317 can be removed using a solvent.
[0081] Another method to deposit and define the metal layer is using the so-called "lift off technique. In this method the photoresist layer can be deposited onto the barrier layer 2310 first. The photoresist layer can be defined using photolithography. The metal layer 2315 can then be deposited through this "lift off mask, and the remaining photoresist removed in a solvent. In this method the metal layer is transferred onto the barrier layer without the need of plasma etching and may have some process costs and speed advantages.
[0082] Referring next to FIG. 23F, a deposition of a second barrier layer 2320 is performed. The second barrier layer can be deposited using the same techniques as the first barrier layer 2310. The second barrier layer 2320 can be the same thickness, or a different thickness as the first barrier layer. In some implementations, the second barrier layer is optional. The second barrier layer 2320 and the first barrier layer 2310 can substantially surround the metal layer 2315, rendering it electrically isolated. In order to etch and define the first and second barrier layer 2310 and 2320, respectively, a second photoresist layer 2327 is deposited and photolithographically defined with clean room techniques.
[0083] The two barrier layers are etched, as illustrated in FIG. 23G. The barrier layers can be etched using a plasma etch. An example of an etching process would be a reactive ion etching using a tetrafluoromethane gas, (CF4). The second photoresist layer 2327 can be removed using a solvent dissolution.
[0084] FIG. 23G illustrates that the edges of the barrier layers 2310 and 2320 are defined, but the etch does not reach the metal layer 2315. This is optional, and in some
implementations the photolithography can include an opening above the metal layer 2315, which would result in exposing the metal layer 2315.
[0085] FIG. 23H illustrates the application of a second polymer layer 2330. The second polymer layer 2330 can be the same or a different polymer from the first polymer layer 2305, and it can be the same or a different thickness. [0086] FIG. 231 illustrates the deposition of a third photoresist 2337, which can form the etching perimeter of the first and second polyimide layers 2305 and 2330, respectively. In some implementations, prior to the applying the third photoresist 2337, a sacrificial layer, such as Silicon Dioxide or Silicon Nitride, is deposited in order to serve as an etch mask for the polyimide etch. For example, a silicon dioxide layer of thickness of about 500 nm can be deposited, which will serve as the etch mask for the process.
[0087] FIG. 23J illustrates the result of an oxygen plasma etching of the first and second polyimide layers 2305 and 2330, respectively. If applied, the silicon dioxide layer can be removed through an additional etch.
[0088] FIG. 23K illustrates the deposition of a fourth photoresist layer 2347. The fourth photoresist layer 2347 does not cover part of the metal layer 2315. The opening 2332 maintained is designed to create a region for a gold layer to grow.
[0089] FIG. 23L illustrates the galvanic growth of a thick gold layer 2350 into the opening 2332. In some implementations, the gold layer 2350 is achieved by connecting the metal traces in the wafer to a perimetric metal band that allows an electrical connection between the edge of the wafer and the metal opening 2332. When immersed in a galvanic bath and a current applied, the gold will grow on the metal layer 2315 using the metal layer 2315 as the seed layer for galvanic growth. In some implementations, the gold layer 2350 is about 2 μπι to about 20 μπι thick. The fourth photoresist layer 2347 can be removed using a solvent.
[0090] FIG. 23M illustrates the removal of the MEMS film from the wafer 2301. The removal of the fourth photoresist layer 2347 exposes the electrode opening 2333. The MEMS film can be removed from the wafer 2301 by the removal of the sacrificial layer 2302 using electrochemically etching. Removal of the sacrificial layer 2301 frees the underside of the MEMS film from the wafer 2301. In some implementations, the sacrificial layer 2301 is removed by placing the wafer in a saline bath with a high NaCl concentration. A platinum electrode also placed in the bath can be used as a reference, and a voltage can be applied to the aluminum layer with respect to the platinum electrode. The electrochemical cell created by the aluminum and TiW etches the aluminum - separating the MEMS film from the wafer 2301. [0091] When the MEMS wafer is completed, and the individual devices have been removed, they still require several process steps before being assembled into the cylindrical shape that is required.
[0092] FIG. 23N illustrates a method 2360 for manufacturing a leadless stimulator. At step 2361, a MEMS film is formed. The method for forming the MEMS film is described above in relation to FIGS. 23A-23M. In general, the MEMS film is formed as a planar film. The MEMS film can include a plurality of electrodes and a ribbon cable that extends from the distal end of the MEMS film.
[0093] At step 2362, a stimulation source is coupled with the MEMS film. Referring to FIG. 8, the stimulation source may be a component of an ASIC 180. The stimulation source (or ASIC 180) can include a plurality of contacts 170. The ribbon cable can also include a plurality of contacts 170. As illustrated in FIG. 8, the contacts 170 of the ASIC 180 can be coupled with the contacts 170 of the ribbon cable. Coupling the contacts 170 of the ASIC 180 with the contacts 170 of the ribbon cable can enable an electrical connection between the ASIC 180 and one or more electrodes.
[0094] Referring again to FIG. 23N, at step 2363, a power supply is coupled with the MEMS film. As illustrated in FIG. 20A and 20B, a power supply 181 can be coupled with the MEMS film. The power supply can include a plurality of contacts, through which an electrical connection is established with the MEMS film. In some implementations, the power supply is coupled to the same face of the ribbon cable as the stimulation source, and in other implementations the power supply is coupled with a face opposite to the face the stimulation source is coupled. In some implementations, other circuitry such as recording circuitry, control circuitry, or other ASICs can be coupled with the ribbon cable.
[0095] At step 2364, the ribbon cable is folded toward a face of the MEMS film. As illustrated in FIG. 12, the ribbon cable 165, with the coupled stimulation source and power supply, are folded toward a face of the MEMS film. The MEMS film can include two primary faces. The first face includes the plurality of electrodes and the second face is the opposite face of the MEMS film. As illustrated in FIG. 12, the ribbon cable 165 is folded toward the second face of the MEMS film. [0096] At step 2365, the MEMS film is formed into a lumen. Also as illustrated in FIG. 12, the sides of the MEMS film are formed around the portion of the ribbon cable to which the stimulation source and power supply are coupled. The formed MEMS film defines a lumen, in which the stimulation source and power supply are disposed. The MEMS film can be heat formed such that the MEMS film maintains it shape after the forming process. In some implementations, the lumen defined by the formed MEMS film is filled with an encapsulating epoxy. The encapsulating epoxy can provide structural stability to the stimulation capsule and can also electrically isolate the electrical components disposed within the lumen.
[0097] FIG. 24 illustrates an example deployment system 305. The deployment system 305 is used to implant the leadless stimulator 100. The deployment system 305 includes a guide tube 300. At the proximal end, deployment system 305 can include a connection plug 310. The connection plug 310 enables electrical connections between the deployment system 305 and a controller or recording device used during the implantation of the leadless stimulator 100. The connection plug 310 is coupled with the other components of the deployment system 305 via the connection cable 315. The connection cable 315 can include electrical conductors, in the form of wires or traces, which electrically couple the distal electrodes 355 to the connection plug 310. The deployment system 305 also includes a depth stop 320 to enable the surgeon to couple the deployment system 305 with stereotactic equipment. In some implementations, the depth stop 320 may also house pre-amplifier circuitry to improve the signals coming from the distal electrodes 355. The depth stop 320 also includes a deployment handle 325. The deployment handle 325 may be pushed up or down by the surgeon to deploy or retract, respectively, the distal legs 360. In FIG. 24, the distal legs 360 are illustrated in the deployed state. The body of the deployment system 305 includes guide tube 300. The guide tube 300 can include a leg support stent that is disposed around an inner cylinder. A MEMS film can be disposed around the leg support stent to form the distal legs 360.
[0098] FIGS. 25A and 25B illustrate a cut away and perspective view, respectively, of the distal end of the guide tube 300. The inner cylinder 330 includes a central lumen 337. The distal most end of the inner cylinder 330 includes a guide 339. The guide 339 can mate with the proximal end of the stimulation capsule 120. [0099] In some implementations, the external diameter of the inner cylinder 330 is between about 0.5 mm and about 3 mm, between about 1 mm and about 2 mm, or about 1 mm and 1.5 mm. In some implementations, the internal diameter of the central lumen 337 is between about 0.25 mm and about 1.5 mm or between about 0.5 mm and about 1 mm. The internal diameter of the central lumen 337 can enable the insertion of the tether 190 and the antenna 200. The guide 339 can have a slightly larger external diameter when compared to the inner cylinder 330. For example, the diameter of the guide 339 may be about 1.5 mm when the outer diameter of the inner cylinder 330 is about 1 mm. The guide 339 can either be a separate piece, which is later coupled with the inner cylinder 330, or the guide 339 can be machined from the same stock material as the inner cylinder 330. The inner wall 340 of the guide 339 can surround the leadless stimulator 100, and the outer wall 341 of the guide 339 can be used to guide the below described distal legs 360 during deployment. In some implementations, the inner cylinder 330 includes a metal, such as surgical stainless steel, and in other implementations, the inner cylinder 330 can include a polymer or other MRI compatible material such as a ceramic or titanium oxide.
[0100] FIGS 26A-26C illustrate an example leg support stent 344. In some
implementations, the external diameter of the leg support stent 344 is between about 0.5 mm and about 3 mm, between about 1 mm and about 2 mm, or about 1 mm and 1.85 mm. The internal diameter of the leg support stent 344 can be at least the external diameter of the inner cylinder 330, such that the leg support stent 344 can be disposed around the inner cylinder 330. The leg support stent 344 can include leg supports 342 at distal end of the leg support stent 344. As illustrated, the leg support stent 344 includes four leg supports 342. In some implementations, the leg supports 342 can be flexible enough to expand with the typical forces that can be applied by hand. Fig. 26B and 26C illustrate the expanded leg supports 342. In some implementations, the leg supports 342 of the leg support stent 344 slide distally along the inner cylinder 330. When the leg supports 342 come into contact with the outer wall 341 of the guide 339, the outer wall 341 can cause the leg supports 342 to expand.
[0101] FIG. 27 illustrates an example MEMS film 350 that can be coupled around the leg support stent 344. The MEMS film 350 can include legs 352. As illustrated the MEMS film 150 includes four legs 352. In some implementations, the legs 352 are between about 5 mm and about 15 mm or between about 7 and about 12 mm in length. The legs 352 can be about 0.25 mm to about 1 mm in width. In some implementations, the legs 352 are about the same length and width as the leg supports 342. One or more surfaces of the legs 352 can include a plurality of microelectrode elements 355. As illustrated, each leg 352 includes five microelectrode elements 355. In some implementations, different legs 352 can include a different number of microelectrode elements 355. Each microelectrode elements 355 can include between 1 and about 10 microelectrode elements 355. In some implementations, the legs 352 include more than 10 microelectrode elements 355. The microelectrode elements 355 can be circular or rectangular in shape and have a diameter between about 100 μιη and about 1000 μιη, or between about 200 μιη and about 700 μιη, or between about 300 μιη and about 500 μιη. The MEMS film 350 can also include a shoulder 357 that can be coupled around the leg support stent 344. The MEMS film 350 can further include a tether 359, which carries traces from the microelectrode elements 355 to the proximal end of the guide tube 300. In some implementations, there is one trace for each microelectrode elements 355 and in other implementations one or more microelectrode elements 355 may be coupled with the same trace.
[0102] FIG. 28A illustrates the MEMS film 350 coupled with the leg support stent 344. The MEMS film 350 can be coupled to the leg support stent 344 with glue or pressure bonding. The legs 352 are aligned and coupled with the leg supports 342. FIG. 28B illustrates the MEMS film 150 coupled with the leg support stent 344, with the leg supports 342 in the retracted state.
[0103] FIG. 29A illustrates an example outer tube 370 of the guide tube 300. The distal end of the outer tube 370 can include leg gaps 372. The outer tube 370 can enable the leg supports 342 to fit within the leg gaps 372. In some implementations, the outer tube 370 can have an outer diameter between about 0.5 and about 2.5 mm. In some implementations, the wall thickness of the outer tube 370 is about 0.2 mm. The outer tube 370 is generally implemented in a medical grade Stainless Steel such as 316, or could be implemented in a polymer such as polyimide to promote improved MRI Compatibility.
[0104] FIG. 29B illustrates an example guide tube 300 with an outer tube 370 in place. The outer tube 370 can be placed concentrically over the MEMS film 350 and the leg support stent 344. As illustrated in FIG. 29B, the assembly guide tube 300 exposes the microelectrode elements 355 through the leg gaps 372 of the outer tube 370. In some implementations, exposure of the microelectrode elements 355 through the leg gaps 372 enables the microelectrode elements 355 to record neural activity as the guide tube 300 descends into brain tissue. In some implementations, the guide tube 300 can perform neural recording to enable a surgeon to identify the guide tube's location with a patient's tissue.
[0105] FIGS. 30A and 30B illustrate two views of the guide tube 300 with the distal legs 360 deployed. In some implementations, when reaching a target site within the tissue, the distal legs 360 can be deployed by a surgeon to perform neural recording. Each of the distal legs 360 can include a plurality of microelectrode elements 355. In the illustrated example of FIGS. 3 OA and 30B, each of the four distal legs 360 include five microelectrode elements 355, for a total of twenty recording and stimulation sites. In some implementations, the guide tube 300 can include more or fewer distal legs 360, each with more or fewer microelectrode elements 355.
[0106] FIGS. 31A and 3 IB illustrate an example deployment mechanism 319. In some implementations, the deployment mechanism 319 can include a handle 325 that can be used to deploy the distal legs 360, as illustrated in FIGS. 30A and 30B. The leg support stent 344 can be attached to the deployment handle 325. Accordingly, movement of the deployment handle 325 can be translated into movement of the leg support stent 344, which results in the deployment or retraction of the distal legs 360. FIG. 31A illustrates the position of the deployment handle 325 when the distal legs 360 are in the deployed state, and FIG. 3 IB illustrates the position of the deployment handle 325 when the distal legs 360 are in the retracted state. The central lumen 337 is visible on the proximal end of the deployment mechanism 319. The deployment mechanism 319 can include depth stops 320 that can limit the movement of the deployment handle 325 in the proximal and distal directions.
[0107] FIGS. 32A and 32B illustrate the distal end of the example deployment system 305 coupled with the leadless stimulator 100. The deployment system 305 includes the guide tube 300 coupled with the leadless stimulator 100. The stimulation capsule 120 is exposed at the distal end of the guide tube 300. In some implementations, the proximal end 127 of the leadless stimulator 100 (hidden in FIGS. 32A and 32B) can couple with the guide 339 (hidden in FIGS. 32A and 32B) of the guide tube 300. When the leadless stimulator 100 is coupled with the guide tube 300, the guide tube 300 can be used to push the leadless stimulator 100 toward the target location in the tissue.
[0108] FIGS. 33A and 33B illustrate the distal end of the example deployment system 305, with the distal legs 360 deployed. In some implementations, when deployed, the distal legs 360 can enable the recording and stimulation of the region surrounding the stimulation capsule 120. In some implementations, the intra-operative recording and stimulation procedure can be used to further determine the final position of the leadless stimulator 100. In some implementations, the recording and stimulation procedure can be used to determine an improved stimulation and recording configuration for the leadless stimulator 100. For example, the procedure may be used to determine if a subset of the electrodes 160 of the leadless stimulator 100 should be used for recording and stimulating.
[0109] FIGS. 34A and 34B illustrate the distal end of the example deployment system 305, with the guide tube 300 and stimulation capsule 120 separated - for example, after the surgeon has begun to retract the deployment system 305 from the patient's tissue. In some implementations, the distal legs 360 are retracted and then the deployment system 305 can be retracted from the tissue, leaving, as illustrated in FIGS. 34A and 34B, the leadless stimulator 100 at the target location.
[0110] FIGS. 35-38 illustrate an example method of implanting the leadless stimulator 100. FIG. 35A and 35B illustrate the leadless stimulator 100 in the preimplantation position. The leadless stimulator 100 is positioned above a craniotomy 1055 in a patient's skull 1050. The craniotomy exposes a portion of the brain 1060. In some implementations, the leadless stimulator 100 and deployment system 305 are lowered into place from the exterior of the patient using stereotactic implantation tools (not illustrated).
[0111] FIGS. 36A and 36B illustrate the positioning of the leadless stimulator 100 into the patient's brain 1060. Using the stereotactic implantation tools, the surgeon drives the deployment system 305 into the patient's brain 1060, which in turn pushes the leadless stimulator 100 into the position. In some implementations, the surgeon can record neural activity as with the deployment system 305 and leadless stimulator 100 as they are lowered toward the target location.
[0112] FIGS. 37A and 37B illustrate the deployment of the distal legs 360 of the leadless stimulator 100. In some implementations, the distal legs 360 are deployed to record neural activity when the leadless stimulator 100 is believed to be at the proper implantation location. The microelectrode elements 355 of the guide tube 300, and optionally the electrodes 160 of the leadless stimulator 100 can be used to record the neural activity of the implanted location. This procedure may be referred to as "targeting." Targeting procedure may include recording the electrical activity of the target anatomy using the microelectrode elements 355 and the electrodes 160. A signal processing software can record and display the neural activity to the neurosurgical team. Responsive to the recorded neural activity, the team may determine if the leadless stimulator 100 is placed in the proper anatomical location. In some
implementations, the microelectrode elements 355 and the electrodes 160 can be used to stimulate the anatomical target in order to evoke a physiological response in the patient - for example, eye twitching or parasthesia. This procedure of neurophysiological recording and evoked patient responses can lead the neurosurgical team to determine the best placement of the leadless stimulator 100.
[0113] FIGS. 38A and 38B illustrate the placement of the leadless stimulator 100 after the retraction of the deployment system 305. Following the targeting procedure, the distal legs 360 can be retracted. The leadless stimulator 100 can be left in place and the deployment system 305 is retracted from the patient. As the deployment system 305 is retracted, the stimulation capsule 120 remains in place and is tethered with the antenna 200 by the tether 190. The antenna 200 may exit the patient through the craniotomy 1055. The surgeon may fill the craniotomy 1055 with surgical cement or bone paste, which can secure the antenna 200 in place. In some implementations, the antenna 200 is wound into a burr hole cover frame to secure and position the antenna 200.
[0114] FIG. 39 illustrates a patient 1000 with a burr hole cover frame 400 in place. FIG. 40 illustrates a closer view of the example burr hole cover frame 400. The burr hole cover frame 400 can include a burr hole cover cap 450 that protects the antenna 200 and area of the skull where the craniotomy was performed. The burr hole cover frame 400 can also include a lower part 410. In some implementations, the burr hole cover cap 450 can be secured to the lower part 410 by the burr hole cover cap 450 clipping into the lower part 410. In another implementation, as illustrated in FIG. 40, the burr hole cover cap 450 can be secured to the lower part 410 by screws 462 through screw holes 456.
[0115] FIG. 41 illustrates a side view of the example burr hole cover frame 400 after implantation into the craniotomy 1055. The burr hole cover frame 400 can include the burr hole cover cap 450 coupled with the lower part 410. The lower part 410 can include a bun- hole insert 412, through which the leadless stimulator 100 exits the patient. The burr hole insert 412 can fill the hole in the skull left by the craniotomy. The antenna 200 can wrap around the circumference of the lower part 410 to ensure the antenna 200 maintains a predetermined loop diameter. In some implementations, the lower part 410 is secured to the patient by one or more screws 462 or glue.
[0116] FIGS. 42A-42C illustrate the example lower part 410 of the burr hole cover frame 400. FIGS. 42A, 42B, and 42C illustrate side, top, and perspective views of the lower part 410, respectively. The lower part 410 can include a cartwheel frame 415. The cartwheel frame 415 can include an antenna notch 417 around the perimeter of the cartwheel frame 415. In some implementations, the antenna 200 is wound around the perimeter of the cartwheel frame 415 and lies within the antenna notch 417. The antenna notch 417 of the cartwheel frame 415 can include a hole 418 from which the antenna 200 can exit the central lumen 411 of the lower part 410 to be wrapped around the perimeter of the cartwheel frame 415. The lower part 410 can also include a burr hole insert 412 that is inserted into the craniotomy 1055 of the patient. The burr hole insert 412 is about 8 mm in diameter in some
implementations, but can range from 3 mm to 15 mm in diameter. The burr hole insert 412 is about 4 mm deep, but can range from 1 mm to 8 mm deep in some implementations.
[0117] FIG. 42B illustrates that the lower part 410 can include securing screw holes 425 on the inner perimeter of the cartwheel frame 415 and on the spokes 416 of the lower part 410. The securing screw holes 425 can be used to secure the burr hole cover frame 400 to the patient's skull by screwing screws through the securing screw holes 425 and into the patient's skull. The lower part 410 can also include screw holes 426 to secure the lower part 410 to the burr hole cover cap 450. In some implementations, the lower part 410 has a diameter 420 of about 25 mm. Generally, the diameter is equivalent to the most efficient antenna diameter for the chosen transmission frequency as described above.
[0118] FIGS. 43A, 43B, and 43C illustrate side, top, and perspective views of the burr hole cover cap 450, respectively. In some implementations, the burr hole cover cap 450 can protect the antenna 200 and the patient's brain after its exposure by the craniotomy. The bun- hole cover cap 450 can include a smoothed edge 452. The smoothed edge 452 can reduce tissue erosion once implanted. The burr hole cover cap 450 can also include three securing screw holes 456 that can align with screw holes 426.
[0119] FIGS. 44A and 44B illustrate different views of the bottom-side of the burr hole cover cap 450. The burr hole cover cap 450 can include a plurality of alignment guides 458 that are used to align the burr hole cover cap 450 with the lower part 410 before the two components are secured together. The burr hole cover cap 450 can also include a central boss 460 that can be used in the alignment of the two components and to plug the central lumen 411.
[0120] FIGS. 45-47 illustrate the wrapping of the antenna 200 around the lower part 410. FIG. 45 illustrates the lower part 410 and the leadless stimulator 100 after implantation. The leadless stimulator 100 is implanted into the patient's brain and the lower part 410 has been inserted into the craniotomy. The tether 190 is coupled with the stimulation capsule 120 and extends through the central lumen 41 1 and transitions into the antenna 200.
[0121] FIG. 46 illustrates the insertion of antenna 200 into the hole 418. The hole 418 begins in the central lumen 411 and traverses through one of the spokes of the lower part 410 to the antenna notch 417.
[0122] As illustrated in FIG. 47, the antenna 200 can then be wrapped around the lower part 410 in the antenna notch 417. Wrapping the antenna 200 around lower part 410 can ensure that the antenna 200 forms a loop of proper diameter to increase the effectiveness of the antenna 200. In some implementations, the antenna 200 can be secured to the lower part 410 with a clip or with a bonding agent. In some implementations, the proximal end of the antenna 200 includes a loop, which can be stretched over the perimeter of the cartwheel frame 415 and into the antenna notch 417. [0123] Deep Brain Stimulation can relieve the symptoms of Movement Disorders. The systems and methods described herein provide a more efficient and simple device to deliver the required therapeutic stimulation and in some cases provide neural recording. In the case of Movement Disorders the systems and methods described herein can provide efficient stimulation of the sub-thalamic nucleus, the Globus Pallidus interna, the Globus Pallidus externus, the Zone Incerta, or the Ventral Intermediate Nucleus to relieve symptoms such as rigidity and tremor. In other therapeutic domains such as psychiatric diseases, the systems and devices described herein can be implanted in the Cingulate Gyrus 25, the Medial Forebrain Bundle, the Nucleus Accumbens, the Ventral Striatum to deliver electrical stimulation and relieve the symptoms of Depression, Anxiety, Phobias, Obsessive
Compulsive Disorder, or Post Traumatic Stress Disorder.
[0124] In some implementations, the leadless stimulator 100 can be implanted into anatomy of the patient other than the brain. For example, the leadless stimulator 100 may be used for pain management, spasticity, movement disorders, and spinal cord injury. In some of these implementations, the leadless stimulator 100 can be implanted near the patient's spinal cord. Fig. 48A demonstrates a representative human anatomy of the spinal column 4800. There are a series of vertebrae 4820 separated by intervertebral discs 4830. The spinal cord 4840 is also represented in the spinal canal 4845. Fig. 48B illustrates a magnified section of the anatomy 4800 demonstrating the same anatomical sections with greater detail.
[0125] FIG. 48C illustrates a perspective view of the anatomy 4800 with four implanted stimulation capsules 120. The implantable antennas 200 remain outside of the epidural space, while the distal ends have been implanted on the surface of the spinal cord. Fig. 48D demonstrates the same surgical position from a different viewpoint angle. FIG. 48E illustrates a side, cut-away view of the patient's spinal cord. The stimulation capsule 120 is implanted dorsal to the spinal cord 1140, vertebrae 1120, and the intervertebral discs 1130.
[0126] FIG. 49 illustrates an example distributed stimulator 900. In some implementations, a plurality of leadless stimulators 100 can be implanted into a patient, and in other implementations a distributed stimulator 900 can be implanted into the patient. The distributed stimulator 900 includes a plurality of stimulation capsules 120 (four as illustrated in FIG. 49) that can act in unison or similar to a plurality of independently implanted stimulation capsules 120. The stimulation capsules 120 are coupled to a central control device 995, which can include central antenna for the plurality of stimulation capsules 120. Each of the stimulation capsules 120 are coupled to the central control device 995 by a tether 190. As illustrated, the stimulation capsule 120 includes a plurality of ring electrodes around the circumference of each stimulation capsule 120.
[0127] Fig. 50 illustrates the example distributed stimulator 900 implanted into a patient. The distributed stimulator 900 is implanted into the lumbar region 1210 of the patient. The distributed stimulator 900 has been implanted in a region that permits the distributed distal capsules to cover a region which would be advantageous to the surgical procedure, for example, the placement of the stimulation capsules 120 near the patient's spinal column as illustrated in FIG. 48E.
[0128] Various implementations of the microelectrode device have been described herein. These embodiments are giving by way of example and not to limit the scope of the present disclosure. The various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, implantation locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the disclosure.
[0129] Devices described herein as either acute or chronic may be used acutely or chronically. They may be implanted for such periods, such as during a surgery, and then removed. They may be implanted for extended periods, or indefinitely. Any devices described herein as being chronic may also be used acutely.
[0130] The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various aspects.
Modifications and variations can be made without departing from its spirit and scope of this disclosure. Functionally equivalent methods and apparatuses may exist within the scope of this disclosure. Such modifications and variations are intended to fall within the scope of the appended claims. The subject matter of the present disclosure includes the full scope of equivalents to which it is entitled. This disclosure is not limited to particular methods, reagents, compounds compositions or biological systems, which can vary. The terminology used herein is for the purpose of describing particular embodiments, and is not intended to be limiting.
[0131] With respect to the use of substantially any plural or singular terms herein, the plural can include the singular or the singular can include the plural as is appropriate to the context or application.
[0132] In general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as "open" terms (e.g., the term "including" should be interpreted as "including but not limited to," the term "having" should be interpreted as "having at least," the term "includes" should be interpreted as "includes but is not limited to," etc.). Claims directed toward the described subject matter may contain usage of the introductory phrases "at least one" and "one or more" to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles "a" or "an" limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases "one or more" or "at least one" and indefinite articles such as "a" or "an" (e.g., "a" and/or "an" should be interpreted to mean "at least one" or "one or more"); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, such recitation can mean at least the recited number (e.g., the bare recitation of "two recitations," without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to "at least one of A, B, and C, etc." is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to "at least one of A, B, or C, etc." is used, in general such a construction would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). Any disjunctive word or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, can contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase "A or B" includes the possibilities of "A" or "B" or "A and B."
[0133] In addition, where features or aspects of the disclosure are described in terms of Markush groups, the disclosure is also described in terms of any individual member or subgroup of members of the Markush group.
[0134] Any ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, etc. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, etc. Language such as "up to," "at least," "greater than," "less than," and the like include the number recited and refer to ranges which can be subsequently broken down into subranges as discussed above. Finally, a range includes each individual member.
[0135] One or more or any part thereof of the techniques described herein can be implemented in computer hardware or software, or a combination of both. The methods can be implemented in computer programs using standard programming techniques following the method and figures described herein. Program code is applied to input data to perform the functions described herein and generate output information. The output information is applied to one or more output devices such as a display monitor. Each program may be implemented in a high level procedural or object oriented programming language to communicate with a computer system. However, the programs can be implemented in assembly or machine language, if desired. In any case, the language can be a compiled or interpreted language. Moreover, the program can run on dedicated integrated circuits preprogrammed for that purpose.
[0136] Each such computer program can be stored on a storage medium or device (e.g., ROM or magnetic diskette) readable by a general or special purpose programmable computer, for configuring and operating the computer when the storage media or device is read by the computer to perform the procedures described herein. The computer program can also reside in cache or main memory during program execution. The analysis, preprocessing, and other methods described herein can also be implemented as a computer-readable storage medium, configured with a computer program, where the storage medium so configured causes a computer to operate in a specific and predefined manner to perform the functions described herein. In some embodiments, the computer readable media is tangible and substantially non-transitory in nature, e.g., such that the recorded information is recorded in a form other than solely as a propagating signal.
[0137] In some embodiments, a program product may include a signal bearing medium. The signal bearing medium may include one or more instructions that, when executed by, for example, a processor, may provide the functionality described above. In some
implementations, signal bearing medium may encompass a computer-readable medium, such as, but not limited to, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, memory, etc. In some implementations, the signal bearing medium may encompass a recordable medium , such as, but not limited to, memory, read/write (R/W) CDs, R/W DVDs, etc. In some implementations, signal bearing medium may encompass a communications medium such as, but not limited to, a digital or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.). Thus, for example, the program product may be conveyed by an RF signal bearing medium, where the signal bearing medium is conveyed by a wireless communications medium (e.g., a wireless communications medium conforming with the IEEE 802.11 standard).
[0138] Any of the signals and signal processing techniques may be digital or analog in nature, or combinations thereof.
[0139] While certain embodiments of this disclosure have been particularly shown and described with references to preferred embodiments thereof, various changes in form and details may be made therein without departing from the scope of the disclosure.

Claims

1. A neurostimulation device, comprising:
a stimulation capsule comprising a proximal and a distal end, the stimulation capsule further comprising:
a MEMS film comprising a plurality of electrodes, the MEMS film formed to define a lumen;
a stimulation source disposed within the lumen and in electrical communication with at least one of the plurality of electrodes; and
a power supply disposed within the lumen and in electrical communication with the stimulation source; and
a tether coupled with the proximal end of the stimulation capsule.
2. The device of claim 1, wherein the MEMS film further comprises a strip or a
serpentine antenna.
3. The device of claim 1, wherein the tether further comprises an antenna.
4. The device of claim 3, wherein the antenna is configured to operate at a center
frequency of one of 6.790 MHz, 13.560 MHz, 27.120 MHz, 40.680 MHz, 433.920 MHz, 915.000 MHz, 2.450 GHz, 5.800 GHz, and 24.125 GHz.
5. The device of claim 3, wherein the antenna forms a loop.
6. The device of claim 3, wherein the antenna comprises one or more wires in electrical communication with the stimulation capsule.
7. The device of claim 6, wherein the one or more wires are each coupled with a wire tether contact disposed on a ribbon cable.
8. The device of claim 7, wherein the ribbon cable extends from a distal end of the MEMS film into the lumen.
9. The device of claim 7, wherein the stimulation source and the power supply are disposed on the ribbon cable.
10. The device of claim 1, wherein a diameter of the stimulation capsule is less than a diameter of the tether.
11. The device of claim 1, further comprising a recording circuit disposed in the lumen, the recording circuit in electrical communication with a portion of the plurality of electrodes.
12. The device of claim 1, wherein the power supply is a battery or super-capacitor.
13. The device of claim 1, wherein the MEMS film comprises a first polymeric layer, a first barrier layer, a metal layer, a second barrier layer, and a second polymeric layer.
14. A method of manufacturing a stimulation device, the method comprising:
forming a MEMS film comprising a plurality of electrodes and a ribbon cable extending from a distal end of the MEMS film;
coupling a stimulation source with a first plurality of contacts, the first plurality of contacts disposed on a first face of the ribbon cable and in electrical communication with at least one of the plurality of electrodes
coupling a power supply with a second plurality of contacts, the second plurality of contacts disposed on a second face of the ribbon cable;
folding the ribbon cable toward a face of the MEMS film; and forming, with the MEMS film, a lumen, the ribbon cable disposed within the lumen.
15. The method of claim 14, further comprising coupling a recording circuit on a third plurality of contacts disposed on the first face of the ribbon cable.
16. The method of claim 14, wherein the first face of the ribbon cable is different than the second face of the ribbon cable.
17. The method of claim 14, further comprising filling the lumen with an encapsulating epoxy.
18. The method of claim 14, coupling a lead wire with a tether contact, the tether contact disposed toward a distal tip of the ribbon cable.
19. The method of claim 14, further comprising heat molding the MEMS film to form the lumen.
20. The method of claim 14, wherein the power source is a rechargeable battery of a super capacitor.
PCT/IB2015/056437 2014-08-27 2015-08-25 Leadless neurostimulator WO2016030822A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP15760290.5A EP3185948B1 (en) 2014-08-27 2015-08-25 Leadless neurostimulator
CA2959281A CA2959281A1 (en) 2014-08-27 2015-08-25 Leadless neurostimulator
EP21184317.2A EP3912676A1 (en) 2014-08-27 2015-08-25 Leadless neurostimulator
JP2017530449A JP2017525545A (en) 2014-08-27 2015-08-25 Leadless nerve stimulator

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/470,356 2014-08-27
US14/470,356 US9403011B2 (en) 2014-08-27 2014-08-27 Leadless neurostimulator

Publications (1)

Publication Number Publication Date
WO2016030822A1 true WO2016030822A1 (en) 2016-03-03

Family

ID=54065420

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/056437 WO2016030822A1 (en) 2014-08-27 2015-08-25 Leadless neurostimulator

Country Status (5)

Country Link
US (3) US9403011B2 (en)
EP (2) EP3185948B1 (en)
JP (1) JP2017525545A (en)
CA (1) CA2959281A1 (en)
WO (1) WO2016030822A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3829698A4 (en) * 2018-07-30 2022-05-11 Epic Neuro, Inc. Transcranial current loop stimulation device
US11589790B2 (en) 2016-05-20 2023-02-28 Imperial College Innovations Limited Implantable neural interface
WO2023057977A1 (en) 2021-10-08 2023-04-13 Albert Ludwigs Universität Freiburg Treatment of psychiatric disorders with deep brain stimulation
US11738203B2 (en) 2014-10-01 2023-08-29 EPIC Neuro, Inc. System and method for transcranial current loop brain stimulation

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009276603B2 (en) 2008-07-30 2015-11-12 Ecole Polytechinique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
US8788064B2 (en) 2008-11-12 2014-07-22 Ecole Polytechnique Federale De Lausanne Microfabricated neurostimulation device
AU2011234422B2 (en) 2010-04-01 2015-11-05 Ecole Polytechnique Federale De Lausanne (Epfl) Device for interacting with neurological tissue and methods of making and using the same
EP3036758A4 (en) * 2013-09-13 2017-06-14 University of Utah Research Foundation Micro-molded electrodes, arrays, and methods of making the same
CN110585588A (en) 2014-05-16 2019-12-20 阿莱瓦神经治疗股份有限公司 Implantable microelectrode device
US11311718B2 (en) 2014-05-16 2022-04-26 Aleva Neurotherapeutics Sa Device for interacting with neurological tissue and methods of making and using the same
US9403011B2 (en) * 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
CN109069824B (en) 2016-02-02 2022-09-16 阿莱瓦神经治疗股份有限公司 Treatment of autoimmune diseases using deep brain stimulation
EP3419713B1 (en) 2016-02-22 2020-04-29 The Charles Stark Draper Laboratory, Inc. Method of manufacturing an implantable neural electrode interface platform
US20170361110A1 (en) * 2016-06-16 2017-12-21 Boston Scientific Neuromodulation Corporation Multi-Conductor Cable in an External Charger for an Implantable Medical Device
US10207103B2 (en) * 2016-07-05 2019-02-19 Pacesetter, Inc. Implantable thin film devices
WO2018080600A1 (en) 2016-10-31 2018-05-03 The Alfred E. Mann Foundation For Scientific Research Nerve cuff electrodes fabricated using over-molded lcp substrates
US10702692B2 (en) 2018-03-02 2020-07-07 Aleva Neurotherapeutics Neurostimulation device
US11065461B2 (en) 2019-07-08 2021-07-20 Bioness Inc. Implantable power adapter
CA3226146A1 (en) 2021-07-09 2023-01-12 The Alfred E. Mann Foundation For Scientific Research Electrode leads having multi-application helical nerve cuffs and associated systems and methods
US20230027020A1 (en) 2021-07-21 2023-01-26 Beijing Funate Innovation Technology Co., Ltd. Physiotherapy sheet and method for using the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070293908A1 (en) * 2006-06-20 2007-12-20 Ebr Systems, Inc. Systems and methods for implantable leadless brain stimulation
US20090105784A1 (en) * 2007-10-18 2009-04-23 Integrated Sensing Systems, Inc. Miniature wireless system for deep brain stimulation
WO2010055421A1 (en) * 2008-11-12 2010-05-20 Aleva Neurotherapeutics, S.A. Microfabricated neurostimulation device
US20130131754A1 (en) * 2005-09-10 2013-05-23 Armen P. Sarvazyan Leadless system for deep brain stimulation using time reversal acoustics

Family Cites Families (565)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1065969A (en) 1977-09-28 1979-11-06 Gratien Bouillon Self-blocking cerebral catheter
US4550733A (en) 1984-01-09 1985-11-05 Pain Suppression Labs, Inc. Electronic dental analgesia apparatus and methodology
US4969468A (en) 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
US4837049A (en) 1986-06-17 1989-06-06 Alfred E. Mann Foundation For Scientific Research Method of making an electrode array
JPH07114768B2 (en) 1987-04-22 1995-12-13 松下電器産業株式会社 X-ray diagnostic device
US4917093A (en) 1987-06-12 1990-04-17 Minnesota Mining And Manufacturing Company Biological tissue stimulator with adjustable high voltage power supply dependent upon load impedance
US4989617A (en) 1989-07-14 1991-02-05 Case Western Reserve University Intramuscular electrode for neuromuscular stimulation system
US5215088A (en) 1989-11-07 1993-06-01 The University Of Utah Three-dimensional electrode device
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5524338A (en) 1991-10-22 1996-06-11 Pi Medical Corporation Method of making implantable microelectrode
GB9207731D0 (en) 1992-04-07 1992-05-27 Proteus Molecular Design Improvements in or relating to vaccines
US5400784A (en) 1993-10-15 1995-03-28 Case Western Reserve University Slowly penetrating inter-fascicular nerve cuff electrode and method of using
US5921924A (en) 1993-12-03 1999-07-13 Avitall; Boaz Mapping and ablation catheter system utilizing multiple control elements
US5501703A (en) 1994-01-24 1996-03-26 Medtronic, Inc. Multichannel apparatus for epidural spinal cord stimulator
US7077822B1 (en) 1994-02-09 2006-07-18 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
US5496369A (en) 1994-02-09 1996-03-05 University Of Iowa Research Foundation Human cerebral cortex neural prosthetic
US5800535A (en) 1994-02-09 1998-09-01 The University Of Iowa Research Foundation Wireless prosthetic electrode for the brain
JPH09508553A (en) 1994-02-09 1997-09-02 ユニヴァーシティ オブ アイオワ リサーチ ファンデーション Human cerebral cortical nerve prosthesis
US5697975A (en) 1994-02-09 1997-12-16 The University Of Iowa Research Foundation Human cerebral cortex neural prosthetic for tinnitus
US6129685A (en) 1994-02-09 2000-10-10 The University Of Iowa Research Foundation Stereotactic hypothalamic obesity probe
US6216043B1 (en) 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
DE4408108A1 (en) 1994-03-10 1995-09-14 Bavaria Med Tech Catheter for injecting a fluid or a drug
US5391250A (en) 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5824029A (en) 1994-04-28 1998-10-20 Medtronic, Inc. Implantable medical system for performing transthoracic impedance measurements associated with cardiac function
US5697651A (en) 1995-03-02 1997-12-16 Senior Flexonics, Inc. Flexible duct joint having a low leakage, pressure-balanced bellows seal
US5927277A (en) 1995-04-28 1999-07-27 Medtronic, Inc. Method and apparatus for securing probes within a burr hole
US5727552A (en) 1996-01-11 1998-03-17 Medtronic, Inc. Catheter and electrical lead location system
US5833714A (en) 1996-01-18 1998-11-10 Loeb; Gerald E. Cochlear electrode array employing tantalum metal
US5755759A (en) 1996-03-14 1998-05-26 Eic Laboratories, Inc. Biomedical device with a protective overlayer
AU714617B2 (en) 1996-04-04 2000-01-06 Medtronic, Inc. Living tissue stimulation and recording techniques
US5628317A (en) 1996-04-04 1997-05-13 Medtronic, Inc. Ultrasonic techniques for neurostimulator control
US6505078B1 (en) 1996-04-04 2003-01-07 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue
US5713922A (en) 1996-04-25 1998-02-03 Medtronic, Inc. Techniques for adjusting the locus of excitation of neural tissue in the spinal cord or brain
US5702429A (en) 1996-04-04 1997-12-30 Medtronic, Inc. Neural stimulation techniques with feedback
US6094598A (en) 1996-04-25 2000-07-25 Medtronics, Inc. Method of treating movement disorders by brain stimulation and drug infusion
US5716377A (en) 1996-04-25 1998-02-10 Medtronic, Inc. Method of treating movement disorders by brain stimulation
US5683422A (en) 1996-04-25 1997-11-04 Medtronic, Inc. Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US5713923A (en) 1996-05-13 1998-02-03 Medtronic, Inc. Techniques for treating epilepsy by brain stimulation and drug infusion
US5782798A (en) 1996-06-26 1998-07-21 Medtronic, Inc. Techniques for treating eating disorders by brain stimulation and drug infusion
US6121351A (en) 1996-09-03 2000-09-19 Eastman Chemical Company Thermoplastic compositions containing anthraquinone polysulfonamide colorants
US5797970A (en) 1996-09-04 1998-08-25 Medtronic, Inc. System, adaptor and method to provide medical electrical stimulation
US5843148A (en) 1996-09-27 1998-12-01 Medtronic, Inc. High resolution brain stimulation lead and method of use
US5752979A (en) 1996-11-01 1998-05-19 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US5800474A (en) 1996-11-01 1998-09-01 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US5957958A (en) 1997-01-15 1999-09-28 Advanced Bionics Corporation Implantable electrode arrays
US5893883A (en) 1997-04-30 1999-04-13 Medtronic, Inc. Portable stimulation screening device for screening therapeutic effect of electrical stimulation on a patient user during normal activities of the patient user
US6128537A (en) 1997-05-01 2000-10-03 Medtronic, Inc Techniques for treating anxiety by brain stimulation and drug infusion
US5975085A (en) 1997-05-01 1999-11-02 Medtronic, Inc. Method of treating schizophrenia by brain stimulation and drug infusion
US6050992A (en) 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US5991668A (en) 1997-09-25 1999-11-23 Medtronic, Inc. Medical electrical lead
US5941906A (en) 1997-10-15 1999-08-24 Medtronic, Inc. Implantable, modular tissue stimulator
US6011996A (en) 1998-01-20 2000-01-04 Medtronic, Inc Dual electrode lead and method for brain target localization in functional stereotactic brain surgery
US7520890B2 (en) 1998-01-26 2009-04-21 Phillips Peter W Reinforced graft and method of deployment
US6415187B1 (en) 1998-02-10 2002-07-02 Advanced Bionics Corporation Implantable, expandable, multicontact electrodes and insertion needle for use therewith
US6205361B1 (en) 1998-02-10 2001-03-20 Advanced Bionics Corporation Implantable expandable multicontact electrodes
US6227203B1 (en) 1998-02-12 2001-05-08 Medtronic, Inc. Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion
US6330466B1 (en) 1998-02-23 2001-12-11 California Institute Of Technology Using a multi-electrode probe in creating an electrophysiological profile during stereotactic neurosurgery
US6024095A (en) 1998-04-10 2000-02-15 Proteus Therapeutics, Inc. Corneal heat and stretch method and apparatus
US6319241B1 (en) 1998-04-30 2001-11-20 Medtronic, Inc. Techniques for positioning therapy delivery elements within a spinal cord or a brain
US6374140B1 (en) 1998-04-30 2002-04-16 Medtronic, Inc. Method and apparatus for treating seizure disorders by stimulating the olfactory senses
US6161047A (en) 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6421566B1 (en) 1998-04-30 2002-07-16 Medtronic, Inc. Selective dorsal column stimulation in SCS, using conditioning pulses
US6018682A (en) 1998-04-30 2000-01-25 Medtronic, Inc. Implantable seizure warning system
US6522930B1 (en) 1998-05-06 2003-02-18 Atrionix, Inc. Irrigated ablation device assembly
US6104960A (en) 1998-07-13 2000-08-15 Medtronic, Inc. System and method for providing medical electrical stimulation to a portion of the nervous system
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US6366813B1 (en) 1998-08-05 2002-04-02 Dilorenzo Daniel J. Apparatus and method for closed-loop intracranical stimulation for optimal control of neurological disease
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9320900B2 (en) 1998-08-05 2016-04-26 Cyberonics, Inc. Methods and systems for determining subject-specific parameters for a neuromodulation therapy
US7599736B2 (en) 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US6125300A (en) 1998-09-11 2000-09-26 Medtronic, Inc. Implantable device with output circuitry for simultaneous stimulation at multiple sites
US6033403A (en) 1998-10-08 2000-03-07 Irvine Biomedical, Inc. Long electrode catheter system and methods thereof
US6205359B1 (en) 1998-10-26 2001-03-20 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator
US6253109B1 (en) 1998-11-05 2001-06-26 Medtronic Inc. System for optimized brain stimulation
US6253110B1 (en) 1999-04-27 2001-06-26 Medtronic Inc Method for tissue stimulation and fabrication of low polarization implantable stimulation electrode
US6109269A (en) 1999-04-30 2000-08-29 Medtronic, Inc. Method of treating addiction by brain infusion
US6356784B1 (en) 1999-04-30 2002-03-12 Medtronic, Inc. Method of treating movement disorders by electrical stimulation and/or drug infusion of the pendunulopontine nucleus
US6353762B1 (en) 1999-04-30 2002-03-05 Medtronic, Inc. Techniques for selective activation of neurons in the brain, spinal cord parenchyma or peripheral nerve
US7650291B2 (en) 1999-06-23 2010-01-19 Koninklijke Philips Electronics N.V. Video visitation system and method for a health care location
DK1026973T3 (en) 1999-06-25 2005-05-23 Neurokinetic Aps Multifunction electrode for stimulation of nerve tissue
US6343226B1 (en) 1999-06-25 2002-01-29 Neurokinetic Aps Multifunction electrode for neural tissue stimulation
US7047082B1 (en) 1999-09-16 2006-05-16 Micronet Medical, Inc. Neurostimulating lead
US6560486B1 (en) 1999-10-12 2003-05-06 Ivan Osorio Bi-directional cerebral interface system
US6882881B1 (en) 1999-10-19 2005-04-19 The Johns Hopkins University Techniques using heat flow management, stimulation, and signal analysis to treat medical disorders
US6295476B1 (en) 1999-11-01 2001-09-25 Medtronic, Inc. Medical lead conductor fracture visualization method and apparatus
US6375666B1 (en) 1999-12-09 2002-04-23 Hans Alois Mische Methods and devices for treatment of neurological disorders
US6556873B1 (en) 1999-11-29 2003-04-29 Medtronic, Inc. Medical electrical lead having variable bending stiffness
US6549812B1 (en) 1999-11-29 2003-04-15 Medtronic, Inc. Medical electrical lead having bending stiffness which increase in the distal direction
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US6434431B1 (en) 2000-01-20 2002-08-13 Medtronic, Inc. Intramuscular medical electrical lead with fixation member
US6356786B1 (en) 2000-01-20 2002-03-12 Electrocore Techniques, Llc Method of treating palmar hyperhydrosis by electrical stimulation of the sympathetic nervous chain
US6356787B1 (en) 2000-02-24 2002-03-12 Electro Core Techniques, Llc Method of treating facial blushing by electrical stimulation of the sympathetic nerve chain
US6587733B1 (en) 2000-02-08 2003-07-01 Medtronic, Inc. Percutaneous surgical lead body with directed stimulation
US6493590B1 (en) 2000-02-09 2002-12-10 Micronet Medical, Inc. Flexible band electrodes for medical leads
US6920359B2 (en) 2000-02-15 2005-07-19 Advanced Bionics Corporation Deep brain stimulation system for the treatment of Parkinson's Disease or other disorders
US6708064B2 (en) 2000-02-24 2004-03-16 Ali R. Rezai Modulation of the brain to affect psychiatric disorders
WO2001072201A2 (en) 2000-03-29 2001-10-04 Arizona Board Of Regents Device for creating a neural interface and method for making same
US7497844B2 (en) 2000-03-31 2009-03-03 Medtronic, Inc. System and method for positioning implantable medical devices within coronary veins
US6853858B2 (en) 2000-05-08 2005-02-08 Brainsgate, Ltd. Administration of anti-inflammatory drugs into the central nervous system
US7289852B2 (en) 2000-06-16 2007-10-30 Medtronic. Inc. Implantable medical device configured for diagnostic emulation through serial communication
US6687538B1 (en) 2000-06-19 2004-02-03 Medtronic, Inc. Trial neuro stimulator with lead diagnostics
US7010351B2 (en) 2000-07-13 2006-03-07 Northstar Neuroscience, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US7672730B2 (en) 2001-03-08 2010-03-02 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20030125786A1 (en) 2000-07-13 2003-07-03 Gliner Bradford Evan Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US6487446B1 (en) 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
US6871098B2 (en) 2000-10-30 2005-03-22 Medtronic, Inc. Method for treating obsessive-compulsive disorder with electrical stimulation of the brain internal capsule
US6804552B2 (en) 2000-11-03 2004-10-12 Medtronic, Inc. MEMs switching circuit and method for an implantable medical device
US6757970B1 (en) 2000-11-07 2004-07-06 Advanced Bionics Corporation Method of making multi-contact electrode array
US6591128B1 (en) 2000-11-09 2003-07-08 Koninklijke Philips Electronics, N.V. MRI RF coil systems having detachable, relocatable, and or interchangeable sections and MRI imaging systems and methods employing the same
US6529774B1 (en) 2000-11-09 2003-03-04 Neuropace, Inc. Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
US6818396B1 (en) 2000-11-28 2004-11-16 Proteus S.A. Process for determination of the activity of a substance using an in vitro functional test
EP1341579B1 (en) 2000-12-07 2006-11-29 Medtronic, Inc. Directional brain stimulation and recording leads
US6594524B2 (en) 2000-12-12 2003-07-15 The Trustees Of The University Of Pennsylvania Adaptive method and apparatus for forecasting and controlling neurological disturbances under a multi-level control
AU2002243347A1 (en) 2000-12-29 2002-07-16 Medtronic, Inc. Non-conformance monitoring and control techniques for an implantable medical device
US7177701B1 (en) 2000-12-29 2007-02-13 Advanced Bionics Corporation System for permanent electrode placement utilizing microelectrode recording methods
US7628780B2 (en) 2001-01-13 2009-12-08 Medtronic, Inc. Devices and methods for interstitial injection of biologic agents into tissue
US6788975B1 (en) 2001-01-30 2004-09-07 Advanced Bionics Corporation Fully implantable miniature neurostimulator for stimulation as a therapy for epilepsy
US6829509B1 (en) 2001-02-20 2004-12-07 Biophan Technologies, Inc. Electromagnetic interference immune tissue invasive system
US6597953B2 (en) 2001-02-20 2003-07-22 Neuropace, Inc. Furcated sensing and stimulation lead
GB0104982D0 (en) 2001-02-28 2001-04-18 Gill Steven Electrode
US6538443B2 (en) 2001-03-20 2003-03-25 Koninklijke Philips Electronics N.V. MRI gradient coil with variable field of view and apparatus and methods employing the same
JP2004526510A (en) 2001-03-30 2004-09-02 ケース ウエスタン リザーブ ユニバーシティ Systems and methods for selectively stimulating components in, on, or near pudendal nerves or pudendal nerve branches to achieve selective physiological responses
US7010343B2 (en) 2001-04-06 2006-03-07 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
US6909920B2 (en) 2001-04-27 2005-06-21 Medtronic, Inc. System and method for positioning an implantable medical device within a body
IL158469A0 (en) 2001-04-27 2004-05-12 Biophysical Mind Technologies Diagnosis, treatment, and research of mental disorder
WO2002087685A2 (en) 2001-05-01 2002-11-07 Second Sight, Llc High-density array of micro-machined electrodes for neural stimulation
US6928320B2 (en) 2001-05-17 2005-08-09 Medtronic, Inc. Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated
US6643552B2 (en) 2001-05-30 2003-11-04 Foster-Miller, Inc. Implantable devices having a liquid crystal polymer substrate
US6479999B1 (en) 2001-06-05 2002-11-12 Koninklijke Philips Electronics N.V. Efficiently shielded MRI gradient coil with discretely or continuously variable field of view
US6560472B2 (en) 2001-06-21 2003-05-06 Microhelix, Inc. Multi-channel structurally robust brain probe and method of making the same
US20090069706A1 (en) 2001-06-21 2009-03-12 Jerome Boogaard Brain probe adapted to be introduced through a canula
US6671544B2 (en) 2001-06-28 2003-12-30 Medtronic, Inc. Low impedance implantable extension for a neurological electrical stimulator
US6622047B2 (en) 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of neuropsychiatric disorders by near-diaphragmatic nerve stimulation
US6622038B2 (en) 2001-07-28 2003-09-16 Cyberonics, Inc. Treatment of movement disorders by near-diaphragmatic nerve stimulation
US20060241717A1 (en) 2001-08-30 2006-10-26 Whitehurst Todd K Treatment of movement disorders by extra dural motor cortex stimulation
US6999819B2 (en) 2001-08-31 2006-02-14 Medtronic, Inc. Implantable medical electrical stimulation lead fixation method and apparatus
DE10143268A1 (en) 2001-09-04 2003-03-20 Heptec Gmbh Neurostimulator for medical use, e.g. for investigation of neuro-degenerative diseases has application electrode that allows different electrical stimuli to be applied as well as mechanical, thermal, magnetic or chemical stimuli
WO2003026738A1 (en) 2001-09-28 2003-04-03 Northstar Neuroscience, Inc. Methods and apparatus for electrically stimulating cells implanted in the nervous system
IL145700A0 (en) 2001-09-30 2002-06-30 Younis Imad Electrode system for neural applications
AUPR851601A0 (en) 2001-10-26 2001-11-29 Cochlear Limited Auditory midbrain implant
US6944497B2 (en) 2001-10-31 2005-09-13 Medtronic, Inc. System and method of treating stuttering by neuromodulation
US7010356B2 (en) 2001-10-31 2006-03-07 London Health Sciences Centre Research Inc. Multichannel electrode and methods of using same
US7187978B2 (en) 2001-11-01 2007-03-06 Medtronic, Inc. Method and apparatus for programming an implantable medical device
US6745079B2 (en) 2001-11-07 2004-06-01 Medtronic, Inc. Electrical tissue stimulation apparatus and method
US7286878B2 (en) 2001-11-09 2007-10-23 Medtronic, Inc. Multiplexed electrode array extension
EP1454156A1 (en) 2001-11-26 2004-09-08 Koninklijke Philips Electronics N.V. Magnetic resonance imaging method with reduced acoustic noise
US7546166B2 (en) 2001-11-29 2009-06-09 Medtronic, Inc. Medical lead designs for lead placement through tissue
US7050856B2 (en) 2002-01-11 2006-05-23 Medtronic, Inc. Variation of neural-stimulation parameters
US6970747B2 (en) 2002-01-11 2005-11-29 Kokones Scott B Neurostimulation lead stylet handle
US6904306B1 (en) 2002-01-23 2005-06-07 Koninklijke Philips Electronics N.V. Method and apparatus for evaluation of contrast agent uptake based on derived parametric images
JP2005516697A (en) 2002-02-01 2005-06-09 ザ クリーブランド クリニック ファウンデイション Neural stimulation transmission device with independently movable transmission structure
CA2477488A1 (en) 2002-02-04 2003-08-14 Great Lake Biosciences, Llc Treatment of neurological disorders using electrical stimulation
US7063767B1 (en) 2002-02-08 2006-06-20 Proteus Technical Solutions, Inc. Process for creating a durable EMI/RFI shield between two or more structural surfaces and shield formed therefrom
US6875205B2 (en) 2002-02-08 2005-04-05 Alaris Medical Systems, Inc. Vial adapter having a needle-free valve for use with vial closures of different sizes
US7317948B1 (en) 2002-02-12 2008-01-08 Boston Scientific Scimed, Inc. Neural stimulation system providing auto adjustment of stimulus output as a function of sensed impedance
US7526341B2 (en) 2002-03-15 2009-04-28 Medtronic, Inc. Amplitude ramping of waveforms generated by an implantable medical device
US6978171B2 (en) 2002-03-15 2005-12-20 Medtronic, Inc. Automated impedance measurement of an implantable medical device
US7236822B2 (en) 2002-03-22 2007-06-26 Leptos Biomedical, Inc. Wireless electric modulation of sympathetic nervous system
US7146222B2 (en) 2002-04-15 2006-12-05 Neurospace, Inc. Reinforced sensing and stimulation leads and use in detection systems
US7697995B2 (en) 2002-04-25 2010-04-13 Medtronic, Inc. Surgical lead paddle
US7076292B2 (en) 2002-04-25 2006-07-11 Medtronic, Inc. Optical communication of neurostimulation-system information
US7024246B2 (en) 2002-04-26 2006-04-04 Medtronic, Inc Automatic waveform output adjustment for an implantable medical device
US6937891B2 (en) 2002-04-26 2005-08-30 Medtronic, Inc. Independent therapy programs in an implantable medical device
US7483748B2 (en) 2002-04-26 2009-01-27 Medtronic, Inc. Programmable waveform pulses for an implantable medical device
US6950706B2 (en) 2002-04-26 2005-09-27 Medtronic, Inc. Wave shaping for an implantable medical device
US7295880B2 (en) 2002-04-29 2007-11-13 Medtronic, Inc. Stimulation control for brain stimulation
US6978178B2 (en) 2002-04-30 2005-12-20 Medtronic, Inc. Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode array
US7298143B2 (en) 2002-05-13 2007-11-20 Koninklijke Philips Electronics N.V. Reduction of susceptibility artifacts in subencoded single-shot magnetic resonance imaging
US7151961B1 (en) 2002-05-24 2006-12-19 Advanced Bionics Corporation Treatment of movement disorders by brain stimulation
US7203548B2 (en) 2002-06-20 2007-04-10 Advanced Bionics Corporation Cavernous nerve stimulation via unidirectional propagation of action potentials
US20040015205A1 (en) 2002-06-20 2004-01-22 Whitehurst Todd K. Implantable microstimulators with programmable multielectrode configuration and uses thereof
US7860570B2 (en) 2002-06-20 2010-12-28 Boston Scientific Neuromodulation Corporation Implantable microstimulators and methods for unidirectional propagation of action potentials
US7181288B1 (en) 2002-06-24 2007-02-20 The Cleveland Clinic Foundation Neuromodulation device and method of using the same
US7006859B1 (en) 2002-07-20 2006-02-28 Flint Hills Scientific, L.L.C. Unitized electrode with three-dimensional multi-site, multi-modal capabilities for detection and control of brain state changes
US7254449B2 (en) 2002-07-31 2007-08-07 Advanced Bionics Corp Systems and methods for providing power to one or more implantable devices
US7373199B2 (en) 2002-08-27 2008-05-13 University Of Florida Research Foundation, Inc. Optimization of multi-dimensional time series processing for seizure warning and prediction
US7328069B2 (en) 2002-09-06 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of and the delivery of drugs to the left and right pudendal nerves
US7427280B2 (en) 2002-09-06 2008-09-23 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by delivering drugs to various nerves or tissues
US7369894B2 (en) 2002-09-06 2008-05-06 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by electrical stimulation of the sacral and/or pudendal nerves
US7328068B2 (en) 2003-03-31 2008-02-05 Medtronic, Inc. Method, system and device for treating disorders of the pelvic floor by means of electrical stimulation of the pudendal and associated nerves, and the optional delivery of drugs in association therewith
US7204833B1 (en) 2002-10-11 2007-04-17 Flint Hills Scientific Llc Multi-modal system for detection and control of changes in brain state
EP1629341A4 (en) 2002-10-15 2008-10-15 Medtronic Inc Multi-modal operation of a medical device system
EP1583464B1 (en) 2002-10-15 2014-04-09 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
US7079977B2 (en) 2002-10-15 2006-07-18 Medtronic, Inc. Synchronization and calibration of clocks for a medical device and calibrated clock
US20050010261A1 (en) 2002-10-21 2005-01-13 The Cleveland Clinic Foundation Application of stimulus to white matter to induce a desired physiological response
US7212851B2 (en) 2002-10-24 2007-05-01 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
US7216000B2 (en) 2002-10-31 2007-05-08 Medtronic, Inc. Neurostimulation therapy manipulation
DE60334399D1 (en) 2002-10-31 2010-11-11 Medtronic Inc METHOD AND DEVICE FOR APPLYING FILTER INFORMATION FOR IDENTIFYING COMBINATIONS OF ELECTRODES
US7035690B2 (en) 2002-11-15 2006-04-25 Medtronic, Inc. Human-implantable-neurostimulator user interface having multiple levels of abstraction
US7599730B2 (en) 2002-11-19 2009-10-06 Medtronic Navigation, Inc. Navigation system for cardiac therapies
US7697972B2 (en) 2002-11-19 2010-04-13 Medtronic Navigation, Inc. Navigation system for cardiac therapies
US7047084B2 (en) 2002-11-20 2006-05-16 Advanced Neuromodulation Systems, Inc. Apparatus for directionally stimulating nerve tissue
WO2004047911A2 (en) 2002-11-22 2004-06-10 International Rehabilitative Sciences, Inc. Surface stimulation for tremor control
US7302298B2 (en) 2002-11-27 2007-11-27 Northstar Neuroscience, Inc Methods and systems employing intracranial electrodes for neurostimulation and/or electroencephalography
US7596415B2 (en) 2002-12-06 2009-09-29 Medtronic, Inc. Medical devices incorporating carbon nanotube material and methods of fabricating same
US7596408B2 (en) 2002-12-09 2009-09-29 Medtronic, Inc. Implantable medical device with anti-infection agent
WO2004052456A1 (en) 2002-12-09 2004-06-24 Medtronic, Inc. Modular implantable medical device
US8712549B2 (en) 2002-12-11 2014-04-29 Proteus Digital Health, Inc. Method and system for monitoring and treating hemodynamic parameters
AU2003303387A1 (en) 2002-12-23 2004-07-22 Medtronic, Inc. Multiple infusion section catheters, systems, and methods
US7216001B2 (en) 2003-01-22 2007-05-08 Medtronic Xomed, Inc. Apparatus for intraoperative neural monitoring
EP1585575A4 (en) 2003-01-24 2011-02-09 Proteus Biomedical Inc Methods and apparatus for enhancing cardiac pacing
US7204798B2 (en) 2003-01-24 2007-04-17 Proteus Biomedical, Inc. Methods and systems for measuring cardiac parameters
AU2003302233A1 (en) 2003-02-04 2004-09-06 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University (Abr/Asu) Using benzocyclobutene as a biocompatible material
US7328057B2 (en) 2003-02-06 2008-02-05 Medtronic, Inc. Shunt passer or like surgical instrument configured for receiving different-sized positioning locators of image-guided surgical system
US20050008660A1 (en) 2003-03-10 2005-01-13 The Regents Of The University Of Michigan Compositions and methods for use of alginate dural sealants
US7647116B2 (en) 2003-03-13 2010-01-12 Medtronic, Inc. Context-sensitive collection of neurostimulation therapy data
US7505815B2 (en) 2003-04-02 2009-03-17 Medtronic, Inc. Neurostimulation therapy usage diagnostics
US7548786B2 (en) 2003-04-02 2009-06-16 Medtronic, Inc. Library for management of neurostimulation therapy programs
US7489970B2 (en) 2003-04-02 2009-02-10 Medtronic, Inc. Management of neurostimulation therapy using parameter sets
US7369893B2 (en) 2004-12-01 2008-05-06 Medtronic, Inc. Method and apparatus for identifying lead-related conditions using prediction and detection criteria
US7319899B2 (en) 2003-04-23 2008-01-15 Medtronic, Inc. Sensing techniques for implantable medical devices
US7369891B2 (en) 2003-04-23 2008-05-06 Medtronic, Inc. Rate control techniques for implantable pulse generator systems
US7463928B2 (en) 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy
US7343206B2 (en) 2003-04-25 2008-03-11 Medtronic, Inc. Implantable medical lead and system, and method of use thereof
US20040225335A1 (en) 2003-05-08 2004-11-11 Whitehurst Todd K. Treatment of Huntington's disease by brain stimulation
US7191016B2 (en) 2003-05-15 2007-03-13 Medtronic, Inc. Medical system including a novel bipolar pacing and sensing pair
US7317947B2 (en) 2003-05-16 2008-01-08 Medtronic, Inc. Headset recharger for cranially implantable medical devices
US7620454B2 (en) 2003-05-19 2009-11-17 Medtronic, Inc. Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof
US7107104B2 (en) 2003-05-30 2006-09-12 Medtronic, Inc. Implantable cortical neural lead and method
US7818048B2 (en) 2003-06-02 2010-10-19 Biosense Webster, Inc. Catheter and method for mapping a pulmonary vein
US7082336B2 (en) 2003-06-04 2006-07-25 Synecor, Llc Implantable intravascular device for defibrillation and/or pacing
US7133718B2 (en) 2003-06-19 2006-11-07 Medtronic, Inc. Method and apparatus for temporarily varying a parameter in an implantable medical device
CA2432810A1 (en) 2003-06-19 2004-12-19 Andres M. Lozano Method of treating depression, mood disorders and anxiety disorders by brian infusion
US7388378B2 (en) 2003-06-24 2008-06-17 Medtronic, Inc. Magnetic resonance imaging interference immune device
US7671594B2 (en) 2003-06-24 2010-03-02 Medtronic, Inc. Magnetic resonance imaging interference immune device
IL156816A0 (en) 2003-07-07 2004-02-08 Brainsgate Ltd Stimulation arena
US7647111B2 (en) 2003-07-31 2010-01-12 Medtronic, Inc. Connector assembly for connecting a lead and an implantable medical device
CA2534363A1 (en) 2003-08-01 2005-02-10 Brad Fowler Apparatus and methods for applying neural stimulation to a patient
US20050033136A1 (en) 2003-08-01 2005-02-10 Assaf Govari Catheter with electrode strip
US20050038489A1 (en) 2003-08-14 2005-02-17 Grill Warren M. Electrode array for use in medical stimulation and methods thereof
US7263405B2 (en) 2003-08-27 2007-08-28 Neuro And Cardiac Technologies Llc System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities
US7313430B2 (en) 2003-08-28 2007-12-25 Medtronic Navigation, Inc. Method and apparatus for performing stereotactic surgery
US7617002B2 (en) 2003-09-15 2009-11-10 Medtronic, Inc. Selection of neurostimulator parameter configurations using decision trees
US7660620B2 (en) 2003-09-29 2010-02-09 Medtronic, Inc. Timing techniques for magnetic resonance imaging
US7623930B2 (en) 2003-09-30 2009-11-24 Medtronic, Inc. Controlling telemetry during magnetic resonance imaging
US7418292B2 (en) 2003-10-01 2008-08-26 Medtronic, Inc. Device and method for attenuating an immune response
US7356369B2 (en) 2003-10-02 2008-04-08 Medtronic, Inc. Z-axis assembly of medical device programmer
US7561921B2 (en) 2003-10-02 2009-07-14 Medtronic, Inc. Neurostimulator programmer with internal antenna
US7206632B2 (en) 2003-10-02 2007-04-17 Medtronic, Inc. Patient sensory response evaluation for neuromodulation efficacy rating
US7286882B2 (en) 2003-10-03 2007-10-23 Medtronic, Inc. Implantable electrical connector system
US8190248B2 (en) 2003-10-16 2012-05-29 Louisiana Tech University Foundation, Inc. Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto
US20050171558A1 (en) 2003-10-17 2005-08-04 Abovitz Rony A. Neurosurgery targeting and delivery system for brain structures
WO2005039696A1 (en) 2003-10-21 2005-05-06 The Regents Of The University Of Michigan Intracranial neural interface system
US7282050B2 (en) 2003-10-31 2007-10-16 Medtronic, Inc. Ablation of exterior of stomach to treat obesity
EP1694403A2 (en) 2003-11-20 2006-08-30 Advanced Neuromodulation Systems, Inc. Electrical stimulation system, lead, and method providing reduced neuroplasticity effects
US7289851B2 (en) 2003-12-04 2007-10-30 Medtronic, Inc. Method and apparatus for identifying lead-related conditions using impedance trends and oversensing criteria
US8060207B2 (en) 2003-12-22 2011-11-15 Boston Scientific Scimed, Inc. Method of intravascularly delivering stimulation leads into direct contact with tissue
CA2454184A1 (en) 2003-12-23 2005-06-23 Andres M. Lozano Method and apparatus for treating neurological disorders by electrical stimulation of the brain
WO2005067563A2 (en) 2004-01-12 2005-07-28 Calypso Medical Technologies, Inc. Instruments with location markers and methods for tracking instruments through anatomical passageways
WO2005067792A1 (en) 2004-01-12 2005-07-28 Calypso Medical Technologies, Inc. Methods and apparatus for stimulating and/or sensing neurons in a patient
US7608458B2 (en) 2004-02-05 2009-10-27 Medtronic, Inc. Identifying patients at risk for life threatening arrhythmias
EP1723432A1 (en) 2004-02-05 2006-11-22 Medtronic, Inc. Methods and apparatus for identifying patients at risk for life threatening arrhythmias
US7232435B2 (en) 2004-02-06 2007-06-19 Medtronic, Inc. Delivery of a sympatholytic cardiovascular agent to the central nervous system to counter heart failure and pathologies associated with heart failure
US7120499B2 (en) 2004-02-12 2006-10-10 Ndi Medical, Llc Portable percutaneous assemblies, systems and methods for providing highly selective functional or therapeutic neuromuscular stimulation
US20050182422A1 (en) 2004-02-13 2005-08-18 Schulte Gregory T. Apparatus for securing a therapy delivery device within a burr hole and method for making same
US20060004422A1 (en) 2004-03-11 2006-01-05 Dirk De Ridder Electrical stimulation system and method for stimulating tissue in the brain to treat a neurological condition
US7542803B2 (en) 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US7330760B2 (en) 2004-03-16 2008-02-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US7491181B2 (en) 2004-03-16 2009-02-17 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US7366572B2 (en) 2004-03-16 2008-04-29 Medtronic, Inc. Controlling therapy based on sleep quality
US7395113B2 (en) 2004-03-16 2008-07-01 Medtronic, Inc. Collecting activity information to evaluate therapy
US7717848B2 (en) 2004-03-16 2010-05-18 Medtronic, Inc. Collecting sleep quality information via a medical device
WO2005089470A2 (en) 2004-03-17 2005-09-29 The Regents Of The University Of Michigan Systems and methods for inducing intelligible hearing
US7174219B2 (en) 2004-03-30 2007-02-06 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8989840B2 (en) 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
EP1735048A4 (en) 2004-04-06 2008-03-26 John K Chapin Teleoperation of a freely roaming animal through brain stimulation
WO2005102449A1 (en) 2004-04-14 2005-11-03 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
GB0409109D0 (en) 2004-04-23 2004-05-26 Medtronic Inc Deep brain stimulation
US7463917B2 (en) 2004-04-28 2008-12-09 Medtronic, Inc. Electrodes for sustained delivery of energy
US7596399B2 (en) 2004-04-29 2009-09-29 Medtronic, Inc Implantation of implantable medical device
US7315759B2 (en) 2004-05-07 2008-01-01 Medtronic, Inc. Implantable medical device with circulation delay measurement and therapy control
WO2005117554A2 (en) 2004-06-01 2005-12-15 California Institute Of Technology Microfabricated neural probes and methods of making same
US7664551B2 (en) 2004-07-07 2010-02-16 Medtronic Transneuronix, Inc. Treatment of the autonomic nervous system
US7483747B2 (en) 2004-07-15 2009-01-27 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7614743B2 (en) 2004-07-20 2009-11-10 Medtronic, Inc. Vital signs monitoring system with wireless pupilometer interface
US7486993B2 (en) 2004-08-05 2009-02-03 Neurotone Systems, Inc. Brain stimulation method and device
US20060049957A1 (en) 2004-08-13 2006-03-09 Surgenor Timothy R Biological interface systems with controlled device selector and related methods
US20060041295A1 (en) 2004-08-17 2006-02-23 Osypka Thomas P Positive fixation percutaneous epidural neurostimulation lead
US20050154425A1 (en) 2004-08-19 2005-07-14 Boveja Birinder R. Method and system to provide therapy for neuropsychiatric disorders and cognitive impairments using gradient magnetic pulses to the brain and pulsed electrical stimulation to vagus nerve(s)
EP1799101A4 (en) 2004-09-02 2008-11-19 Proteus Biomedical Inc Methods and apparatus for tissue activation and monitoring
US7877149B2 (en) 2004-09-02 2011-01-25 Proteus Biomedical Inc. Electrical angle gauge
WO2006029257A2 (en) 2004-09-08 2006-03-16 Spinal Modulation Inc. Neurostimulation methods and systems
WO2006034305A2 (en) 2004-09-21 2006-03-30 University Of Florida Research Foundation, Inc. Multiple lead method for deep brain stimulation
US20070265683A1 (en) 2004-09-24 2007-11-15 Dov Ehrlich Method and Apparatus for Treatment of Tinnitus and Other Neurological Disorders by Brain Stimulation in the Inferior Colliculi and/or In Adjacent Areas
US7925329B2 (en) 2004-10-08 2011-04-12 Proteus Biomedical, Inc. Implantable doppler tomography system
US7578819B2 (en) 2005-05-16 2009-08-25 Baxano, Inc. Spinal access and neural localization
US7613520B2 (en) 2004-10-21 2009-11-03 Advanced Neuromodulation Systems, Inc. Spinal cord stimulation to treat auditory dysfunction
US7519432B2 (en) 2004-10-21 2009-04-14 Medtronic, Inc. Implantable medical lead with helical reinforcement
US7729780B2 (en) 2004-10-21 2010-06-01 Vardiman Arnold B Various apparatus and methods for deep brain stimulating electrodes
US7322832B2 (en) 2004-10-26 2008-01-29 Medtronic, Inc. Radio frequency antenna flexible circuit interconnect with unique micro connectors
US7337010B2 (en) 2004-10-29 2008-02-26 Medtronic, Inc. Medical device having lithium-ion battery
US7563541B2 (en) 2004-10-29 2009-07-21 Medtronic, Inc. Lithium-ion battery
US7641992B2 (en) 2004-10-29 2010-01-05 Medtronic, Inc. Medical device having lithium-ion battery
US7662509B2 (en) 2004-10-29 2010-02-16 Medtronic, Inc. Lithium-ion battery
US7582387B2 (en) 2004-10-29 2009-09-01 Medtronic, Inc. Lithium-ion battery
US7526340B2 (en) 2004-10-29 2009-04-28 Medtronic, Inc. Division approximation for implantable medical devices
EP1805833B1 (en) 2004-10-29 2011-02-23 Medtronic, Inc. Method of charging lithium-ion battery
US7682745B2 (en) 2004-10-29 2010-03-23 Medtronic, Inc. Medical device having lithium-ion battery
US7288066B2 (en) 2004-11-01 2007-10-30 Medtronic, Inc. Data compression method for implantable medical devices
US8121687B2 (en) 2004-11-01 2012-02-21 Proteus Biomedical, Inc. Cardiac motion characterization by strain measurement
US7497863B2 (en) 2004-12-04 2009-03-03 Medtronic, Inc. Instrument guiding stage apparatus and method for using same
US7937160B2 (en) 2004-12-10 2011-05-03 Boston Scientific Neuromodulation Corporation Methods for delivering cortical electrode leads into patient's head
US7819812B2 (en) 2004-12-15 2010-10-26 Neuropace, Inc. Modulation and analysis of cerebral perfusion in epilepsy and other neurological disorders
US8041419B2 (en) 2004-12-17 2011-10-18 Medtronic, Inc. System and method for monitoring or treating nervous system disorders
US8000795B2 (en) 2004-12-17 2011-08-16 Lozano Andres M Cognitive function within a human brain
US9327069B2 (en) 2004-12-21 2016-05-03 Boston Scientific Neuromodulation Corporation Methods and systems for treating a medical condition by promoting neural remodeling within the brain
US20080077186A1 (en) 2006-04-18 2008-03-27 Proteus Biomedical, Inc. High phrenic, low capture threshold pacing devices and methods
WO2006069323A1 (en) 2004-12-22 2006-06-29 Proteus Biomedical, Inc. Implantable hermetically sealed structures
JP5112879B2 (en) 2004-12-22 2013-01-09 プロテウス デジタル ヘルス, インコーポレイテッド Segmented electrodes that are implantable and addressable
US7809446B2 (en) 2005-01-05 2010-10-05 Boston Scientific Neuromodulation Corporation Devices and methods for brain stimulation
US7783359B2 (en) 2005-01-05 2010-08-24 Boston Scientific Neuromodulation Corporation Devices and methods using an implantable pulse generator for brain stimulation
US7400927B1 (en) 2005-01-06 2008-07-15 Chester Litvin Method and system for psychological treatment by brain stimulation of the psychologically disordered object
US8788044B2 (en) 2005-01-21 2014-07-22 Michael Sasha John Systems and methods for tissue stimulation in medical treatment
US8600521B2 (en) 2005-01-27 2013-12-03 Cyberonics, Inc. Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity
DE602006010515D1 (en) 2005-01-31 2009-12-31 Medtronic Inc METHOD FOR PRODUCING A MEDICAL LINE
US7657316B2 (en) 2005-02-25 2010-02-02 Boston Scientific Neuromodulation Corporation Methods and systems for stimulating a motor cortex of the brain to treat a medical condition
WO2006094072A2 (en) 2005-03-01 2006-09-08 Functional Neuroscience Inc. Method of treating cognitive disorders using neuromodulation
US8244347B2 (en) 2005-03-04 2012-08-14 Andres M. Lozano Methods and apparatus for effectuating a lasting change in a neural function of a patient, including via mechanical force on neural tissue
US7591970B2 (en) 2005-03-07 2009-09-22 Medtronic, Inc. Medical device anchor and method of manufacture thereof
US7555345B2 (en) 2005-03-11 2009-06-30 Medtronic, Inc. Implantable neurostimulator device
US7231256B2 (en) 2005-03-11 2007-06-12 Medtronic, Inc. Neurostimulation site screening
EP1863561A4 (en) 2005-03-15 2011-04-20 Univ California Method and system for modulating energy expenditure and neurotrophic factors
US7729768B2 (en) 2005-03-25 2010-06-01 Proteus Biomedical, Inc. Implantable cardiac motion powered piezoelectric energy source
US7421297B2 (en) 2005-03-31 2008-09-02 Medtronic, Inc. Monopolar stimulation assembly including at least one remote electrode
US20090292346A1 (en) 2005-03-31 2009-11-26 St. Jude Medical Ab Porous Niobium Oxide as Electrode Material and Manufacturing Process
US7594889B2 (en) 2005-03-31 2009-09-29 Medtronic, Inc. Integrated data collection and analysis for clinical study
JP5027797B2 (en) 2005-03-31 2012-09-19 プロテウス バイオメディカル インコーポレイテッド Automatic optimization of multi-electrode pacing for cardiac resynchronization
US7321798B2 (en) 2005-03-31 2008-01-22 Medtronic, Inc. Trans-septal/trans-myocardial ventricular pacing lead
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US8078275B2 (en) 2005-04-15 2011-12-13 Functional Neuromodulation Inc. Regulation of neurotrophins
US7406351B2 (en) 2005-04-28 2008-07-29 Medtronic, Inc. Activity sensing for stimulator control
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US7623923B2 (en) 2005-04-28 2009-11-24 Medtronic, Inc. Tube sensor for penile tumescence
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US20120004520A1 (en) 2005-04-28 2012-01-05 Proteus Biomedical, Inc. Communication System with Multiple Sources of Power
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
WO2006119103A2 (en) 2005-04-29 2006-11-09 Medtronic, Inc. Event-based lead impedance monitoring
US7515961B2 (en) 2005-04-29 2009-04-07 Medtronic, Inc. Method and apparatus for dynamically monitoring, detecting and diagnosing lead conditions
US7389147B2 (en) 2005-04-29 2008-06-17 Medtronic, Inc. Therapy delivery mode selection
EP1883450B1 (en) 2005-04-29 2009-12-09 Medtronic, Inc. Distributed lead functionality testing
DE102005019968A1 (en) 2005-04-29 2006-11-02 Valerij Ortmann Biostable neuroelectrode for deriving electrical signals/electrically stimulating neuronal tissue, comprises flexible and/or rigid substrate from electric conductive/non-conductive material, and electrodes arranged in the substrate surface
WO2006119046A1 (en) 2005-04-30 2006-11-09 Medtronic, Inc. Impedance-based stimulation adjustment
WO2006130794A2 (en) 2005-06-01 2006-12-07 University Of Florida Research Foundation, Inc. Neuralprobe and methods for manufacturing same
US8831739B2 (en) 2005-06-02 2014-09-09 Huntington Medical Research Institutes Microelectrode array for chronic deep-brain microstimulation for recording
US9014796B2 (en) 2005-06-14 2015-04-21 Regents Of The University Of Michigan Flexible polymer microelectrode with fluid delivery capability and methods for making same
CN101578119A (en) 2005-06-16 2009-11-11 迈克尔·J·拉塞尔 Guided electrical transcranial stimulation technique
WO2007002144A2 (en) 2005-06-23 2007-01-04 University Of Florida Research Foundation, Inc. Brain stimulation method for weight control
US20060293721A1 (en) 2005-06-28 2006-12-28 Cyberonics, Inc. Vagus nerve stimulation for treatment of depression with therapeutically beneficial parameter settings
EP1906872A2 (en) 2005-07-12 2008-04-09 Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California Probe for identifying injection site for deep brain neural prostheses
US7532935B2 (en) 2005-07-29 2009-05-12 Cyberonics, Inc. Selective neurostimulation for treating mood disorders
US7680540B2 (en) 2005-07-29 2010-03-16 Medtronic, Inc. Multi-application trial stimulator
US7769472B2 (en) 2005-07-29 2010-08-03 Medtronic, Inc. Electrical stimulation lead with conformable array of electrodes
US7499752B2 (en) 2005-07-29 2009-03-03 Cyberonics, Inc. Selective nerve stimulation for the treatment of eating disorders
US7983751B2 (en) 2005-08-12 2011-07-19 Proteus Biomedical, Inc. Measuring conduction velocity using one or more satellite devices
US8005526B2 (en) 2005-08-31 2011-08-23 The Regents Of The University Of Michigan Biologically integrated electrode devices
EP1759725A1 (en) 2005-08-31 2007-03-07 Université Libre De Bruxelles Electro-biochemical probe for intramuscular and intracerebral analysis
US7640059B2 (en) 2005-09-08 2009-12-29 Medtronic, Inc. External presentation of electrical stimulation parameters
US7551960B2 (en) 2005-09-08 2009-06-23 Medtronic, Inc. External presentation of electrical stimulation parameters
US8374696B2 (en) 2005-09-14 2013-02-12 University Of Florida Research Foundation, Inc. Closed-loop micro-control system for predicting and preventing epileptic seizures
CA2562205A1 (en) 2005-09-28 2007-03-28 Medtrode Inc. Implantable transcranial pulse generator having a collapsible portion
CN101583309B (en) 2005-10-07 2012-07-04 神经连结科技公司 Modular multichannel microelectrode array and methods of making same
US7725192B2 (en) 2005-10-12 2010-05-25 The General Hospital Corporation Methods of increasing learning rate
US20070088403A1 (en) 2005-10-19 2007-04-19 Allen Wyler Methods and systems for establishing parameters for neural stimulation
US20070088404A1 (en) 2005-10-19 2007-04-19 Allen Wyler Methods and systems for improving neural functioning, including cognitive functioning and neglect disorders
US7729773B2 (en) 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US7555344B2 (en) 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US7590451B2 (en) 2005-10-31 2009-09-15 Medtronic, Inc. Axial lead connector for implantable medical devices
US7684867B2 (en) 2005-11-01 2010-03-23 Boston Scientific Neuromodulation Corporation Treatment of aphasia by electrical stimulation and/or drug infusion
US20070106143A1 (en) 2005-11-08 2007-05-10 Flaherty J C Electrode arrays and related methods
WO2007120290A2 (en) 2005-11-22 2007-10-25 Proteus Biomedical, Inc. External continuous field tomography
WO2007075477A2 (en) 2005-12-19 2007-07-05 University Of Florida Closed-loop state-dependent seizure prevention systems
US20070142872A1 (en) 2005-12-21 2007-06-21 Mickle Marlin H Deep brain stimulation apparatus, and associated methods
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US7603161B2 (en) 2005-12-30 2009-10-13 Medtronic, Inc. Position detection in a magnetic field
US7957808B2 (en) 2006-01-13 2011-06-07 Vanderbilt University System and methods of deep brain stimulation for post-operation patients
US20070173908A1 (en) 2006-01-20 2007-07-26 Cyberonics, Inc. Transcutaneous trigeminal nerve stimulation to treat motion sickness
US7606622B2 (en) 2006-01-24 2009-10-20 Cardiac Pacemakers, Inc. Method and device for detecting and treating depression
US20070173890A1 (en) 2006-01-24 2007-07-26 Cyberonics, Inc. Stimulation mode adjustment for an implantable medical device
US20070179558A1 (en) 2006-01-30 2007-08-02 Gliner Bradford E Systems and methods for varying electromagnetic and adjunctive neural therapies
AU2007212587B2 (en) 2006-02-03 2012-07-12 Synecor, Llc Intravascular device for neuromodulation
US20070197892A1 (en) 2006-02-23 2007-08-23 Medtrode Inc. Non-planar multi-channel electrode array
US7822483B2 (en) 2006-02-24 2010-10-26 Medtronic, Inc. Electrical and activation field models for configuring stimulation therapy
US7657319B2 (en) 2006-02-24 2010-02-02 Medtronic, Inc. Programming interface with an unwrapped 2D view of a stimulation lead with complex electrode array geometry
US7676273B2 (en) 2006-02-24 2010-03-09 Medtronic, Inc. Stimulation templates for programming a stimulation lead with complex electrode array geometry
US8209018B2 (en) 2006-03-10 2012-06-26 Medtronic, Inc. Probabilistic neurological disorder treatment
US20070213784A1 (en) 2006-03-13 2007-09-13 Neuropace, Inc. Seizure therapy and suppression using an implantable device
US7689289B2 (en) 2006-03-22 2010-03-30 Medtronic, Inc. Technique for adjusting the locus of excitation of electrically excitable tissue with paired pulses
UA92792C2 (en) 2006-03-23 2010-12-10 Валерий Павлович Лебедев Transcranial electrostimulation device
US8190251B2 (en) 2006-03-24 2012-05-29 Medtronic, Inc. Method and apparatus for the treatment of movement disorders
US8131368B2 (en) 2006-03-24 2012-03-06 Medtronic, Inc. Implantable medical device with material for reducing MRI image distortion
US7526339B2 (en) 2006-03-27 2009-04-28 Medtronic, Inc. IPG connector headers for implantable medical devices
US8615309B2 (en) 2006-03-29 2013-12-24 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US7949401B2 (en) 2006-04-11 2011-05-24 Advanced Neuromodulation Systems, Inc. Electromagnetic signal delivery for tissue affected by neuronal dysfunction, degradation, damage, and/or necrosis, and associated systems and methods
US8165683B2 (en) 2006-04-21 2012-04-24 Medtronic, Inc. Method and apparatus for detection of nervous system disorders
US20080269835A1 (en) 2006-04-21 2008-10-30 Medtronic, Inc. Method and apparatus for detection of nervous system disorders
US7761145B2 (en) 2006-04-21 2010-07-20 Medtronic, Inc. Method and apparatus for detection of nervous system disorders
US20070249953A1 (en) 2006-04-21 2007-10-25 Medtronic, Inc. Method and apparatus for detection of nervous system disorders
AU2007241646A1 (en) 2006-04-24 2007-11-01 Volastic Co. Limited Injection moulding nozzle and tip therefor
US7660630B2 (en) 2006-04-27 2010-02-09 Medtronic, Inc. Variable implantable medical device power characteristics based upon implant depth
US7610083B2 (en) 2006-04-27 2009-10-27 Medtronic, Inc. Method and system for loop recording with overlapping events
US7359837B2 (en) 2006-04-27 2008-04-15 Medtronic, Inc. Peak data retention of signal data in an implantable medical device
US7962220B2 (en) 2006-04-28 2011-06-14 Cyberonics, Inc. Compensation reduction in tissue stimulation therapy
US9084901B2 (en) 2006-04-28 2015-07-21 Medtronic, Inc. Cranial implant
US8326431B2 (en) 2006-04-28 2012-12-04 Medtronic, Inc. Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US7715920B2 (en) 2006-04-28 2010-05-11 Medtronic, Inc. Tree-based electrical stimulator programming
US8086316B2 (en) 2006-05-24 2011-12-27 Drexel University Wireless controlled neuromodulation system
WO2008005478A2 (en) 2006-07-05 2008-01-10 Brainvital Corporation Treatment of neurological disorders via electrical stimulation, and methods related thereto
WO2008003318A1 (en) 2006-07-05 2008-01-10 Aarhus Universitet A research model system and a method for using electrical stimulation and/ chemical stimulation to induce depressive illness in research animals
DE102006036069B4 (en) 2006-07-18 2008-09-04 Cerbomed Gmbh Audiological transmission system
US8073545B2 (en) 2006-07-21 2011-12-06 Neuropace, Inc. Treatment and warning of recurring therapy and other events using an implantable device
US7996088B2 (en) 2006-07-26 2011-08-09 Cyberonics, Inc. Vagus nerve stimulation by electrical signals for controlling cerebellar tremor
US8682445B2 (en) 2006-07-28 2014-03-25 Cyberonics, Inc. Patient management system for treating depression using an implantable medical device
US8321025B2 (en) 2006-07-31 2012-11-27 Cranial Medical Systems, Inc. Lead and methods for brain monitoring and modulation
US20080027540A1 (en) 2006-07-31 2008-01-31 Cumming J Stuart Stabilized accommodating intraocular lens
WO2008017055A2 (en) 2006-08-02 2008-02-07 Northstar Neuroscience, Inc. Methods for treating neurological disorders, including neuropsychiatric and neuropsychological disorders, and associated systems
ES2699474T3 (en) 2006-08-07 2019-02-11 Alpha Omega Neuro Tech Ltd Brain electrodes
US8909342B2 (en) 2006-08-15 2014-12-09 Andres M. Lozano Method for treating eating disorders
US8172762B2 (en) 2006-09-01 2012-05-08 Proteus Biomedical, Inc. Simultaneous blood flow and hematocrit sensor
US9162051B2 (en) 2006-09-21 2015-10-20 Neuropace, Inc. Treatment of language, behavior and social disorders
EP2066396B1 (en) 2006-09-22 2013-03-27 Sapiens Steering Brain Stimulation B.V. Implantable multi-electrode device
WO2008035344A2 (en) 2006-09-22 2008-03-27 Bar-Ilan University A device and method for deep brain stimulation as a new form of treating chronic depression
WO2008038208A2 (en) 2006-09-26 2008-04-03 Koninklijke Philips Electronics, N.V. Tissue stimulation method and apparatus
US20110040204A1 (en) 2006-10-19 2011-02-17 The Regents Of The University Of California Neurological stimulation and analysis
US20080103578A1 (en) 2006-10-31 2008-05-01 Medtronic, Inc. Implantable medical elongated member with in situ formed fixation element
US8280514B2 (en) 2006-10-31 2012-10-02 Advanced Neuromodulation Systems, Inc. Identifying areas of the brain by examining the neuronal signals
US7684873B2 (en) 2006-10-31 2010-03-23 Medtronic, Inc. Implantable medical lead including a directional electrode and fixation elements along an interior surface
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US7853303B2 (en) 2006-11-16 2010-12-14 National Research Council Of Canada Neurological probe and method of using same
WO2008064269A2 (en) 2006-11-20 2008-05-29 Second Sight Medical Products, Inc. Method of improving electrode tissue interface
US9314618B2 (en) 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
US20100114272A1 (en) 2006-12-07 2010-05-06 Sebastian Haidarliu Multiple micro-wire electrode device and methods
US20080139870A1 (en) 2006-12-12 2008-06-12 Northstar Neuroscience, Inc. Systems and methods for treating patient hypertonicity
EP2091606B1 (en) 2006-12-13 2016-05-25 Medtronic Bakken Research Center B.V. First time right placement of a dbs lead
WO2008076925A2 (en) 2006-12-15 2008-06-26 Proteus Biomedical, Inc. Universal connector for implantable medical device
FR2909883B1 (en) 2006-12-18 2012-11-30 Commissariat Energie Atomique MULTI-ARM SENSOR AND SYSTEM FOR DEEP ELECTRICAL NEUROSTIMULATION COMPRISING SUCH A PROBE
US20080154331A1 (en) 2006-12-21 2008-06-26 Varghese John Device for multicentric brain modulation, repair and interface
EP2097134B1 (en) 2006-12-21 2014-02-12 Sapiens Steering Brain Stimulation B.V. Biomimetic neurostimulation device
US8700167B2 (en) 2006-12-22 2014-04-15 Ebs Technologies Gmbh Apparatus and method for stimulating a brain of a person
US20080172103A1 (en) 2007-01-17 2008-07-17 Vanderbilt University Methods and system for brain stimulation
US7711428B2 (en) 2007-01-18 2010-05-04 Medtronic, Inc. Hermetic lead connector assembly
US8095210B2 (en) 2007-01-19 2012-01-10 California Institute Of Technology Prosthetic devices and methods and systems related thereto
DE102007003799A1 (en) 2007-01-25 2008-07-31 Anm Adaptive Neuromodulation Gmbh Implant for stimulation of nerve cells
US7391257B1 (en) 2007-01-31 2008-06-24 Medtronic, Inc. Chopper-stabilized instrumentation amplifier for impedance measurement
US7385443B1 (en) 2007-01-31 2008-06-10 Medtronic, Inc. Chopper-stabilized instrumentation amplifier
US20080188905A1 (en) 2007-02-02 2008-08-07 Somatics Llc Stimulus dose system and method for electroconvulsive therapy
US8755896B2 (en) 2007-02-05 2014-06-17 University Of Southern California Treatment of consumption disorders with biostimulation
US7844345B2 (en) 2007-02-08 2010-11-30 Neuropace, Inc. Drug eluting lead systems
US7894890B2 (en) 2007-02-09 2011-02-22 Neuropace, Inc. Devices and methods for monitoring physiological information relating to sleep with an implantable device
EP2111661B1 (en) 2007-02-14 2017-04-12 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US7502217B2 (en) 2007-02-16 2009-03-10 Medtronic, Inc. Filtering capacitor feedthrough assembly
US7594828B2 (en) 2007-02-26 2009-09-29 Medtronic, Inc. Implantable neurostimulator adapters
US7563141B2 (en) 2007-02-26 2009-07-21 Medtronic, Inc. Implantable neurostimulator adapters
US8731673B2 (en) 2007-02-26 2014-05-20 Sapiens Steering Brain Stimulation B.V. Neural interface system
US7949403B2 (en) 2007-02-27 2011-05-24 Accelerated Care Plus Corp. Electrical stimulation device and method for the treatment of neurological disorders
WO2008107815A1 (en) 2007-03-02 2008-09-12 Koninklijke Philips Electronics N.V. Electrode system for deep brain stimulation
WO2008107822A1 (en) 2007-03-02 2008-09-12 Koninklijke Philips Electronics N.V. Electrode system for deep brain stimulation
US7711436B2 (en) 2007-03-09 2010-05-04 Medtronic, Inc. Medical device electrical lead design for preventing transmittance of unsafe currents to a patient
US7429938B1 (en) 2007-03-26 2008-09-30 Medtronic, Inc. Method of compressing waveform data with differential entropy based compression
US20080242976A1 (en) 2007-03-30 2008-10-02 Proteus Biomedical, Inc. Electric field tomography
US7682355B2 (en) 2007-04-19 2010-03-23 Medtronic, Inc. Refined infection monitoring
US7611483B2 (en) 2007-04-19 2009-11-03 Medtronic, Inc. Indicator metrics for infection monitoring
US7604629B2 (en) 2007-04-19 2009-10-20 Medtronic Inc. Multi-parameter infection monitoring
EP2144665B1 (en) 2007-04-26 2014-12-17 Medtronic, Inc. Implantable medical lead with multiple electrode configurations
US7668601B2 (en) 2007-04-26 2010-02-23 Medtronic, Inc. Implantable medical lead with multiple electrode configurations
EP1985579B1 (en) 2007-04-27 2018-01-10 IMEC vzw Connecting scheme for the orthogonal assembly of microstructures
WO2008133683A1 (en) 2007-04-27 2008-11-06 Medtronic, Inc. Implantable medical device for treating neurological conditions with an initially disabled cardiac therepy port and leadless ecg sensing
US8000788B2 (en) 2007-04-27 2011-08-16 Medtronic, Inc. Implantable medical device for treating neurological conditions including ECG sensing
DE102007022960A1 (en) 2007-05-16 2008-11-20 Forschungszentrum Jülich GmbH stimulation device
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
EP2155322A2 (en) 2007-06-04 2010-02-24 Koninklijke Philips Electronics N.V. Insertion system and lead for treatment of a target tissue region
CN101687097B (en) 2007-07-10 2014-02-26 沙皮恩斯脑部刺激控制有限公司 Neurostimulation system
US20100292602A1 (en) 2007-07-11 2010-11-18 Mayo Foundation For Medical Education And Research Seizure forecasting, microseizure precursor events, and related therapeutic methods and devices
US20090027504A1 (en) 2007-07-25 2009-01-29 Suk Hwan Lim System and method for calibrating a camera
US8187161B2 (en) 2007-08-31 2012-05-29 Proteus Biomedical, Inc. Self-referencing communication in implantable devices
EP4011289A1 (en) 2007-09-25 2022-06-15 Otsuka Pharmaceutical Co., Ltd. In-body device with virtual dipole signal amplification
US7479910B1 (en) 2007-09-26 2009-01-20 Medtronic, Inc. Capacitive digital-to-analog converter reset in an implantable medical device analog-to-digital converter
US7474247B1 (en) 2007-09-26 2009-01-06 Medtronic, Inc. Detecting overloading of an analog-to-digital converter of an implantable medical device
US7623053B2 (en) 2007-09-26 2009-11-24 Medtronic, Inc. Implantable medical device with low power delta-sigma analog-to-digital converter
US8565894B2 (en) 2007-10-17 2013-10-22 Neuronexus Technologies, Inc. Three-dimensional system of electrode leads
US8224417B2 (en) 2007-10-17 2012-07-17 Neuronexus Technologies, Inc. Guide tube for an implantable device system
WO2009052425A1 (en) 2007-10-17 2009-04-23 Neuronexus Technologies Implantable device including a resorbable carrier
US8355768B2 (en) 2007-12-17 2013-01-15 California Institute Of Technology Micromachined neural probes
US8055353B2 (en) 2008-02-12 2011-11-08 Proteus Biomedical, Inc. Medical carriers comprising a low-impedance conductor, and methods of making and using the same
WO2009131749A2 (en) 2008-02-28 2009-10-29 Proteus Biomedical, Inc. Integrated circuit implementation and fault control system, device, and method
JP2011513865A (en) 2008-03-05 2011-04-28 プロテウス バイオメディカル インコーポレイテッド Multi-mode communication ingestible event marker and system and method of using the same
US20090240314A1 (en) 2008-03-24 2009-09-24 Kong K C Implantable electrode lead system with a three dimensional arrangement and method of making the same
US20090292325A1 (en) 2008-05-02 2009-11-26 Cederna Paul S Hybrid bioelectrical interface device
EP2286348A2 (en) 2008-05-28 2011-02-23 Koninklijke Philips Electronics N.V. Method and system for determining a threshold for spike detection of electrophysiological signals
DE102008002331A1 (en) 2008-06-10 2009-12-17 Biotronik Crm Patent Ag Electrotherapy device for the treatment of tachycardiac arrhythmias in the heart
US8852206B2 (en) 2008-06-12 2014-10-07 The Regents Of The University Of Michigan Probe insertion device for implanting a probe into tissue
CN102124323B (en) 2008-06-20 2015-11-25 国武孝人 Electrode
US8218580B2 (en) 2008-07-15 2012-07-10 Intel Corporation Managing timing of a protocol stack
AU2009276603B2 (en) 2008-07-30 2015-11-12 Ecole Polytechinique Federale De Lausanne (Epfl) Apparatus and method for optimized stimulation of a neurological target
KR101214453B1 (en) 2008-08-13 2012-12-24 프로테우스 디지털 헬스, 인코포레이티드 Ingestible circuitry
CN102186534B (en) 2008-10-15 2015-12-16 沙皮恩斯脑部刺激控制有限公司 For the probe of implantable medical device
DE202009018906U1 (en) 2008-10-15 2014-05-12 Sapiens Steering Brain Stimulation B.V. Probe for an implantable electro-stimulation device
US8986338B2 (en) 2008-10-29 2015-03-24 Cook Biotech Incorporated Vascular plugs
WO2010052642A1 (en) 2008-11-05 2010-05-14 Koninklijke Philips Electronics N.V. Device for cranial implantation, and system and use thereof
WO2010055444A1 (en) 2008-11-12 2010-05-20 Koninklijke Philips Electronics N.V. Neurosurgical guiding tool
CN102215906B (en) 2008-11-13 2014-03-12 沙皮恩斯脑部刺激控制有限公司 Spiraled wires in deep-brain stimulator probe
EP2349466A4 (en) 2008-11-13 2013-03-20 Proteus Digital Health Inc Shielded stimulation and sensing system and method
US20110130809A1 (en) 2008-11-13 2011-06-02 Proteus Biomedical, Inc. Pacing and Stimulation Apparatus and Methods
KR101192690B1 (en) 2008-11-13 2012-10-19 프로테우스 디지털 헬스, 인코포레이티드 Ingestible therapy activator system, therapeutic device and method
EP2346567A4 (en) 2008-11-13 2012-04-25 Proteus Biomedical Inc Multiplexed multi-electrode neurostimulation devices
JP2012508639A (en) 2008-11-14 2012-04-12 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Implantable medical system
WO2010059527A2 (en) 2008-11-18 2010-05-27 Proteus Biomedical, Inc. Sensing system, device, and method for therapy modulation
US8386007B2 (en) 2008-11-21 2013-02-26 Wisconsin Alumni Research Foundation Thin-film micro electrode array and method
EP2358275A2 (en) 2008-12-02 2011-08-24 Proteus Biomedical, Inc. Optimial drive frequency selection in electrical tomography
SG172077A1 (en) 2008-12-11 2011-07-28 Proteus Biomedical Inc Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
TWI503101B (en) 2008-12-15 2015-10-11 Proteus Digital Health Inc Body-associated receiver and method
EP2393551A4 (en) 2009-02-09 2013-04-17 Proteus Digital Health Inc Multiplexed multi-electrode neurostimulation devices with integrated circuit having integrated electrodes
WO2010105250A2 (en) 2009-03-13 2010-09-16 Proteus Biomedical, Inc. Volume sensing
US8952152B2 (en) 2009-03-24 2015-02-10 Proteus S.A. Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof
CA2758519A1 (en) 2009-04-16 2010-10-21 Boston Scientific Neuromodulation Corporation Deep brain stimulation current steering with split electrodes
WO2010122503A1 (en) 2009-04-23 2010-10-28 Koninklijke Philips Electronics N.V. System comprising a box for implanting in a body part
MX2011011506A (en) 2009-04-28 2012-05-08 Proteus Biomedical Inc Highly reliable ingestible event markers and methods for using the same.
EP2424588A4 (en) 2009-04-29 2013-05-22 Proteus Digital Health Inc Methods and apparatus for leads for implantable devices
JP5903043B2 (en) 2009-07-24 2016-04-13 サピエンス ステアリング ブレイン スティムレーション ベー ヴィ Medical tools for electrical stimulation
US9119543B2 (en) 2009-07-30 2015-09-01 Medtronic Bakken Research Center B.V. System and method for deep brain stimulation
US20110034970A1 (en) 2009-08-04 2011-02-10 Boston Scientific Neuromodulation Corporation Neurostimulation lead and system and methods of making and using
US8261428B2 (en) 2009-11-25 2012-09-11 National Tsing Hua University Method for assembling a 3-dimensional microelectrode structure
US8874232B2 (en) 2009-11-30 2014-10-28 Boston Scientific Neuromodulation Corporation Electrode array having concentric split ring electrodes and methods of making the same
CN102711903A (en) 2009-12-23 2012-10-03 沙皮恩斯脑部刺激控制有限公司 High resolution electrical stimulation leads
US20120303088A1 (en) 2010-01-26 2012-11-29 Sapiens Steering Brain Stimulation B.V. System and A Method for Determination of an Orientation of a Biomedical Stimulation Device
US9242086B2 (en) 2010-01-27 2016-01-26 Medtronic Bakken Research Center B.V. System for medical stimulation comprising a probe
US8332020B2 (en) 2010-02-01 2012-12-11 Proteus Digital Health, Inc. Two-wrist data gathering system
CN102762253A (en) 2010-02-12 2012-10-31 沙皮恩斯脑部刺激控制有限公司 Method and system for determining settings for deep brain stimulation
CN102834141B (en) 2010-03-01 2015-11-25 沙皮恩斯脑部刺激控制有限公司 For determining the method and system of the setting of deep brain stimulation
US8615311B2 (en) 2010-03-15 2013-12-24 Rutgers, The State University Of New Jersey Microelectorode array, methods for preparing the same and uses thereof
US8099170B2 (en) 2010-03-19 2012-01-17 Medtronic, Inc. Electrical stimulation based on phase response mapping
AU2011234422B2 (en) 2010-04-01 2015-11-05 Ecole Polytechnique Federale De Lausanne (Epfl) Device for interacting with neurological tissue and methods of making and using the same
WO2011127252A2 (en) 2010-04-07 2011-10-13 Proteus Biomedical, Inc. Miniature ingestible device
EP2559162A2 (en) 2010-04-12 2013-02-20 Sapiens Steering Brain Stimulation B.V. Control circuitry and method for controlling a bi-directional switch system, a bi-directional switch, a switching matrix and a medical stimulator
WO2012015756A2 (en) 2010-07-29 2012-02-02 Proteus Biomedical, Inc. Hybrid housing for implantable medical device
WO2012056039A1 (en) 2010-10-29 2012-05-03 Sapiens Steering Brain Stimulation B.V. Multi-electrode neurostimulation device
CN103167893A (en) 2010-10-29 2013-06-19 沙皮恩斯脑部刺激控制有限公司 Planning system for neurostimulation therapy
WO2012061420A2 (en) 2010-11-04 2012-05-10 Proteus Biomedical, Inc. Networked application with a physiological detector
BR112013012337A2 (en) 2010-11-25 2019-09-24 Sapiens Steering Brain Stimulation Bv medical probe and method for providing a medical probe
US20120184837A1 (en) 2011-01-14 2012-07-19 Sapiens Steering Brain Stimulation B.V. Brain Mapping Probe
US10137303B2 (en) 2011-05-16 2018-11-27 Second Sight Medical Products, Inc. Cortical interface for motor signal recording and sensory signal stimulation
WO2013014206A1 (en) 2011-07-25 2013-01-31 Imec Method and device for stimulation/recording of cells
EP2620179A1 (en) 2012-01-24 2013-07-31 Sapiens Steering Brain Stimulation B.V. Device for planning a neuromodulation therapy
EP2623154A1 (en) 2012-02-06 2013-08-07 Sapiens Steering Brain Stimulation B.V. Neurostimulation System
EP2626110A1 (en) 2012-02-08 2013-08-14 Sapiens Steering Brain Stimulation B.V. A thin film for a lead for brain applications
US9956396B2 (en) 2012-02-08 2018-05-01 Medtronic Bakken Research Center B.V. Thin film for a lead for brain applications
EP2626111B1 (en) 2012-02-08 2016-08-17 Medtronic Bakken Research Center B.V. Medical system and method for planning a neuromodulation therapy
EP2626108A1 (en) 2012-02-08 2013-08-14 Sapiens Steering Brain Stimulation B.V. A lead for brain applications
EP2626109A1 (en) 2012-02-08 2013-08-14 Sapiens Steering Brain Stimulation B.V. A probe system for brain applications
EP2653187A1 (en) 2012-04-20 2013-10-23 Sapiens Steering Brain Stimulation B.V. A freestanding thin film, especially a freestanding thin film for a system for neural applications
EP2656875A1 (en) 2012-04-25 2013-10-30 Sapiens Steering Brain Stimulation B.V. Lead for a neurostimulation and/or neurorecording system
EP2656876A1 (en) 2012-04-25 2013-10-30 Sapiens Steering Brain Stimulation B.V. A thin film for a lead for neural applications
EP2674193A1 (en) 2012-06-11 2013-12-18 Sapiens Steering Brain Stimulation B.V. Synchronization of the operation of an implantable medical device with the application of RF and/or gradient fields in an MRI system
US9144510B2 (en) 2012-06-13 2015-09-29 Cook Medical Technologies Llc Systems and methods for deploying a portion of a stent using at least one coiled member
US9498617B2 (en) 2012-06-19 2016-11-22 Lawrence Livermore National Security, Llc Conformally encapsulated multi-electrode arrays with seamless insulation
US8897891B2 (en) 2012-08-03 2014-11-25 Boston Scientific Neuromodulation Corporation Leads with electrode carrier for segmented electrodes and methods of making and using
US9403011B2 (en) * 2014-08-27 2016-08-02 Aleva Neurotherapeutics Leadless neurostimulator
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130131754A1 (en) * 2005-09-10 2013-05-23 Armen P. Sarvazyan Leadless system for deep brain stimulation using time reversal acoustics
US20070293908A1 (en) * 2006-06-20 2007-12-20 Ebr Systems, Inc. Systems and methods for implantable leadless brain stimulation
US20090105784A1 (en) * 2007-10-18 2009-04-23 Integrated Sensing Systems, Inc. Miniature wireless system for deep brain stimulation
WO2010055421A1 (en) * 2008-11-12 2010-05-20 Aleva Neurotherapeutics, S.A. Microfabricated neurostimulation device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11738203B2 (en) 2014-10-01 2023-08-29 EPIC Neuro, Inc. System and method for transcranial current loop brain stimulation
US11589790B2 (en) 2016-05-20 2023-02-28 Imperial College Innovations Limited Implantable neural interface
EP3829698A4 (en) * 2018-07-30 2022-05-11 Epic Neuro, Inc. Transcranial current loop stimulation device
WO2023057977A1 (en) 2021-10-08 2023-04-13 Albert Ludwigs Universität Freiburg Treatment of psychiatric disorders with deep brain stimulation

Also Published As

Publication number Publication date
EP3912676A1 (en) 2021-11-24
US20160059016A1 (en) 2016-03-03
JP2017525545A (en) 2017-09-07
US9572985B2 (en) 2017-02-21
US9889304B2 (en) 2018-02-13
US20170143982A1 (en) 2017-05-25
CA2959281A1 (en) 2016-03-03
EP3185948B1 (en) 2021-08-11
EP3185948A1 (en) 2017-07-05
US20160303375A1 (en) 2016-10-20
US9403011B2 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
US9889304B2 (en) Leadless neurostimulator
US11730953B2 (en) Deep brain stimulation lead
US11123548B2 (en) Microfabricated neurostimulation device
JP5793190B2 (en) Method for manufacturing a brain stimulator
JP2010519949A (en) Electrode system for deep brain stimulation
US20160143555A1 (en) Lead and a system for medical applications

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15760290

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017530449

Country of ref document: JP

Kind code of ref document: A

Ref document number: 2959281

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2015760290

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015760290

Country of ref document: EP